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ABSTRACT 
 
A series of studies has been undertaken to facilitate the identification and development 
of chiral lanthanide complexes that are able to report on changes in their local 
environment through modulation of the circular polarization of their emission. Reports 
of such systems remain relatively rare in the literature, notwithstanding the prevalence 
and importance of chirality in biological systems.  
 
The work described herein is separated into five chapters, the first of which comprises a 
discussion of relevant background information, along with a comprehensive review of 
responsive lanthanide-based CPL probes reported to date. A classification of these 
probes is built up, which informs the content of the following three chapters. 
 
Chapter 2 describes work undertaken in the pursuit of a novel lanthanide-based system 
for use as a CPL probe for the detection of proteins. The synthesis of an enantiopure 
lanthanide complex was undertaken and characterisation of this system carried out with 
reference to a structurally related racemic complex. A series of comparative 
investigations designed to probe the relative protein binding capability of these 
complexes was subsequently performed, which revealed that the observation of induced 
CPL from racemic lanthanide systems may be brought about by a change in complex 
constitution. This is the first example of such an effect from a well-defined racemic 
lanthanide complex in solution. Chapter 3 goes on to detail studies undertaken to 
demonstrate the utility of this racemic lanthanide system as a probe for chiral detection.  
 
Chapter 4 describes investigations carried out in an attempt to identify new systems 
exhibiting chiral quenching effects in solution. Initially, two pairs of enantiomeric 
electron-rich quenching species were assessed for their ability to quench the emission 
from an enantiopure DOTA-derived lanthanide complex differentially. Subsequently, 
investigations were focussed on examining the quenching of emission from novel 
enantiopure lanthanide complexes based on a 1,4,7-triazacyclononane framework,  
using cobalt complexes as the quenching species. 
 
Finally, Chapter 5 contains experimental procedures for each compound synthesised, as 
well as general experimental procedures. 
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1.1 Overview 
 
The word luminescence was coined in 1888 by Eilhardt Wiedemann, a German 
physicist
1
 and can be defined as 'spontaneous emission of radiation from an 
electronically or vibrationally excited species not in thermal equilibrium with its 
environment'.
2
 As such, the word luminescence is a hypernym and refers to various 
categories of emitted radiation, defined by the mode of excitation. The contents of this 
thesis focus on the discussion and demonstration of luminescence phenomena in 
relation to lanthanide complexes, arising specifically as a result of the absorption of 
photons. This is termed photoluminescence.  
 
It should be noted at the outset that the applications of photoluminescence in science 
and technology are wide-ranging. For example, species which are able to absorb UV 
light and emit in the blue range of the visible spectrum are frequently employed as 
optical brighteners. Meanwhile, the use of photoluminescent inks in the printing of bank 
notes facilitates their authentication.
1
 However, in the context of this thesis it is 
especially important to note that photoluminescence phenomena may also be exploited 
as an analytical tool. For example, luminescence imaging employs photoluminescent 
systems as emissive probes in the investigation of biological systems. Although many of 
these emissive probes act simply as cellular stains, others have been developed which 
are able to report on specific conditions within a cell, by modulation of their 
luminescence output.
3, 4
 At present, the overwhelming majority of these responsive 
probes exploit changes in luminescence intensity or lifetime in order to report on their 
environment; the modulation of the circular polarization of the emitted light, otherwise 
known as circularly polarized luminescence (CPL), is rarely considered. The prevalence 
and importance of chirality in biological systems means that CPL probes could provide 
a rich source of information on their chiral environment that is yet to be fully exploited. 
 
This review begins with a short discussion of CPL spectroscopy. The potential offered 
by luminescent lanthanide complexes in the development of chiral probes exploiting 
CPL is highlighted and the general principles that underpin the design of these 
complexes are considered. Finally, a brief consideration of the stereochemistry in 
representative lanthanide systems is followed by a discussion of examples of lanthanide 
complexes from the literature that have been found to modulate their CPL output as a 
response to change in their environment. 
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1.2 Circularly polarized luminescence 
 
CPL spectroscopy is a technique, developed mainly in the 1970s, that is based on the 
measurement of the differential spontaneous emission of left and right circularly 
polarized light by luminescent systems.
5
 As such, it is often described as the emission 
equivalent of circular dichroism (CD) spectroscopy, a more widespread chiroptical 
technique concerned with the differential absorption of left and right circularly 
polarized light. The two techniques are complimentary tools, which can be used to 
investigate the stereochemical and electronic structural properties of the emissive and 
ground states of luminescent systems respectively.
 
 
1.2.1 CPL spectroscopy - instrumentation 
 
Due to the fact that CPL spectrometers have only recently become available 
commercially, the majority of CPL studies recorded in the literature to date have been 
performed using custom-built instruments, designed and developed by individual 
research groups.
6, 7
 As is to be expected, each of these individually constructed 
spectrometers share common features, the most pertinent of which is the inclusion of a 
circular analyzer, located between the luminescent sample and the detector unit. In order 
to understand the function of the circular analyzer in the acquisition of CPL spectral 
data, it is worthwhile to first briefly recall the classical description of circularly 
polarized light and how it relates to light that is linearly polarized.  
 
The classical description of light portrays it as a transverse wave with both an electric 
and a magnetic field component. These components oscillate in a fixed relationship to 
one another and are oriented perpendicular to each other and to the direction of 
propagation. When considering the polarization of light, it is conventional to describe 
only the electric field vector, which can itself be divided into two perpendicular 
components. It is important to note that, although these components oscillate with 
identical frequency, their phase and amplitude may differ. In the case of circularly 
polarized light, the components are of the same amplitude, but there is a phase 
difference that is exactly one quarter of the wavelength. Hence, when one component is 
zero, the other is at its maximum or minimum amplitude. Meanwhile, for linearly 
polarized light, the components may differ in amplitude but must be in phase.  
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Figure 1.1: Representations of left and right circularly polarized light, shown alongside a representation 
of linearly polarized light. In each case, the separate components of the electric field vector are shown in 
blue and green. The overall evolution of the electric field vector is shown in red. 
 
In a modern CPL spectrometer, the circular analyzer typically comprises two units, 
namely a photoelastic modulator (PEM) and a linear polarizer.
7
 The modulator is 
driven, normally at a frequency of 50 kHz, such that it may act as an oscillating quarter-
wave plate. On alternate cycles of the oscillation, it acts as a quarter-wave advancing 
and a quarter-wave retarding element, shifting the phase between the electric field 
vector components of the light. Hence, in accordance with the discussion above, the 
PEM serves to convert the left and right circularly polarized light emitted by the sample 
to linearly polarized light. This light is selected by the linear polarizer and may then be 
wavelength resolved by an emission monochromator and detected. The circular 
polarization of the luminescence is determined by analysis of differences in the 
measured intensity of the linear polarization in phase with the modulation. Although 
many of the first custom-built CPL spectrometers made use of a lock-in amplifier for 
detection, more recent instruments typically employ photon-counting detection. A 
schematic diagram depicting the full instrumental setup for a representative CPL 
spectrometer is shown in Figure 1.2.  
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Figure 1.2: Block diagram of a custom-built CPL spectrometer. In the case of this instrument the 
excitation source may be an argon-ion laser, with or without a tunable dye laser, or a xenon arc lamp. The 
excitation monochromator is removed for laser excitation. Following conversion to linearly polarized 
light and wavelength resolution, the emission is detected by a photomultiplier tube (PMT), operating in 
photon-counting mode. Adapted from comprehensive chiroptical spectroscopy.
7
  
 
It should be noted that variations on the basic instrumental set up described overleaf 
allow for a variety of less conventional and often highly informative CPL studies to be 
performed, many of which facilitate the observation of CPL from systems that do not 
have natural optical activity. For example, if a static magnetic field is applied along the 
direction of emission detection, then CPL may be observed from achiral luminescent 
species.
8
 Such magnetically induced CPL has typically been used to elicit electronic 
structural information, rather than to acquire stereochemical information, and will not 
be discussed further in this review. A second adaptation, which has served to provide 
valuable information from systems not demonstrating natural CPL in the context of this 
review, is the use of circularly polarized excitation light.
9
 This facilitates the study of 
CPL from racemic mixtures by achieving preferential excitation of one enantiomer. 
Provided that the rate of racemisation in the excited state is slower than the rate of 
emission, the emitted light will show partial circular polarization in steady-state 
measurements. This technique has found particular use in the verification of so-called 
Continuous Wave 
Light Source 
Monochromator 
Sample 
 
 
PEM + 
Linear 
Polarizer 
Filter Monochromator 
 
PEM Control 
Unit 
Amplifier & 
Discriminator 
Differential photon 
counter 
PMT 
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'outer sphere' effects leading to the induction of CPL in racemic systems, which will be 
discussed in Section 1.5.2.  
 
An additional development that has proven particularly effective in the study of 
enantioselective quenching phenomena (Section 1.5.2.2) is the adaptation of 
instrumentation to facilitate the collection of time-resolved CPL spectral data.
10
 This is 
achieved through the use of a pulsed excitation light source. Combination of the 
aforementioned methodologies has facilitated the study of the kinetics of excited state 
racemisation processes.
11, 12
 
 
1.2.2 CPL spectroscopy - observables and parameters  
 
Results of CPL investigations are commonly reported in terms of the emission 
dissymmetry factor, gem(λ), which was devised by Emeis and Oosterhoff as part of their 
pioneering studies into the observation of CPL from chiral molecules in solution.
13
 The 
emission dissymmetry factor is defined using equation 1. 
 
                                                           λ   
    λ 
  λ 
                                                (eqn. 1) 
 
In this equation, ΔI(λ) is known as the emission circular intensity differential and is 
equal to the difference in intensities of the left and right circularly polarized components 
of the emitted radiation. Meanwhile, I(λ) is the total intensity of emitted radiation and as 
such it is equal to the sum of its left and right circularly polarized components. Both of 
these quantities are observed experimentally. From equation 1 it can be deduced that the 
theoretical maximum value of gem is ±2. 
 
                              (eqn. 2)                                            (eqn. 3) 
 
For a given transition between two states, a and b, it is also possible to express the 
emission dissymmetry factor in terms of associated quantities. The rotatory strength, 
Rab, of the transition is related to the sign and magnitude of the CPL associated with that 
transition, whilst the dipole strength, Dab, is influential in determining the intensity of 
the total luminescence. The following equation is defined to express gem in terms of 
these quantities.
14
  
 
                                                                
    
   
                                                (eqn. 4) 
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The rotatory and dipole strengths of the transition can in turn be expressed in terms of 
its magnetic and electric dipole moments, m and µ. This gives rise to another expression 
for gem, where τ is the angle between the magnetic and electric transition dipole 
moments. 
                    (eqn. 5)                                     
                (eqn. 6) 
 
                                                   
                                               (eqn. 7) 
 
Owing to the fact that magnetic dipole transition moments are typically much smaller 
than their electric dipole counterparts, the µ
2
 term tends to dominate this expression, 
meaning it can be simplified further to give equation 8. 
 
                                                            
    
   
                                                  (eqn. 8) 
 
Generally speaking, transitions which are electric dipole allowed and magnetic dipole 
forbidden will be associated with small values of gem, whilst magnetic dipole allowed 
and electric dipole forbidden transitions will have the highest values of gem.  
 
1.2.3 Systems exhibiting CPL 
 
As was previously mentioned, the first observations of CPL from chiral molecules in 
solution were made by Emeis and Oosterhoff in the late 1960s and early 1970s. In these 
experiments, the separated enantiomers of trans-β-hydrindanone and trans-β-
thiohydrindanone were investigated, with results demonstrating the potential utility of 
CPL as a structural probe of emissive states.
15
 Subsequent studies have demonstrated 
the observation of CPL for a variety of chiral molecules in solution, including organic 
systems, biomolecules and inorganic metal complexes.
16
 
 
Generally speaking, it is apparent from the literature that CPL phenomena are best 
exemplified by chiral lanthanide complexes. These complexes not only act as pure 
spherical emitters, eliminating issues associated with anisotropy, but also tend to exhibit 
the highest values of gem, typically two orders of magnitude greater than those observed 
for organic systems. In spite of this, it is worth highlighting one particular recent report 
of CPL in an organic system, before going on to discuss typical luminescence 
characteristics of lanthanide complexes and general principles underpinning their 
design.  
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Figure 1.3: (A) trans-β-hydrindanone and trans-β-thiohydrindanone (S,S) enantiomer shown, (B) π-
conjugated anion receptor. 
 
The π-conjugated molecule depicted in Figure 1.3 has been shown to possess anion 
binding capabilities, which were recently demonstrated for both chloride and acetate.
17
 
With respect to anion-responsive chiroptical properties in particular, it was found that 
the circular polarization of the emission associated with the π-π* transition of this 
molecule, occurring between roughly 500 and 600 nm, was increased significantly in 
the presence of both chloride and acetate. Whilst emission dissymmetry factors 
determined in the absence of either of these anions were negligible, values of around 4 x 
10
-3 
were recorded in their presence.
18
 The low values of gem observed may be ascribed 
to a lack of magnetic dipole character in the π-π* transition. It was suggested that the 
observed changes in the circularly polarized emission could be attributed to 
conformational changes of the π-conjugated system, induced by anion binding.  
 
Although results such as those outlined in the preceding paragraph are noteworthy when 
considering systems exhibiting CPL, the authors' claim that the system described above 
is 'the first example of chemical-stimuli-responsive CPL properties'
17
 is somewhat 
exaggerated. As will be demonstrated in Section 1.5 of this review, there exist several 
examples of lanthanide-based systems exhibiting such an effect.  
 
1.3 Luminescent lanthanide complexes 
 
When considering the design of chiral probes exploiting CPL as a signalling 
mechanism, there are a number of additional features of lanthanide luminescence which 
make the complexes of these ions particularly attractive. These features will be 
considered in the following sections of this review, which will also outline basic 
considerations in the design of emissive lanthanide complexes. It should be noted that, 
in the synthesis of lanthanide complexes for use as chiral probes exploiting CPL, 
particular concern should be given to maximising the emission quantum yield, Φ, i.e. 
(A)                          (B) 
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the ratio of the number of photons emitted by lanthanide luminescence to the number of 
photons absorbed. This is because the extent of circular polarization in the overall 
emission will always be small, so the observed signal must be maximised if such probes 
are to find use in biological systems. 
 
1.3.1 Lanthanide ion luminescence 
 
Excluding ytterbium and to some extent europium, the emission spectra of lanthanide 
complexes are characterised by sharp emission bands occurring at wavelengths virtually 
independent of the coordination environment. In addition, lanthanide luminescence is 
long-lived, with typical emission lifetimes falling in the micro- to millisecond range. 
This second feature facilitates the use of time-gated detection methods, which 
incorporate a delay between the excitation pulse and the measurement of lanthanide 
luminescence.
19
 The use of these methods increases detection sensitivity and lowers 
detection limits, by generating images that are devoid of shorter-lived background 
fluorescence, with an improved signal-to-noise ratio.  
 
 
Figure 1.4: Illustration of the principle of a time-gated detection method.
19
 
 
The intriguing luminescent properties offered by lanthanide ions may be extremely 
advantageous in the pursuit of chiral systems as responsive CPL probes. An explanation 
of these properties can be obtained by considering the electronic transitions to which the 
emission is attributed. Lanthanide ions show a distinct preference for the +3 oxidation 
state when in solution, with the energy expended in the removal of an f electron being 
offset by additional stabilisation associated with interactions of the triply charged ions.
20
 
It is apparent from consideration of the valence electronic configurations of the 
lanthanide ions in this oxidation state, shown in Table 1.1, that the observation of 
luminescence from lanthanide ion complexes results from the occurrence of 4f-4f 
intraconfigurational transitions. Hence, the appearance of the emission as sharp bands 
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may be attributed to the fact that the 4f shell is shielded by the filled 5s and 5p shells. 
This means that the energy levels of the 4f 
n
 electronic configurations are largely 
unaffected by the ligand field. Meanwhile, the fact that intraconfigurational transitions 
are formally Laporte forbidden explains their long emission lifetimes. It should be noted 
that an additional consequence of this fact is that the transitions have low oscillator 
strengths. This will be discussed further in Section 1.3.3. 
 
Table 1.1: Ground state valence electronic configurations of the lanthanide atoms and their ions. The 
Xenon core, [Xe], corresponds to 1s
2
2s
2
2p
6
3s
2
3p
6
3d
10
4s
2
4p
6
4d
10
5s
2
5p
6
.
20
 
 
Atomic 
number 
Name Symbol 
Valence 
configuration of 
element 
Valence 
configuration of 
Ln
III 
57 Lanthanum La [Xe]5d
1
6s
2
 [Xe] 
58 Cerium Ce [Xe]4f
1
5d
1
6s
2
 [Xe]4f
1
 
59 Praseodymium Pr [Xe]4f
3
6s
2
 [Xe]4f
2
 
60 Neodymium Nd [Xe]4f
4
6s
2
 [Xe]4f
3
 
61 Promethium Pm [Xe]4f
5
6s
2
 [Xe]4f
4
 
62 Samarium Sm [Xe]4f
6
6s
2
 [Xe]4f
5
 
63 Europium Eu [Xe]4f
7
6s
2
 [Xe]4f
6
 
64 Gadolinium Gd [Xe]4f
7
5d
1
6s
2
 [Xe]4f
7
 
65 Terbium Tb [Xe]4f
9
6s
2
 [Xe]4f
8
 
66 Dysprosium Dy [Xe]4f
10
6s
2
 [Xe]4f
9
 
67 Holmium Ho [Xe]4f
11
6s
2
 [Xe]4f
10
 
68 Erbium Er [Xe]4f
12
6s
2
 [Xe]4f
11
 
69 Thulium Tm [Xe]4f
13
6s
2
 [Xe]4f
12
 
70 Ytterbium Yb [Xe]4f
14
6s
2
 [Xe]4f
13
 
71 Lutetium Lu [Xe]4f
14
5d
1
6s
2
 [Xe]4f
14
 
 
Each lanthanide ion has a large number of electronic energy levels due to splitting of the 
4f 
n
 electronic configurations, primarily as a result of spin-orbit coupling.
21
 These 
electronic energy levels may be represented in the form of term symbols, 
2S+1
LJ,
 
derived 
using the Russell-Saunders coupling scheme.
 
Here, 2S+1 represents the multiplicity of 
the term, meanwhile L indicates the total orbital angular momentum quantum number 
and J the total angular momentum quantum number.
22
 A partial energy level diagram 
for the lanthanide aqua ions is shown in Figure 1.5. The characteristic bands observed in 
lanthanide emission spectra can be attributed to transitions from the emissive state to the 
various electronic energy levels within the ground state manifold. 
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Figure 1.5: Partial energy level diagram for the lanthanide aqua ions showing emissive levels in red.
23
 
 
With the exception of lanthanum and lutetium, which have no possible f-f transitions, 
all of the lanthanide ions are luminescent. For each of the emissive lanthanide ions, the 
efficiency of luminescence is indicated by its intrinsic quantum yield, ΦLn, which may 
be thought of as the quantum yield that would result from direct excitation of the 
lanthanide ion.
23
 This can be defined by comparing the rate constant of radiative decay 
of the lanthanide ion, kr, to the rate constants for all possible deactivation pathways, 
with knr denoting non-radiative processes.  
 
                                                           Φ    
  
       
                                               (eqn. 9) 
 
For lanthanide luminescence, the intrinsic quantum yield is highly dependent on the 
energy gap between the emissive state and the highest lying electronic energy level of 
the ground state manifold.
23
 A smaller gap will facilitate non-radiative deactivation 
processes, including coupling to solvent vibrational modes. It is  clear from Figure 1.5 
that the largest energy gaps are seen for Eu
III
, Gd
III
 and Tb
III
. The energy gaps for Eu
III
 
and Tb
III
 are 12,300 (
5
D0 → 
7
F6) and 14,800 (
5
D4 → 
7
F0) cm
-1
 respectively, 
corresponding to emission in the visible region of the spectrum.
23
 Meanwhile, the 
energy gap for Gd
III
 is much larger and corresponds to emission in the UV region of the 
spectrum. As was previously mentioned, when designing lanthanide complexes for use 
as chiral probes exploiting CPL, it is highly desirable to maximise the overall quantum 
yield of emission. Hence, the above analysis distinguishes Eu
III
 and Tb
III
 as the best ions 
to use in applications such as these.  
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1.3.2 Features of europium and terbium emission 
 
As is the case for all of the luminescent lanthanide ions, the emission spectra of 
europium and terbium complexes are composed of a series of sharp bands, 
corresponding to electronic transitions from the emissive state to the various possible 
energy levels of the ground manifold. In the case of europium, the commonly observed 
bands are due to the 
5
D0 → 
7
FJ (J = 0 - 4) transitions, with the emissive state lying at 
roughly 17,200 cm
-1
.
24
 Meanwhile for terbium the emissive state is 
5
D4 and lies at 
20,400 cm
-1
, the bands are due to the 
5
D4 → 
7
FJ (J = 6 - 3) transitions. It should be noted 
that the transitions are often referred to by the associated change in the total angular 
momentum quantum number, J. 
 
  
Figure 1.6: Representative emission spectra for europium (left) and terbium (right) complexes in aqueous 
solution. 
 
As is apparent from Figure 1.6, fine structure can arise within each emission band due 
to the weak influence of the ligand environment.
25
 This fine structure is particularly 
evident for complexes of europium, due to the fact that the emissive 
5
D0 state is non-
degenerate and cannot be split by the ligand field.
26
 This means that the number of 
possible transitions within a band is limited to 2J+1, where J is the total angular 
momentum of the electronic energy level to which the transition is occurring. Hence, 
analysis of the ΔJ = 0 band (5D0
 → 7F0 transition) of a europium emission spectrum can 
be used to diagnose the presence of more than one chemically distinct europium-
containing species in solution, provided they are not undergoing exchange on the 
emission timescale. The general characteristics of emission spectra for europium and 
terbium complexes in aqueous solution are summarised in Table 1.2.  
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Table 1.2: Transitions from the emissive states of europium and terbium.
27
  
 
Transition  Spectral 
region (nm) 
Relative 
intensity 
Comments 
Terbium     
5
D4 → 
7
F6
 
485-500 Medium-strong Moderate sensitivity to ligand environment 
 → 7F5 540-555 Strongest Best probe transition 
 → 7F4
 
580-595 Medium Moderate sensitivity to ligand environment 
 → 7F3 615-625 Medium-weak Some structure under high resolution 
Europium     
5
D0 → 
7
F0 578-580 Weak Non-degenerate, appears as a single sharp 
line 
 → 7F1 585-600 Strong Sharp and structured under high resolution; 
up to 3 transitions observed 
 → 7F2
 
610-630 Strong Exhibits hypersensitivity to ligand 
environment 
 → 7F3 645-660 Weak Strictly forbidden, always very weak 
 → 7F4 680-705 Weak Exhibits hypersensitivity to ligand 
environment 
 
As is highlighted in Table 1.2, an additional characteristic of europium luminescence is 
the apparent high sensitivity of certain emission bands to the local environment. For a 
given europium complex, variations in the coordination environment of the metal ion 
typically lead to changes in the form and relative intensity of the electric-dipole allowed 
ΔJ = 2 and ΔJ = 4 bands, which are described as being hypersensitive. This sensitivity 
has been exploited in the development of a number of europium-based probes for 
ratiometric analyses, where the ratio of emission intensity for one or more pairs of 
spectral bands is monitored in order to deduce information about the local environment. 
Ratiometric measurements are typically more reliable than those of total intensity, as 
they are independent of probe concentration, meaning results are unaffected by factors 
such as uneven distribution or susceptibility to photobleaching and quenching.
28 
 
For europium complexes derived from a ligand framework based on 1,4,7,10-
tetraazacyclododecane (cyclen), the structure of which will be discussed in Section 1.4.2 
of this review, particular sensitivity in the emission spectral form has been linked to 
changes in the nature and polarizability of the axial donor.
29, 30
 The complex [Eu.L
1
]
-
, 
which was developed as a ratiometric sensor for monitoring changes in intracellular pH, 
serves to illustrate this.
31
 For this complex, an intense transition was observed at 680 nm 
in the emission spectrum obtained at pH 8, the relative intensity of which decreased as 
the pH was lowered. Overall, an 80% change in the ratio of the emission at 680 nm 
CHAPTER ONE: INTRODUCTION 
- 13 - 
 
compared to that at 587 nm was observed when the pH was varied from 4.5 to 8. In 
accordance with these results, it was postulated that this band could be attributed to 
axial N ligation at high pH.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Plot of the intensity ratio vs. pH for [Eu.L
1
]
- 
(295 K, 0.1 M NaCl). The structures of the 
europium species at the limiting ratios are highlighted, along with their emission spectra.
31
  
 
As is to be expected, the characteristics of the circularly polarized emission of europium 
and terbium complexes are broadly similar to those of the total emission. However, it 
should be noted that in many cases CPL is effective in providing spectral simplification 
within bands. One reason for this is because the polarization of adjacent transitions may 
differ, thus allowing them to be distinguished more easily. The total emission and CPL 
spectra of [Eu.L
2
] (Figure 1.8) serve to illustrate this point, with the resolution of the ΔJ 
= 3 and ΔJ = 4 bands being particularly clear in the CPL spectrum.32 
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Figure 1.8: The structure of [Eu.L
2
] is shown alongside total emission (top) and CPL (bottom) spectra 
recorded for its Δ (blue) and Λ (orange) enantiomers in aqueous MeOH (295 K).32 
 
When considering CPL spectra of europium and terbium complexes, it is apparent that 
certain transitions tend to be associated with higher emission dissymmetry factors than 
others.
33
 This observation can be explained fairly easily if the relationships outlined in 
Section 1.2.2 are taken into consideration. The analysis presented in this section leads to 
the deduction that transitions which are magnetic dipole allowed and electric dipole 
forbidden will have the highest values of gem. On the basis of the first part of this 
statement, it can be deduced that for europium complexes the 
5
D0 → 
7
F1 transition is 
expected to be associated with the largest value of gem. Similarly, for terbium complexes 
the largest values of gem are anticipated for the 
5
D4 → 
7
FJ (J = 5 - 3) transitions. This is 
because these are the transitions which do not break the formal selection rules relating 
to the total angular momentum quantum number, J (i.e. ΔJ = 0, ± 1 excluding 0 ↔ 0), 
and are therefore magnetic dipole allowed. It should be noted that in practice gem values 
for the 
5
D4 → 
7
F5  transition of terbium complexes at around 545 nm are commonly 
found to be significantly greater than those associated with the other magnetic dipole 
allowed transitions.
33
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1.3.3 Sensitised emission 
 
For the emission discussed in the preceding sections to occur, it is first necessary to 
promote the lanthanide ion to an excited state. The Laporte forbidden nature of the 4f-4f 
transitions means that their associated molar absorption coefficients are very low (~ 5 - 
10 M
-1
cm
-1
) and direct excitation does not lead to efficient population of the lanthanide 
excited states.
34
 This issue is typically overcome by designing complexes such that 
indirect excitation of the lanthanide ion may be achieved via a sensitising chromophore. 
This 'antenna effect' was discovered in 1942 by Weissman, who noted that, for certain 
compounds, europium luminescence could be observed following irradiation with light 
that was only absorbed by the organic constituents.
35
  
 
An advantage associated with the use of sensitised emission is that there is a large 
Stokes' shift between the absorption of the sensitiser and the lanthanide luminescence. 
This can aid in distinguishing the lanthanide emission from background fluorescence 
and means there are no problems associated with concentration dependent self-
absorption. The key processes involved in the sensitisation pathway may be illustrated 
with a Jablonski diagram (Figure 1.9). 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.9: Simplified Jablonski diagram representing the key processes involved in the indirect 
excitation of a lanthanide ion. 
 
The absorption of a photon leads to the excitation of the sensitiser to a vibrationally 
excited singlet state, Sn (n = 2, 3...), which will rapidly undergo vibrational relaxation 
and internal conversion to populate a high vibrational level within the S1 manifold. 
Further vibrational relaxation then occurs so only the lowest vibrational level of the S1 
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state is populated. This is in accordance with Kasha's rule, which was proposed in 1950 
and states that 'the emitting level of a given multiplicity is the lowest excited level of 
that multiplicity'.
36
 From the S1 state, the sensitiser may decay radiatively by 
fluorescence, or alternatively, intersystem crossing can occur, transferring the energy to 
the triplet excited state of the sensitiser. It is suggested that the efficiency of this second, 
spin forbidden process is enhanced in lanthanide complexes because there is a sizeable 
amount of spin-orbit coupling due to the heavy atom effect of the lanthanide ion.
34
 
Finally, if the lanthanide excited state is lower in energy than the triplet state of the 
sensitiser then it may become populated by energy transfer and subsequently relax to its 
ground state, yielding the characteristic lanthanide luminescence. Alternatively, the T1 
state of the sensitiser may decay radiatively by phosphorescence.  
 
For a sensitised lanthanide complex, the overall luminescence quantum yield, Φ, can be 
calculated according to the following equation, where ηISC and ηET are the efficiencies of 
the intersystem crossing and ligand to lanthanide energy transfer processes 
respectively.
37
 Meanwhile, ΦLn is the intrinsic quantum yield of the lanthanide ion, 
which was defined and discussed in Section 1.3.1.  
 
                                                                  
                                            (eqn. 10) 
 
It is clear from this expression that, in order to synthesise lanthanide complexes with 
high quantum yields, it is key to not only incorporate lanthanide ions with high intrinsic 
quantum yields, but also to identify ligands and sensitisers that will facilitate efficient 
intersystem crossing and energy transfer processes.  
 
1.3.4 Luminescence deactivation pathways 
 
In order to gain a thorough understanding of the dependence of the overall 
luminescence quantum yield for a sensitised lanthanide complex on the efficiency of 
intersystem crossing and energy transfer, time should be taken to appreciate the various 
luminescence deactivation pathways that may quench each of the excited states 
involved in the sensitisation pathway. Scheme 1.1 shows the unwanted competitive 
deactivating pathways associated with the process of sensitised emission. 
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Scheme 1.1: Deactivating pathways following excitation of the sensitiser (kET is the rate constant for 
energy transfer, keT is the rate constant for electron transfer).  
 
As is apparent, each of the excited states involved in the sensitisation pathway is 
susceptible not only to the radiative deactivation processes mentioned in the previous 
discussion, but also to non-radiative quenching. 
 
1.3.4.1 Quenching of the sensitiser singlet state 
 
The singlet excited state of the sensitiser has been found to be particularly vulnerable to 
non-radiative deactivation by electron transfer.
 
This was demonstrated in a study carried 
out in 1998, which examined the quenching of europium and terbium complexes by 
halide anions.
38
 Titrations were carried out in which the variation in emission intensity 
of both the ligand fluorescence and metal-based luminescence were monitored as a 
function of halide ion concentration. For the complexes examined it was found that the 
extent of the quenching effect observed at a given anion concentration could be 
correlated to the ease of oxidation of the halide, supporting the hypothesis of an electron 
transfer quenching mechanism. Meanwhile, at a given concentration of added anion, the 
ligand fluorescence was typically found to be quenched to a greater extent than the 
metal-based luminescence and no change in the lifetime of the metal-based emission 
was detected. These observations are consistent with a quenching mechanism affecting 
the sensitiser singlet state. 
 
1.3.4.2 Quenching of the sensitiser triplet state 
 
The triplet excited state of the sensitiser is especially susceptible to quenching by 
molecular oxygen. Several examples of this effect have appeared in the literature and in 
some cases it has been exploited to develop responsive systems.
39-43
 Recently it was 
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demonstrated that the production of singlet oxygen associated with this quenching effect 
may be employed in the induction of regioselective cell death.
44
  
 
A second mechanism by which the triplet excited state may be deactivated non-
radiatively was hypothesised in 2007, on the basis of results from a study concerned 
with examining the quenching of europium and terbium systems by urate, ascorbate, 
iodide and several catechol derivatives.
45
 It was anticipated that these species would 
yield a reduction in emission intensity as a result of direct quenching of the lanthanide 
excited state by electron transfer; a collisional process that is thermally activated. 
However, in the case of urate, ascorbate and the catechols, it was found that the 
efficiency of the observed quenching effect diminished as the temperature was 
increased, suggesting that this was not the case for these species. It was proposed that 
the quenching effect observed in the presence of these electron-rich reductants occurred 
via formation of an exciplex, involving the triplet excited state of the chromophore. This 
hypothesis was verified by a later study, which showed that no quenching of the 
lanthanide luminescence was observed in the presence of these species if the lanthanide 
ion was excited directly using a high-powered laser, and gathered evidence in support of 
the existence of an exciplex.
46
 
 
 
 
At this point it should be noted that for a given terbium complex, its europium analogue 
will typically prove to be less sensitive to quenching with respect to processes operating 
by deactivation of the triplet excited state of the chromophore. This is because the 
energy of the 
5
D4 emissive state in terbium is higher than that of the 
5
D0 emissive state 
in europium meaning that, for a common ligand, it will be closer in energy to the triplet 
excited state of the chromophore. Hence, back energy transfer from the lanthanide 
excited state will occur more readily in terbium complexes meaning there is increased 
repopulation of the triplet state of the sensitising chromophore and more quenching of 
this state may occur. The complex [Ln.L
3
]
3-
 has been developed as a potential urate 
sensor, in accordance with this principle.
47
 It has been shown that a mixture of [Eu.L
3
]
3- 
and [Tb.L
3
]
3-
 can be used to assess the concentration of urate in solution by considering 
the intensity ratio of terbium emission at 546 nm to europium emission at 616 nm. 
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Figure 1.10: Variation of the Tb (546 nm) to Eu (616 nm) emission ratio as a function of the 
concentration of sodium urate (295 K, 0.1 M HEPES, pH 7.4). The inserts show spectra recorded at 
varying concentrations of urate. It can clearly be seen that the terbium emission at 546 nm is quenched 
more efficiently by urate than the europium emission at 616 nm.
47
  
 
1.3.4.3 Quenching of the lanthanide excited state 
 
The lanthanide excited state itself is prone to deactivation by several non-radiative 
pathways. For example, lanthanide complexes have been developed for FRET 
applications based on intermolecular energy transfer from the lanthanide excited state to 
an energy-matched proximal acceptor group.
48
 Meanwhile, direct quenching of this state 
has in some cases been attributed to an electron transfer process, 'driven' by the free 
energy it possesses. In the 2007 study outlined in the previous section, the quenching of 
europium and terbium luminescence by iodide was shown to occur via this 
mechanism.
45
 In contrast to the other species examined, quenching of the lanthanide 
luminescence by iodide was found to be more effective at higher temperature.  
 
When considering the use of sensitised lanthanide complexes to probe aqueous media, it 
is particularly pertinent to consider an additional non-radiative deactivation pathway 
relating to the lanthanide excited state (Scheme 1.1). As was mentioned in Section 
1.3.1, vibrational energy transfer from the lanthanide excited state to X-H oscillators (X 
= O, N, C) can lead to a reduction in luminescence intensity and lifetime.
49
 Although in 
many situations it is considered advantageous to maximise the luminescence quantum 
yield of a given lanthanide complex, there are numerous examples of responsive 
systems which utilise this quenching effect to their advantage. By intentionally 
designing complexes such that when in aqueous solution the lanthanide ion must 
complete its coordination sphere with bound water molecules, the possibility of 
luminescence modulation and therefore analyte sensing by their displacement is 
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realised.
50-53 
Conversely, responsive systems have also been reported where the 
hydration state is increased in the presence of the target analyte, also resulting in 
modulation of the luminescence output.
54
  
 
It should be noted that the determination of the hydration state of a given europium or 
terbium complex is possible by comparison of the excited state lifetimes in H2O and 
D2O.
55
 The quenching of lanthanide luminescence is less efficient in D2O, due to the 
fact that O-D oscillators possess lower stretching frequencies than their corresponding 
O-H equivalents. This means that coupling of the excited states can only occur with 
higher vibrational overtones, where the Franck-Condon overlap factor is less 
favourable. It has been shown that for europium complexes, quenching by X-D 
oscillators is at least 200 times less effective compared to X-H oscillators.
56
 Similar 
reasoning can be used to explain why terbium complexes typically show greater 
resistance to quenching by O-H oscillators than their europium analogues. As can be 
seen from Figure 1.11, for europium complexes coupling of the excited state occurs to 
the third vibrational overtone of proximate O-H oscillators. Hence, the Franck-Condon 
overlap factor is more favourable than for terbium complexes, where coupling is to the 
fourth vibrational overtone. 
Figure 1.11: Partial energy level diagram for europium and terbium electronic energy levels, compared to 
idealised vibrational energy levels of O-H and O-D oscillators.  
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1.3.5 Design criteria for highly emissive lanthanide complexes 
 
As was discussed in the previous section, the various quenching phenomena affecting 
the excited states involved in the sensitisation pathway can be exploited to great effect. 
However, it is evident that, in order to synthesise lanthanide complexes with high 
quantum yields, it is key to minimise time spent in the singlet and triplet excited states 
and therefore avoid their radiative and non-radiative deactivation. This explains the 
dependence of the overall luminescence quantum yield on the efficiency of both the 
intersystem crossing and energy transfer processes, which was first mentioned in 
Section 1.3.3.  
 
Concerning the sensitising chromophore, it is clear that a small singlet-triplet energy 
gap is required in order to facilitate efficient intersystem crossing and minimise 
deactivation of the singlet state by competitive pathways. Similarly, the energy of the 
triplet excited state in relation to the lanthanide excited state is of high importance, with 
a smaller energy gap being optimum for efficient energy transfer. However, in this case 
the avoidance of thermally-activated back energy transfer is also necessary and it has 
been suggested that a gap of at least 1,700 cm
-1
 is therefore required.
57
 It is thought that 
the energy transfer step of the sensitised emission pathway occurs via either a Förster or 
Dexter mechanism, which are both distance dependent.
58, 59  
Hence, efficient energy 
transfer may also be promoted by ensuring the sensitising chromophore is located in 
close proximity to the lanthanide ion. In all cases efficient absorption of light is 
obviously advantageous, so it is beneficial to incorporate sensitising chromophores with 
high extinction coefficients. 
 
With respect to the ligand, the design must be such that the number of accessible 
binding sites offered to the lanthanide ion is sufficient and completion of the 
coordination sphere by binding small molecules such as water is not necessary. It 
should be noted that the coordination chemistry of the lanthanide ions is dominated by 
coordination numbers falling in the range 7-9.
60
  
 
Several additional considerations relating specifically to the development of systems for 
use in biological applications may also be outlined. Regarding the chromophore, the 
excitation wavelength should be in excess of 340 nm, such that absorption of excitation 
light by common biomolecules is avoided.
61
 Meanwhile, toxicity associated with 
CHAPTER ONE: INTRODUCTION 
- 22 - 
 
premature metal decomplexation should be minimised by ensuring that complexes are 
both kinetically and thermodynamically stable.
 
 
Over the years, a variety of lanthanide-based systems has been developed which fulfil 
the criteria outlined above to varying degrees. Some of these may be considered as 
modular systems, where the chromophore is synthesised separately and then appended 
to a macrocylic ligand scaffold. In other cases, such as helical assemblies and many 
linear multidentate systems, the chromophore forms a more integral part of the ligand 
framework. Examples of both types of system will be presented in the following 
section, which focuses on a consideration of the stereochemistry in representative 
complexes. 
 
1.4 Understanding the origin of chirality in lanthanide complexes 
 
It is important to note that only the 4f-4f transitions of complexes in which the 
lanthanide ion is located in a chiral environment will demonstrate natural optical 
activity. In such complexes the presence of dissymmetry in the ligand field means that 
the electric and magnetic dipole moments associated with the transitions are non-
orthogonal and therefore optical activity can be observed.
62
 This is in accordance with 
equation 8, defined in Section 1.2.2. 
 
1.4.1 Selected examples of chiral lanthanide complexes 
 
The chiral environment of a lanthanide ion in a complex may arise in a number of ways, 
one of which is due to a chiral arrangement of the ligand molecules. When the tridentate 
ligand pyridine-2,6-dicarboxylate (DPA) binds to a lanthanide ion, an anionic tris 
chelate complex with trigonal dihedral symmetry is formed.
63
 The arrangement of the 
ligands around the lanthanide is often described as resembling a three-bladed propeller, 
which can either be left (Λ) or right (Δ) handed about the trigonal symmetry axis. The 
helical arrangement of the chelate rings about the lanthanide centre therefore yields two 
enantiomeric species, which exist as a racemic mixture in water at room temperature.  
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Figure 1.12: Representation of the D3 symmetric species Δ-[Ln(DPA)3]
3-
 (left) and its enantiomer, Λ-
[Ln(DPA)3]
3-
 (right), viewed along the trigonal symmetry axis. 
 
It should be noted that the examination of racemic systems such as [Ln(DPA)3]
3-
 using 
standard CPL techniques (i.e. unpolarized excitation light) will not lead to the 
observation of optical activity under normal conditions. However, in the presence of 
chiral additives an induced CPL effect may occur, therefore facilitating their use as 
responsive CPL probes. As will be outlined later in this introduction, the vast majority 
of studies in this area have made use of the complex described above. In contrast, when 
it comes to current examples of responsive lanthanide-based CPL probes based on 
enantiopure systems, there are a number of different complexes that have been 
identified.  
 
The synthesis of enantiopure complexes is typically achieved by the inclusion of 
asymmetric centres in the ligand molecules.
64, 65
 This is illustrated in the case of the tris 
chelate lanthanide complexes derived using the tridentate ligand L
4
.
66, 67
 As is apparent 
from Figure 1.13, this ligand is closely related to DPA in terms of its core structure and 
it is therefore not surprising that the ligands have been found to arrange around the 
lanthanide centre in a three bladed 'propeller-like' manner when used in complex 
formation. However, in this case the formation of a single complex enantiomer has been 
found to be favoured in solution, provided the ligand molecule is synthesised such that 
the two chiral centres had the same relative stereochemistry, i.e. (S,S)-L
4
 or (R,R)-L
4
. 
Crystal structures obtained for [Eu((R,R)-L
4
)3]
3+
 and [Eu((S,S)-L
4
)3]
3+ 
showed that these 
complexes favour a left (Λ) and right (Δ) handed arrangement of the ligands 
respectively in the solid state. Meanwhile, CPL spectra recorded in solution showed a 
mirror image relationship between the signals observed for the two complexes, 
implying that they are enantiomeric. Emission dissymmetry factors of ±0.19 and ±0.18 
were calculated for the emission at 590.5 and 595.3 nm within the ΔJ = 1 manifold. It 
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has been suggested that these complexes may find use in the development of lanthanide 
CPL spectra-structure correlations.
67
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Structures of (R,R) and (S,S)-L
4
 and their Λ and Δ europium complexes alongside the total 
luminescence (bottom) and CPL (top) spectra of the ΔJ = 1 band for the tris chelate complexes in MeCN 
at 295 K. CPL traces for the Λ and Δ complexes are shown by dashed and dotted lines respectively. 
Meanwhile, the solid lines represents CPL recorded for a tris chelate europium complex formed using 
(R,S)-L
1.4
.
66, 67
  
 
The fact that the chirality of the ligand may be effective in determining the overall 
configuration of a complex has also been demonstrated for systems of many other 
architectures. For instance, the synthesis and chiroptical properties of a pair of 
enantiomeric, dinuclear triple-stranded europium helicates has recently been reported.
68
 
As can be seen from Figure 1.14, the two metal binding sites incorporated into each 
ligand were comprised of the same tridentate chelating group as found in L
4
. Evidence 
for the helical nature of the structures formed was gathered through the use of 
1
H NMR 
spectroscopy and investigations into the hydration state of the metal centres, which 
suggested the formation of species of high symmetry in which each europium ion was 
in a nine-coordinate environment. The enantiomeric nature of the helicates was 
confirmed by several methods including CPL spectroscopy, which gave mirror image 
spectra for the two species. Emission dissymmetry factors calculated for the emission 
within the ΔJ = 1 manifold were comparable in sign and magnitude to those found for 
the mononuclear complexes of L
4
. For example, at 593 nm the emission dissymmetry 
factor was found to be -0.23 for the helicate derived from (R,R)-L
5
.
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Figure 1.14: Structure of the chiral ligands, L
5
 and L
5
, used in the synthesis of enantiopure dimetallic 
helicates, shown with a representation of the overall helicate structure. Total luminescence (top) and CPL 
(bottom) spectra are also presented for Eu2:L
5
3 (blue) and Eu2:L
5
3 (red) in MeOH.
68
 
 
Further examples of lanthanide systems in which a chiral environment has been created 
by the inclusion of asymmetric atoms in the coordinating ligands include the europium 
and terbium complexes of L
6
 and L
7
 respectively.
69
 Both of these enantiopure, 
octadentate ligands incorporate stereogenic centres in their backbones. In the case of L
6
, 
four asymmetric centres can be found in the tetrapodal arms, whilst for L
7
, there are two 
stereogenic centres located in the central region of the oligoamine backbone. Both the 
europium complex, [Eu(L
6
)(H2O)], and the terbium complex, [Tb(L
7
)], have been 
found to exhibit CPL in aqueous solution at pH 7.4, with results of 
1
H NMR studies and 
luminescence lifetime measurements suggesting the presence of only one dominant 
emitting species in solution. It should be noted that, while the terbium complex in 
particular has been found to exhibit an impressive luminescence quantum yield in 
aqueous solution (Φ = 0.57), the CPL activity of these complexes was found to be 
relatively modest, with emission dissymmetry factors not exceeding ±0.12.
69
 Recent 
attempts to synthesise analogues of these complexes in which exceptional luminescence 
quantum yields are combined with higher degrees of optical activity have been of mixed 
success.
70, 71
 Of the chelating units examined, only one has been identified which 
conserves all the desirable photophysical and structural properties associated with 
[Tb(L
7
)], whilst also roughly doubling the observed gem values.   
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Figure 1.15: Structure of L
6
 and L
7
 shown with a schematic representation of the design principle for 
each ligand. Red and blue spheres denote oxygen and nitrogen respectively. In the case of the terbium 
complex, the green sphere is representative of the location of the chiral information in the ligand 
framework. The total luminescence (bottom) and CPL (top) spectra of the ΔJ = 1 bands of [Eu(L6)(H2O)] 
(left) and [Tb(L
7
)] (right) are also shown (295 K, 0.1 M Tris buffer, pH 7.4).
69, 70
 
 
A final example of this so-called chirality transfer effect which is worth highlighting 
concerns a lanthanide complex that has been shown to exhibit exceptional optical 
activity. Whilst values of gem for the majority of enantiopure lanthanide complexes 
described in the literature fall in the range ±0.1 - 0.5, much larger values have been 
reported for the complex Cs[Eu((+)-hfbc)4]; a gem value of +1.38 has been observed at 
595 nm when the complex is in chloroform.
72
 Studies of this complex have revealed that 
the high degree of circular polarization in the emission may be attributed to the 
occurrence of dynamic coupling between the f-f transitions and the ligand-centred π-π* 
transition.
73
 On the basis of exciton CD measurements and 
19
F NMR data, a solution 
state structure was proposed for this complex and several of its analogues.
74, 75
 In this 
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structure, the coordination of the lanthanide ion by the four bidentate 3-
heptafluorobutylryl-(+)-camphorate ligands occurs in such a manner that the eight 
oxygen donor atoms define two square bases. The wrapping of the ligands gives rise to 
a Δ helicity and the caesium ion is encapsulated, with weak interactions of this metal 
ion with the fluorocarbon moieties of the ligand molecules having been alleged.
72, 75
  
 
 
 
 
 
Figure 1.16: Ligand structure and representation of overall complex structure for Cs[Ln((+)-hfbc)4]. 
Total emission (left) and CPL (right) spectra are shown for the ΔJ = 1 transition of Cs[Eu((+)-hfbc)4] in 
CHCl3 at 295 K.
72, 75  
 
1.4.2 Examining the stereochemistry of macrocylic systems 
 
It is important to note that, while the use of CPL has been fundamental in the 
characterisation of all of the enantiopure systems discussed up to this point, for most of 
them no results have yet been reported concerning the modulation of their CPL output 
in response to changes in their environment. Indeed, a survey of the literature reveals 
that the majority of lanthanide-based systems which have been identified as showing 
such an effect are derived from a common macrocyclic framework, namely that of 
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). 
 
       
 
 
 
Figure 1.17: The structure of [LnDOTA]
-
 shown alongside diagrams depicting the limiting orientations 
of the cyclen ring and possible lay-outs of the acetate arms. 
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The geometry of the complex [LnDOTA]
-
 can be described in terms of two torsion 
angles. Firstly, the N-C-C-O angle of the acetate arms, which can be +30
o
 or -30
o
 (Δ 
and Λ respectively), and secondly the N-C-C-N angle of the macrocyclic ring, which 
can be +60
o
 or -60
o
 (δ and λ respectively).76 The different possible combinations of 
these two structurally independent elements of chirality give rise to the four 
stereoisomers depicted in Figure 1.18, which are related as two enantiomeric pairs.
77
 
When in solution it is possible for the four stereoisomers to interconvert via ring 
inversion (δ ↔ λ) and cooperative arm rotation (Δ ↔ Λ), yielding a racemic mixture 
which will exhibit no CPL if examined using a standard experimental procedure. 
 
 
Figure 1.18: Schematic representation of the four stereoisomers of [LnDOTA]
-
. 
 
As is apparent from this representation of the stereoisomers, the geometry adopted by 
the Λ(δδδδ)/Δ(λλλλ) enantiomeric pair in solution differs to that observed for the 
Δ(δδδδ)/Λ(λλλλ) pair. In each case, the coordination polyhedron is defined by two 
square bases, one comprising the four nitrogen atoms of the macrocylic ring and the 
other the four oxygen donor atoms of the pendant arms. The two geometries may be 
distinguished by the angle between these square bases, which is roughly 40
o
 in the case 
of the former pair, and 15
o
 for the latter.
77
 The geometries are commonly referred to as 
square antiprismatic (SAP) and twisted square antiprismatic (TSAP) respectively and 
have slightly different characteristics. For example, the coordination polyhedron is 
typically more compressed in a SAP structure and the 'bite angle' wider. It should be 
Δ(δδδδ)                                                                                                                 Λ(δδδδ) 
 
 
 
 
 
 
 
 
 
 
 
Δ(λλλλ)                                                                                                                  Λ(λλλλ) 
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noted that a given lanthanide DOTA complex will typically favour either a SAP or 
TSAP geometry and therefore exist as a major and a minor enantiomeric pair in 
solution. 
 
As was shown to be the case for the lanthanide architectures discussed previously, it has 
been found that the inclusion of asymmetric centres in the ligand framework of 
complexes derived from DOTA-based ligands may yield the formation of enantiopure 
complexes in solution. Typically, the incorporation of stereogenic centres directly on 
the macrocycle will suppress the rate of ring inversion.
78, 79
 Meanwhile, the integration 
of chirality into the pendant arms will generally inhibit arm rotation.
80-82 
Due to the fact 
that all lanthanide complexes derived from a DOTA framework will show preference 
towards either a SAP or TSAP geometry, the implementation of only one of the 
strategies outlined above will normally lead to the preferential formation of a single 
stereoisomer in solution. For example, NMR studies have shown that the europium 
complex of the enantiopure octadentate ligand (S)-L
9
 exists in solution as Λ(δδδδ) and 
Δ(δδδδ) stereoisomers, in a ratio of 12:1 i.e. the ring is effectively locked and a SAP 
geometry is favoured.
83
 
 
 
Scheme 1.2: Selected chiral ligands employed in the preferential synthesis of single stereoisomers.  
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In some cases it has been found that the incorporation of asymmetry solely into the 
pendant arms is effective in achieving exclusively the formation of a single 
stereoisomer.
84-86
 For example, the europium complex of the C4-symmetric tetraamide 
ligand (RRRR)-L
13
, in which a chiral centre is incorporated into each of the pendant 
arms in a position δ to the ring nitrogen,  has been shown by 1H NMR spectroscopy to 
exist as solely one stereoisomer in solution.
87, 88
 Well-defined CPL spectra have been 
reported for both terbium and europium complexes of this ligand, with enantiomeric 
complexes giving rise to mirror image spectra. For the europium complex derived from 
(RRRR)-L
13
, emission dissymmetry factors of -0.12 and +0.18 were reported for the two 
bands observed within the ΔJ = 1 manifold. 
 
 
 
 
 
       
 
 
 
 
 
Figure 1.19: Structure of the tetraamide ligand L
13
 accompanied by the total luminescence and circularly 
polarized luminescence spectra for the ΔJ = 1 band of the two enantiomers of [Tb.L13]3+ (293 K, degassed 
MeCN).
88
 
 
In accordance with the discussion above, it may be deduced that the best way to ensure 
the sole existence of only one stereoisomer in solution is through the use of ligands in 
which asymmetry is incorporated in both the macrocyclic ring and the pendant arms.
 
 
However, it should be noted that whilst this method has been demonstrated successfully 
with ligands such as L
12
, recent studies involving complexes of this ligand have 
reported the presence of two species in solution.
89-91
 NMR experiments have shown that 
these species may be thought of as regioisomers, with their existence being attributed to 
the fact that it is possible for the ring substituent to be located in one of two non-
equivalent positions (Figure 1.20). 
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Figure 1.20: Possible locations of a ring substitution for a given conformation of 
tetraazacyclododecane.
77
 
 
Before going on to discuss examples of responsive lanthanide-based CPL probes from 
the literature, it is first worth mentioning that, although in general spectra-structure 
correlations for lanthanide complex CPL are not well understood, some effort has been 
made with regard to identifying the factors that determine the sign and magnitude of gem 
for lanthanide complexes based on substituted DOTA ligands. It has been suggested that 
for such complexes changes in the angle of twist about the principal axis and variations 
in the local ligand field (particularly the polarizability of any axial donor) will both lead 
to modulation of the total emission and/or CPL output and therefore changes in 
observed gem values.
92
 In particular, the CPL is predicted to follow a sin4θ dependence 
for such complexes, where θ is the angle of twist about the principal axis. Hence, a twist 
angle of 0
o
 or 45
o
 will result in no CPL, whilst CPL will be at its highest when θ = ± 
22.5
o
. From this it may be implied that higher CPL may in theory be expected for 
complexes adopting a TSAP geometry, whose twist angles are typically closer to this 
idealised value than their SAP analogues.  
 
Speaking more generally, an additional factor which plays a key role in determining the 
size and magnitude of gem for any given lanthanide complex is its conformational 
rigidity. As was discussed in Section 1.2.2, gem is dependent on the angle between the 
electric and magnetic transition dipoles, τ, with large values being expected if these 
dipoles are parallel or antiparallel (i.e. τ = 0o or 180o). Therefore, restriction of any 
conformational exchange processes which lead to perturbation of this angle as a 
function of time is necessary if a given lanthanide complex is to find use as a responsive 
CPL probe. It is important to note that, while in some cases τ may be correlated to the 
aforementioned twist angle θ, there does not necessarily exist any explicit relationship 
between these two angles for a given lanthanide complex. 
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1.5 Responsive lanthanide-based CPL probes 
 
When considering the development of lanthanide systems that are able to report on 
changes in their environment through modulation of their CPL output, it is clear that 
only systems where a reasonable understanding of the origin of the observed CPL 
modulation can be attained will ever show promise with regard to their use in real-world 
applications. In accordance with this, early examples of responsive CPL behaviour, 
from so-called 'mixed ligand' solutions, will not be presented in the following sections 
of this review, which aim to provide a comprehensive overview of well-defined 
lanthanide complexes that show modulation of their CPL output in response to 
environmental change.  
 
A classification of systems fitting the description given above may be built up in 
accordance with first the complex stereochemistry (achiral, racemic or enantiopure) and 
second the manner by which the change in CPL is brought about. The discussion in the 
following sections is arranged according to this classification. In each case, examples of 
systems belonging to the given category are presented and a consideration of their 
practical utility as responsive CPL probes is undertaken. Before embarking on a detailed 
discussion in accordance with this outline, it is informative to first draw attention to a 
recent example of responsive lanthanide-based CPL reported in the literature that will 
not be considered again later.  
 
 
 
 
 
 
 
 
 
 
Figure 1.21: Ligand structure for complexes of the general formula M[Ln((+)-hfbc)4], whose solution 
structure was discussed in Section 1.4.1. Total emission (bottom) and CPL (top) spectra are shown for the 
ΔJ = 1 transition of M[Eu((+)-hfbc)4], where M = Na
+
, K
+
, Rb
+
, Cs
+
 (left to right) (295 K, 2 mM CHCl3 
solution).
93
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Modulation of the CPL output from the complex Cs[Eu((+)-hfbc)4], was observed to 
occur in both ethanol and chloroform solution when the caesium metal ion was 
substituted for a different alkali metal ion.
93
 The emission dissymmetry factor at 595 nm 
was determined for M
I
 = Na
+
, K
+
, Rb
+
 and Cs
+
 and found to vary in accordance with the 
size of the metal ion. For example, in chloroform solution the emission dissymmetry 
factor at this wavelength was reported to take values ranging between +0.15 (M
I
 = Na
+
) 
and +1.38 (M
I
 = Cs
+
). Without further evidence, it would be tempting to attribute this 
variation in optical activity to a change in polarizability in the primary coordination 
environment of the complex associated with the various alkali metal ions. However, in 
the case of this system, it was subsequently shown that the observed modulation of the 
CPL output may be attributed to a change in complex constitution, with NMR studies 
revealing competitive dissociation of the M
I
[Eu((+)-hfbc)4] complexes to give the 
neutral tris-chelated complex, Eu(hfbc)3, in the case of Na
+
, K
+
 and Rb
+
.
73
 
Notwithstanding the fact that this lanthanide system is inherently unsuitable for 
application in biological systems due to a lack of aqueous solubility, this example helps 
to illustrate the importance of gaining as much understanding as possible of the origin 
of observed CPL modulation in systems that are to be developed for use as optical 
probes.  
 
1.5.1 Exploring the use of achiral lanthanide systems 
 
In cases where the complexation of a lanthanide ion by achiral ligands does not result in 
a chiral structure, the complex itself will be achiral and therefore exhibit no CPL if 
examined under standard conditions. There exist two examples in the literature of 
achiral lanthanide systems in which a CPL signal is apparently induced in the presence 
of a chiral additive.  
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Figure 1.22: Structures of [Eu(L
14
)2]
-
 and C shown alongside the total luminescence (bottom) and CPL 
(top) spectra of the ΔJ = 1 band for [Eu(L14)2]
-
 in aqueous solution in the presence and absence of both 
enantiomers of the chiral additive.
94
 
 
The europium complex, [Eu(L
14
)2]
-
, is known to adopt an achiral structure of D2d 
symmetry in the solid state.
95, 96
 A recent study has shown that in solution this complex 
exhibits CPL in the presence of the chiral amino acid derivative, C.
94
  It was 
demonstrated that mirror image CPL spectra could be generated by the addition of (S)- 
and (R)-C to aqueous solutions of [Eu(L
14
)2]
-
. The maximum values of gem associated 
with the interaction were approximately ±0.03, roughly an order of magnitude smaller 
than those typically observed for lanthanide-based systems. Various investigations were 
carried out in an attempt to identify the mechanism by which this induced CPL arose, 
with the authors concluding that the amino acid derivative is able to bind to the 
europium centre in the complex, giving rise to chiral species of the general formula 
[Eu(L
14
)2(C)]
-
 in solution. 
 
A critical analysis of the results presented for this system may however conclude that 
the diminutive values of gem determined are more consistent with the observed CPL 
being attributed to only one component of a more complex mixture of emissive species 
present in solution. There is precedent for such a hypothesis, with several early studies 
of CPL from lanthanide species formed in 'mixed ligand' solutions having been later 
questioned on the basis of the fact that the CPL active species was shown to account for 
only part of the total emission observed.
97, 98
 In the example presented here, it is likely 
that the observed CPL may be attributed to the formation of complexes of the formula 
[Eu(L
14
)2]
-
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[Eu(L
14
)(C)]
+
, which are in turn outnumbered in solution by more emissive achiral 
complexes of the original composition.    
 
The second example of this induced CPL effect reported for an achiral lanthanide 
systems pertains to a europium-containing polymer, which has been found to exhibit 
CPL when in the presence of the amino acid proline.
99
 Approximately mirror image 
spectra were recorded in the presence of enantiomerically pure samples of D- and L-
proline, with particularly large emission dissymmetry factors apparent in the ΔJ = 1 
emission band (gem ≈ ±0.4 at 596 nm). The authors suggest that specific orientation of 
the guest-molecule may be encouraged by the well-defined structure of the conjugated 
polymer, however, no further comment is offered regarding the exact nature of the 
interaction between the polymer and the amino acid. 
 
1.5.2 Sensing through perturbation of a dynamically racemic complex 
 
As was discussed in Section 1.4, lanthanide complexes derived from achiral ligands will 
typically exist in solution as a racemic mixture, provided complexation yields a chiral 
structure. The induction of a CPL effect for such systems is possible in the presence of a 
chiral additive and has been demonstrated to occur via two mechanisms, which will be 
described and exemplified below. As was mentioned in Section 1.4.1, the vast majority 
of work carried out in this area has examined the induction of CPL by perturbation of Δ- 
and Λ-[Ln(DPA)3]
3- 
in solution. In accordance with this, only results pertaining to this 
system will be considered here. 
 
1.5.2.1 Disruption of the ground state equilibrium: The Pfeiffer effect 
 
One way in which the introduction of a chiral additive to a solution containing a 
racemic mixture of Δ- and Λ-[Ln(DPA)3]
3- 
can lead to optical activity is by perturbation 
of the ground-state equilibrium. For this to be achieved, outer sphere association of the 
complex with the optically active chiral additive first need occur. This leads to a build 
up of an enantiomeric excess in the ground state because the formation of one 
diastereomeric outer sphere association complex is more energetically favourable than 
that of the other. As long as other chiral effects, such as enantioselective excited state 
quenching, are absent then the enantiomeric excess in the excited state will be equal to 
that of the ground state, leading to the observation of optical activity.  
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This so-called 'Pfeiffer effect' was discovered in the 1930s and first demonstrated with 
regard to the observation of induced CPL from  [Ln(DPA)3]
3-
 (Ln = Eu
3+
 and Tb
3+
) 
systems roughly 50 years later.
100-102 
It should be noted that although the binding 
constants of DPA for lanthanide ions are of such a magnitude that added chiral species 
should not be able to compete for coordination to the metal centre,
103
 the importance of 
verifying the origin of an observed induced CPL signal has been highlighted in many 
studies of this effect. That the induced signal does not occur as a result of a change in 
the primary lanthanide coordination environment is supported in general by the fact 
that, for a given lanthanide-DPA complex, the CPL spectral form has been found to be 
identical across reported instances of the Pfeiffer effect. The absence of  change in the 
primary coordination environment has also been verified in some cases by other 
methods, such as comparison of the CPL spectrum obtained from a Pfeiffer-perturbed 
system with that of the 'pure' enantiomer (see Section 1.2.1).
104, 105
 It should be noted 
that evidence has also been gathered to support the ascribing of the Pfeiffer effect to the 
formation of outer-sphere association complexes. This has been achieved through 
1
H 
NMR studies examining the upfield shift of amino acid resonances induced in the 
presence of [Eu(DPA)3]
3-
.
106
 
 
Over the years, the Pfeiffer effect has been demonstrated for [Ln(DPA)3]
3-
 complexes 
with a number of different chiral additives including vitamin B12 derivatives,
107
 
sugars
108
 and, most recently, amino-acid based ionic liquids.
109
 Observations made over 
the course of these studies have led to the implication of a wide range of non-covalent 
interactions in the formation of the outer-sphere association complexes, from hydrogen 
bonding to electrostatic and hydrophobic effects. With such a range of interactions 
involved in the formation of these complexes, it is perhaps unsurprising that the sign 
and magnitude of the induced CPL observed in these studies frequently appears to show 
no meaningful correlation to the specific structural characteristics of the added 
substrate.  
 
It is unlikely that the Pfeiffer effect will ever find employment in the selective detection 
of a desired chiral substrate in a complex mixture. However, it does show great promise 
with regard to its ability to distinguish enantiomers of a given analyte in solution. 
Otherwise unpublished results outlined in a review written by Muller have demonstrated 
a clear correlation between the measured CPL signal from [Tb(DPA)3]
3-
 in aqueous 
solution and the nature and amount of serine present (Figure 1.23).
110
 Although 
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intriguing, it is important to take into account the preliminary nature of these results, 
given that Muller does not provide any evidence verifying the origin of this observed 
induced CPL signal. 
 
Figure 1.23 Left: Plot of gem values at 543 nm for 0.01 M [Tb(DPA)3]
3-
 in the presence of (R)- and (S)-
serine, as a function of the percentage of (R)-serine present (total serine concentration 0.40 M). Right: 
CPL spectra for the ΔJ = 1 transition of  0.01 M [Tb(DPA)3]
-
 in the presence of 0.40 M (S)- and (R)-
serine (top, dashed and solid lines respectively) and the corresponding total luminescence spectrum 
(bottom) (295 K, pH 7).  
 
1.5.2.2 Enantioselective excited state quenching 
 
The second mechanism by which a chiral additive may lead to the induction of a CPL 
signal from a solution containing a racemic mixture of Δ- and Λ-[Ln(DPA)3]
3- 
is by 
chiral discrimination in the excited state. Although racemisation of [Ln(DPA)3]
3-
 occurs 
too quickly to allow chemical separation of the enantiomers, it is slow compared to the 
rate of radiative decay (for example, for [Eu(DPA)3]
3- 
the racemisation lifetime in 
aqueous solution at approximately 31 
o
C is 17.7 ms, whilst the emission lifetime is 1.60 
ms).
12 
This means that in the presence of a chiral quencher, an enantiomeric excess will 
be generated in the excited state over time, if the ΛL* - Q and ΔL* - Q quenching rates 
differ. The occurrence of such stereoselective energy transfer or preferential charge 
transfer will therefore lead to an induced CPL signal.
 
 
Induction of CPL from a [Ln(DPA)3]
3-  
system via this mechanism was first observed in 
1989.
10
 In this first study it was shown that CPL could be observed from solutions 
containing a racemic mixture of 10 mM [Tb(DPA)3]
3-
 when enantiomerically resolved 
samples of the trigonal dihedral transition metal complex [Ru(phen)3]
2+
 were present at 
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a concentration of just 5 µM. The origin of the effect was inferred through the 
performance of several additional experiments. Firstly, the ground-state population of 
the lanthanide complex was probed by CD, with the measurements revealing a lack of 
optical activity in this state. This confirmed that the racemic equilibrium in the ground 
state of [Tb(DPA)3]
3-
 was unperturbed by the presence of [Ru(phen)3]
2+
 so the optical 
activity observed could not be attributed to a Pfeiffer effect. Meanwhile, disruption of 
the primary coordination sphere of the lanthanide ion was ruled out by comparison of 
the observed CPL spectral form for the 
5
D4 → 
7
F5 transition to that recorded for the 
'pure' enantiomer. Finally, the variation in gem at 543 nm as a function of the ratio of the 
transition metal to terbium complex concentration was recorded and found to be non-
linear. This observation led to the deduction that the effect must be attributed to a 
dynamic mechanism, as opposed to a static ion-pairing mechanism. On the basis of this 
evidence it was concluded that the induction of CPL could be ascribed to a 'chiral 
quenching' effect, where a single transition metal complex was able to quench the 
emission of several terbium complexes during the lifetime of the excited state. 
Quantification of the extent of this effect was made possible by the measurement of 
time-resolved CPL data, which was used to estimate differential rate constants for the 
quenching of Δ- and Λ-[Tb(DPA)3]
3-
 by Λ-[Ru(phen)3]
2+
.  
 
 
 
 
 
 
Figure 1.24 Left: CPL (top) and TL (bottom) for the 
5
D4 → 
7
F5 transition of [Tb(DPA)3]
3-
 (10 mM) in 
the presence of [Ru(phen)3]
2+ 
(5 µM). Middle: Variation in gem at 543 nm as a function of the ratio of the 
transition metal to terbium complex concentration. Right: Time-resolved CPL (noisy trace) and TL 
(smooth trace) as a function of time after excitation at 543.5 nm (bottom) and variation in gem as a 
function of time (top).
10
 
 
The majority of studies of this effect have employed transition metal complexes in the 
role of the chiral quencher and, generally speaking, the use of time-resolved CPL 
spectroscopy in the identification and characterisation of the degree and sense of 
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enantioselective quenching is typical. The associated theory and measurement 
methodology for TR-CPL studies was further developed soon after the initial 
publication described above,
111
 and, using transition metal-based quenchers, 
investigations have been carried out into the effect of variation in the electronic and 
stereochemical structures of the interacting species on quenching rates and 
enantioselectivity.
112-115
 In addition, the effect of sample variables such as solvent, 
temperature, pressure and ionic strength has also been assessed.
116-120
 Results observed 
in all of these studies have been analysed on the basis that quenching occurs via an 
energy transfer process, typically assumed to involve diastereomeric Ln
*
 - Q encounter 
complexes, which have non-identical relative stabilities and energy transfer 
efficiencies.
121
  
 
It is important to highlight that a number of metalloproteins and vitamin B12 derivatives 
have also been found to be capable of inducing a CPL signal from [Ln(DPA)3]
3-
 in 
solution via this mechanism.
122-124
 In the case of the corrinoid vitamin B12 and its 
derivatives, the observation of an enantioselective quenching effect has been attributed 
to energy transfer in a hydrogen-bonded encounter complex.
125
 It has been demonstrated 
that these enantioselective quenching effects can be exploited to provide information 
about the accessibility of this chromophore and therefore may be used to investigate and 
monitor processes such as its binding to proteins.
126
 Results such as this serve to 
demonstrate the potential utility of this effect with regard to the development of 
responsive lanthanide-based CPL probes.  
 
1.5.3 Lanthanide complexes containing chiral ligands 
 
As was discussed in Section 1.4, lanthanide complexes derived from chiral ligands will 
typically exist in solution as one major stereoisomer if complexation yields a chiral 
structure. The modulation of the CPL output from such enantiopure complexes in the 
presence of a chosen analyte may be induced via one of two mechanisms, both of which 
will be described and exemplified below.  
 
1.5.3.1 Sensing through a change in the primary coordination environment 
 
The first mechanism by which modulation of the CPL output may occur for an 
enantiopure lanthanide system is through a change in the primary coordination 
environment of the lanthanide ion. Such a change may comprise the displacement of a 
weakly bound primary ligand donor or coordinated water molecule, typically yielding 
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an alteration in the hydration state of the given lanthanide complex. Alternatively, the 
modulation of the CPL output may be brought about by a more subtle change in the 
primary coordination environment, such as an alteration of the strength of interaction or 
polarizability of a primary ligand donor. As was discussed in Section 1.3.4.3, the former 
of these approaches has been employed to great effect in the development of ratiometric 
lanthanide-based systems, where changes in the total luminescence output are exploited 
to signal the presence of a target analyte. It is therefore perhaps unsurprising that all of 
the enantiopure systems for which CPL modulation has been demonstrated as a result of 
change in the primary coordination environment are also based on this well-explored 
principle. 
 
 
 
 
 
The earliest example in the literature of an 'enantiopure' lanthanide-based system where 
an alteration of the observed CPL spectral signature has been demonstrated in the 
presence of a chosen analyte was published in 1998.
53
 In this study, the analyte binding 
capabilities of the complex (SSS)-[Ln.L
15
(OH2)2]
3+ 
(Ln = Eu
3+
 or Tb
3+
) were evaluated. 
Following its synthesis, the speciation of this complex was determined using NMR 
spectroscopy, with spectra revealing that it exists in solution as a mix of four 
stereoisomers, in a ratio of 3.5 : 1 : 0.5 : 0.25. Although at this time no effort was made 
to assign the helicity of the major stereoisomer in solution, a later study involving this 
complex suggested that a Δ configuration was adopted.50 This conclusion was made on 
the basis of a comparison of the CPL spectral fingerprint recorded for (SSS)-
[Ln.L
15
(OH2)2]
3+ 
in the absence of additives to the CPL spectrum of a related tetraamide 
complex, whose absolute configuration had been verified by X-ray crystallography. 
 
(SSS)-[Ln.L
15
(OH2)2]
3+
 R = H 
 (SSS)- [Ln.L
16
(OH2)2]
3+
 R = Me 
(SSS)-[Ln.L
17
(OH2)2]
4+
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Preliminary experiments monitoring changes in hydration state and total emission 
spectral form of (SSS)-[Ln.L
15
(OH2)2]
3+
 in the presence of a number of anions were 
reported as part of the 1998 study.
53
 These experiments revealed that HCO3
-
 and CO3
2- 
were distinctive in their ability to form a chelated adduct with the lanthanide ion centre, 
with the presence of this adduct being confirmed by ESMS. CPL measurements were 
used to probe the excited state structure of (SSS)-[Eu.L
15
(OH2)2]
3+
, both in the presence 
and absence of 40 mM HCO3
-
 and 10 mM HPO4
2-
. In both cases results showed a 
modulation of the CPL output compared to that observed for the free complex. In the 
case of HCO3
-
, the intensity of the circularly polarized transitions was roughly halved. 
Meanwhile, for HPO4
2-
 the CPL intensity was unchanged but the form of the ΔJ = 1 
manifold was altered, with an additional component becoming distinguishable.  
                       
 
Figure 1.25: Total emission (top) and CPL (bottom) spectra for (SSS)-[Eu.L
15
(OH2)2]
3+
 alone (left; 293 
K, 0.1 M MES, pD 6.9) and with 40 mM HCO3
-
 (middle) and 10 mM HPO4
2- 
(right).
53
 
 
Additional investigations into the anion binding behaviour of both enantiomers of 
[Ln.L
15
(OH2)2]
3+
 and its N-alkylated analogues [Ln.L
16
(OH2)2]
3+
 and [Ln.L
17
(OH2)2]
4+
 
were published in 2000.
50
 As part of this study, further CPL spectra were obtained for 
both enantiomers of [Eu.L
15
(OH2)2]
3+
 in the presence of 10 equivalents of added HCO3
-
, 
HPO4
2-
, lactate and malonate.
50
 Although the binding of both lactate and malonate to the 
metal centre had been verified by other methods, only the former two anions caused 
significant perturbation of the observed CPL signal in comparison to the spectrum 
obtained for the complex in the absence of anion. For the N-alkylated complexes the 
binding of these two anions to the metal centre was also examined using both total 
emission and CPL spectroscopic techniques. While little change in form was observed 
for either complex with HPO4
2-
, a noticeable variation was apparent with HCO3
-
. It 
should be noted that, for a given enantiomer, the N-alkylated complexes 
[Eu.L
16
(OH2)2]
3+
 and [Eu.L
17
(OH2)2]
4+
 have identical CPL spectra and therefore 
identical helicity. However, the CPL spectral fingerprint of these complexes differs 
significantly in both the sign and relative intensity of the ΔJ = 1 and ΔJ = 2 bands in 
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comparison to [Eu.L
15
(OH2)2]
3+
. An emission spectrum of [Eu.L
17
(OH2)2]
4+
 was 
subsequently obtained in a solution designed to simulate an extracellular anionic 
environment.
50
 The form of the spectrum was seen to mimic that of the carbonate 
adduct, suggesting preferential binding of this species under these conditions. In 
accordance with this result, a titration was performed in a mixed anionic background 
where the change in the emission dissymmetry factor at 614 nm was measured as a 
function of added HCO3
-
 concentration. The binding curve generated was in good 
agreement with those produced using total intensity or intensity ratio data. 
 
 
 
 
 
 
 
 
 
 
Figure 1.26: Variation in the emission dissymmetry factor measured at 614 nm for the complex (SSS)-
[Eu.L
17
(OH2)2]
4+
 as a function of added NaHCO3 (pH 7.4, 100 mM NaCl, 0.9 mM Na2HPO4, 0.13 mM 
sodium citrate, 2.3 mM sodium lactate).
50
  
 
On the basis of preliminary 
1
H NMR studies of the complex [Eu.L
15
(OH2)2]
3+
 in the 
presence and absence of 10 equivalents of HCO3
-
 it was suggested that binding of this 
anion to the metal centre causes a change in complex geometry, from a square-
antiprismatic structure to a twisted square-antiprismatic structure.
50
 The modulation of 
the CPL output was therefore tentatively attributed to a change in twist angle. However, 
this conclusion was later discounted following a subsequent study in which a variety of 
anion adducts of the complex [Yb.L
15
(OH2)2]
3+
 were prepared and crystal structures 
obtained, therefore allowing the emission dissymmetry factors of the ternary complexes 
to be correlated to the nature of the most likely axial donor.
127
 It was hypothesised that 
the variation in the circular polarization and 
1
H NMR spectra of the chelated adducts 
can be attributed to a change in the axial donor polarizability, rather than an alteration of 
the helicity around the lanthanide centre.  
 
It should be noted that the modulation of the CPL output of the complexes discussed 
above has also been demonstrated with a number of other analytes. For example, a CPL 
experiment using (SSS)-[Eu.L
16
(OH2)2]
3+
 has shown that the binding interactions of a 
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variety of phosphate anions with this complex may be distinguished on the basis of 
subtle differences in the CPL spectral fingerprints.
128
 Meanwhile, CPL spectroscopic 
techniques have also been exploited in studies concerned with examining the DNA 
binding capabilities of [Eu.L
17
(OH2)2]
4+
.
129
 On the basis of comparison of CPL spectral 
data obtained in the presence of DNA and that obtained with HPO4
2-
, it was deduced 
that the binding interaction between this complex and DNA constituted the formation of 
an adduct in which the europium centre was coordinated to an oligonucleotide 
phosphate group. Further exploitation of this complex as a DNA binding probe was 
unfortunately prohibited due to the occurrence of substantial charge transfer quenching 
of the intermediate phenanthridinium singlet excited state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.27: Total emission (bottom) and CPL (top) spectra for (RRR)-Λ (bold) and (SSS)-Δ-
[Eu.L
16
(OH2)2]
3+
 (dashed) in the presence of 10 equivalents of N-acetyl-O-phospho-L-tyrosine, a 
phosphorylated hexapeptide, D-glucose-6-phosphate, O-phospho-L-tyrosine and HPO4
2-
 (left to right) 
(293 K, 0.1 M MOPS, pH 7.4).
128 
 
An additional example of a coordinatively unsaturated lanthanide system displaying 
modulation of its CPL output in response to bicarbonate binding has been described in 
the literature more recently.
130
 In contrast to the work described above, where changes 
in the CPL spectral signature were only investigated for europium based systems, this 
work describes modulation of the CPL output for both europium and terbium analogues 
of the complex (SS)-[Ln.L
18
(OH2)2]
3+
 when in the presence of bicarbonate. In doing 
this, it highlights the way in which the use of systems that report on changes in their 
environment via CPL modulation, as opposed to ratiometric measurements of total 
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intensity, can better facilitate the exploitation of terbium-based complexes as responsive 
probes.  
 
 
 
As for the systems that have previously been described in this section, the mechanism 
by which CPL modulation is brought about involves the displacement of coordinated 
water molecules from the lanthanide ion centre by the target analyte. Changes in the 
CPL spectral fingerprint for (SS)-[Eu.L
18
(OH2)2]
3+
 in the presence of bicarbonate were 
most pronounced in the ΔJ = 1 and ΔJ = 2 manifolds of the spectrum, with the relative 
sign of the two transitions observed in the ΔJ = 1 manifold becoming inverted. In the 
case of (SS)-[Tb.L
18
(OH2)2]
3+
, the CPL spectrum in the presence of bicarbonate showed 
most change within the ΔJ = 1 (545 nm) manifold and an increased intensity in the ΔJ = 
-1 (630 nm) manifold. Generally speaking, emission dissymmetry values were seen to 
increase in the presence of bicarbonate, in contrast to behaviour observed for the 
triamide based systems. It was suggested that the observed changes in the CPL 
fingerprint could be attributed to an altered local helicity at the lanthanide centre in the 
ternary complex, with a different twist angle and more rigid coordination geometry. It 
should be noted that the CPL spectral signature for (SS)-[Tb.L
18
(OH2)2]
3+
 was also 
recorded in the presence of citrate but no significant change in form was apparent in 
comparison to the unbound complex. 
 
 
 
 
 
(SS)-[Ln.L
18
(OH2)2]
3+
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Figure 1.28 Left: CPL spectra of (SS)-[Eu.L
18
(OH2)2]
3+ 
in the presence (blue) and absence (red) of 30 
mM sodium bicarbonate (295 K, 0.1 M NaCl). Right: CPL spectra of (SS)-[Tb.L
1.18
(OH2)2]
3+ 
(green); in 
the presence of 30 mM sodium bicarbonate (blue) and in the presence of 2 mM sodium citrate (yellow) 
(295 K, 0.1 M NaCl).
130 
 
The structurally related complex, (SS)-[Eu.L
19
(OH2)]
3+
, also recently reported in the 
literature, provides an example of a system in which a change in primary coordination 
environment as a result of the reversible displacement of one of the ligand donors leads 
to an altered CPL output.
131
 In this system, a sulphonamide moiety is incorporated into 
the ligand framework, which is deprotonated at high pH and able to bind to the 
lanthanide centre. However, at low pH this is not the case and the coordination sphere is 
instead completed by a bound water molecule. This pH dependent change in the primary 
coordination environment of the europium complex is signalled by alterations in the 
CPL fingerprint. At higher pH larger emission dissymmetry factors are apparent, 
perhaps indicative of a rigidified structure in which the angle between the electric and 
magnetic transition dipole vectors is subject to less variation over time in comparison to 
the structure at low pH. It was shown that variation in the emission dissymmetry factor 
with pH could be used to calculate a protonation constant for the complex, which was in 
good agreement with the value derived using total emission spectral changes. 
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Figure 1.29: Schematic showing structural changes accompanying alteration in solution pH for (SS)-
[Eu.L
19
(OH2)]
3+
. These changes result in alteration of both the total emission and CPL spectral signature, 
giving rise to changes in gem. The variation in the emission dissymmetry factor at 632 nm as a function of 
pH is shown (pKa = 5.65 (± 0.04), 295 K,  0.1 M NaCl).
131
 
 
1.5.3.2 Sensing through a change in complex configuration 
 
The second mechanism by which modulation of the CPL output may occur for an 
enantiopure lanthanide system is through a change in complex configuration. Such a 
change may comprise concerted arm rotation or an alternative rearrangement of the 
coordination polyhedron, both of which will lead to an altered CPL output.  
 
At present, there is only one example in the literature of a lanthanide-based system in 
which the modulation of the CPL output is brought about through a change in the 
complex configuration. In this system, (SSS)-[Ln.L
20
]
3+
, the ligand framework 
incorporates three chiral arms and a tetraazatriphenylene sensitising moiety and may be 
thought of as being derived from DOTA. Comparison of the CPL spectral form for this 
complex to that of related systems in which the absolute configuration has been verified 
by X-ray crystallography has allowed the identification of the major stereoisomer as one 
adopting a square antiprismatic Δ(λλλλ) configuration.84, 132 As is expected, the (RRR) 
(SS)-[Eu.L
19
(OH2)]
3+
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analogue of this complex adopts an enantiomeric Λ(δδδδ) configuration, verified by the 
observation of mirror image CPL spectra.  
 
 
 
 
 
 
 
 
 
 
The modulation of the CPL output from (SSS)-Δ-[Ln.L20]3+ was observed as part of a 
study in which the binding of this complex and its enantiomer by the protein serum 
albumin was examined using a variety of methods.
133
 Whilst no significant change in 
CPL spectral form was observed for the (RRR)-Λ stereoisomer, for (SSS)-Δ-[Ln.L20]3+ it 
was found that a dramatic modulation of the CPL output was induced in the presence of 
the protein serum albumin (Figure 1.30). The sign of the CPL signal was found to be 
inverted for the majority of transitions when the (SSS)-Δ complex was in the presence of 
this protein, for both the europium and terbium analogues. It was suggested that this 
observation was consistent with the preferential stabilisation of the Δ complex isomer as 
a Λ complex when in the presence of serum albumin.  
 
 
 
Figure 1.30: CPL spectra of (SSS)-[Ln.L
20
]
3+
 (left = Eu
3+
, right = Tb
3+
) in the presence (red) and absence 
(blue) of 15 µM bovine serum albumin (D2O, 295 K).
134
 
 
In a later publication, distinct similarity was noted between the CPL spectral form of 
(SSS)-[Eu.L
20
]
3+
 in the presence of serum albumin and the CPL spectrum recorded for a 
structurally related lanthanide complex, (SSS)-Λ-[Eu.L21]3+, in the absence of any 
additive.
135
   On the basis of this observation, it was concluded that the configurations 
adopted by these systems under the conditions mentioned above must be identical. Due 
(SSS)-Δ-[Ln.L20]3+ 
a. R = H 
b. R = CO2Me 
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to the fact that CPL inversion was noted for these systems in comparison to (SSS)-Δ-
[Ln.L
20
]
3+ 
it was suggested that they favour a square antiprismatic Λ-(δδδδ) 
configuration in solution, therefore implying that both cooperative arm rotation and ring 
inversion are induced in (SSS)-Δ-[Ln.L20]3+ when in the presence of serum albumin. 
Additional evidence to support the adoption of a Λ-(δδδδ) configuration by (SSS)-Λ-
[Ln.L
21
]
3+
 in solution was provided by 
1
H NMR data, which showed a reduced dipolar 
shift for (SSS)-Λ-[Eu.L21]3+ in comparison to (SSS)-Δ-[Eu.L20]3+, seemingly consistent 
with the proposed structural differences between the complexes. An alternative and 
perhaps more likely interpretation of this data would be that the reduced dipolar shift is 
indicative of the predominance of a twisted square antiprismatic stereoisomer in 
solution for (SSS)-Λ-[Ln.L21]3+. This hypothesis is supported by the fact that the 
splitting within the ΔJ = 1 band of the total emission spectrum is smaller for (SSS)-Λ-
[Eu.L
21
]
3+
 in comparison to (SSS)-Δ-[Eu.L20]3+. Taking into account the comparative 
CPL spectra, this revised interpretation of the data implies that (SSS)-Λ-[Ln.L21]3+ 
exists predominantly as the twisted square antiprismatic Λ-(λλλλ) stereoisomer in 
solution. Hence, the presence of serum albumin induces concerted arm rotation for 
(SSS)-Δ-[Ln.L20]3+ in solution and likely additional polyhedral distortion, but the 
configuration of the ring may be thought of as being conserved. Given the nature of the 
observed changes in the CPL spectral signature of (SSS)-[Ln.L
20
]
3+
, it must be the case 
that the structural changes induced in the presence of protein lead to alteration of the 
rotatory strength of the transitions, perhaps implying that in this case some relationship 
does exist between the twist angle around the principal axis, θ, and the angle between 
the magnetic and electric transition dipoles, τ. 
 
 
 
Figure 1.31: Comparison of the CPL spectral signature of (SSS)-[Eu.L
20
]
3+
 (blue) in the presence of 
added BSA (30 μM) with that observed for (SSS)-Λ-[Eu.L21]3+ (black) in the absence of any additive (295 
K, 0.1 M HEPES, pH 7.4, 15 µM complex).
135
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The nature of the interaction between (SSS)-[Ln.L
20
]
3+
 and serum albumin in solution 
has been probed using saturation transfer difference (STD) NMR techniques as well as 
via competitive binding studies and DFT modelling and docking simulations.
136
 These 
experiments have revealed that the formation of (SSS)-Λ-[Ln.L20]3+ involves non-
covalent interactions between the ligand sensitising moiety and the hydrophobic pocket 
in drug-site(II) of serum albumin. The phenylmethyl pendant arms were also shown to 
be implicated in the primary protein binding interaction, therefore providing some 
enlightenment with regard to the lack of CPL modulation observed for the (RRR)-Λ 
stereoisomer.  
 
Although further experiments exploiting the responsive CPL properties of (SSS)-Δ-
[Ln.L
20
]
3+
 have yet to be reported in the literature, it may be envisaged that instrumental 
advances could yet facilitate the exploitation of this complex in the intracellular 
mapping of serum albumin.  
 
1.6 Project aims 
 
As outlined in the preceding sections of this chapter, there exists in the literature a 
number of examples of lanthanide systems exploiting modulation of their CPL output to 
report on aspects of their environment, such as the presence of a chosen analyte. 
Notwithstanding these reports, it remains the case that the overwhelming majority of 
responsive lanthanide-based probes developed to date utilise changes in luminescence 
intensity or lifetime in order to convey information. In light of this fact, the aim of the 
work described in this thesis is to identify and develop new lanthanide-based systems 
where the presence of a given analyte is indicated by changes in the observed CPL 
output. The following chapters detail research conducted in pursuit of this aim. Chapter 
2 outlines the discovery of a novel mechanism through which CPL modulation can be 
brought about, and explores the possibility of its application to the sensing of acute 
phase proteins. Meanwhile, Chapter 3 builds on this work, demonstrating the way in 
which this mechanism may also be exploited for the determination of enantiomeric 
excess in solutions containing a known concentration of a chosen chiral analyte. Finally, 
Chapter 4 focuses on work carried out with a view to the identification of macrocyclic 
lanthanide systems with potential utility in chiral quenching studies. 
 
  
 
 
  
CHAPTER TWO 
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2.1 Introduction 
 
The contents of this chapter detail work undertaken in the pursuit of a novel lanthanide-
based system for use as a responsive CPL probe. The initial focus of the work described 
herein was the synthesis and characterisation of an enantiopure complex, derived from a 
chiral ligand framework. The synthetic target was chosen following consideration of 
work detailed in a communication published in 2010, concerning the racemic complex 
[Ln.L
22
]
+
.
137
 In this communication it was reported that the emission spectral fingerprint 
of [Eu.L
22
]
+
 underwent a dramatic change in form when in the presence of the protein 
serum albumin, showing a large increase in the relative intensity of the ΔJ = 2 transition 
and changes in the splitting of the ΔJ = 1 manifold. As was outlined in Section 1.3.2 of 
Chapter 1, changes in the emission spectral profile of a europium complex such as these 
are typically indicative of an alteration in the metal ion coordination environment.  
 
 
[Ln.L
22
]
+ 
(R)-[Ln.L
23
]
+
 
Ln = Eu
3+
, Tb
3+
 
 
As was illustrated in the previous chapter, the circularly polarized emission of a given 
enantiopure lanthanide complex is also typically sensitive to changes in the metal ion 
coordination environment. Hence, it was proposed that by synthesising an analogue of 
[Ln.L
22
]
+
 containing a chiral ligand framework, it would be possible to create a 
responsive probe where interactions with chiral species, such as serum albumin, were 
not only signalled by changes in the emission spectral form but also by variations in the 
CPL fingerprint.  
 
On the basis of the fact that the introduction of a stereogenic centre α to the ring 
nitrogen has been observed to impart rigidity into lanthanide complexes, leading to one 
diastereomeric form being favoured in solution, the complex (R)-[Ln.L
23
]
+
 was chosen 
as the synthetic target.
80
 It was hoped that the small alteration to the ligand framework 
would not affect the analyte binding abilities of the enantiopure complex, in comparison 
to [Ln.L
22
]
+
. 
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2.2 Synthetic aspects 
 
2.2.1 Synthesis of the chromophore 
 
The azaxanthone chromophore was synthesised according to previously described 
methods.
138
 The synthetic pathway is shown in Scheme 2.1. 
 
Scheme 2.1: Chromophore synthesis. 
 
Reaction of 2-methyl-1-azaxanthone with N-bromosuccinimide, using dibenzoyl 
peroxide as a radical initiator yielded a mixture of the unreacted reagent, along with the 
mono- and di-brominated products. The mono-brominated product was isolated for use 
by column chromatography on silica gel and is characterised by the presence of a singlet 
at ~ 4.6 ppm in its 
1
H NMR spectrum, corresponding to the methylene group protons.  
 
 
Figure 2.1: Comparison of  
1
H NMR spectra for 2-methyl-1-azaxanthone (1) and its mono- (2) and di-
brominated (3) analogues (CDCl3, 295 K, 400 MHz). 
10 
10 
10 
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2.2.2 Synthesis of the chiral pendant arm 
 
In previous instances, the incorporation of an enantiomerically pure glutarate arm into a 
cyclen based complex has been achieved by the use of either (S)-2-bromopentanedioic 
acid 5-benzyl ester 1-tert-butyl ester or its 1,5-dimethyl ester analogue.
139, 140 
 Taking 
into account the nature of the target complex it may at first seem intuitive to attempt the 
synthesis of (S)-2-bromopentanedioic acid 5-methyl ester 1-tert-butyl ester. However, 
the preparation of this species from the commercially available precursor, (S)-glutamic 
acid 5-methyl ester, via the established procedure used in the synthesis of the 5-benzyl 
ester analogue mentioned above (Scheme 2.2) is precluded. The methyl ester would be 
likely to undergo hydrolysis under the acidic conditions used in the first stage of this 
synthesis, yielding a species in which neither of the carboxylate groups are protected. 
(S)-2-Bromopentanedioic acid 5-benzyl ester 1-tert-butyl ester was therefore prepared 
in accordance with Scheme 2.2. In this derivative, the two carboxylate groups are 
protected in an orthogonal manner, facilitating their selective removal at different stages 
of the subsequent synthetic procedure. 
 
 
Scheme 2.2: Synthetic pathway for the preparation of (S)-2-bromopentanedioic acid 5-benzyl ester 1-tert-
butyl ester. The overall yield was 13%. 
 
In the initial step of the reaction, a solution of aqueous sodium nitrite was added 
dropwise to a solution of the glutamic acid based starting material and sodium bromide 
salt in 1 M HBr. The temperature of the reaction solution was maintained at -5 
o
C over 
the course of the addition. The combination of sodium nitrite and the mineral acid HBr 
leads to the in situ generation of nitrous acid, which induces the formation of a 
diazonium salt from the starting material. The diazo group is easily displaced by 
bromide in two successive SN2 reactions, in this case yielding (S)-2-bromopentanedioic 
acid 5-benzyl ester. This species was isolated and used without purification in the next 
step of the reaction, which involved the protection of the carboxylate functionality as a 
tert-butyl ester. In order to achieve the esterification, the glutamic acid derivative was 
dissolved in tert-butyl acetate which was then acidified using perchloric acid. The 
solution was left to stir at room temperature overnight and, following work up, the 
product was purified by column chromatography. 
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2.2.3 Synthesis of the ligand 
 
In order to accomplish the synthesis of the target ligand, L
23
,
 
it was first necessary to 
produce 1,4,7,10-tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester, 1, a 
protected cyclen derivative. This was achieved using a published procedure and gave 
the desired product in reasonable yield.
141
 The full ligand synthesis is shown in Scheme 
2.3. 
 
 
Scheme 2.3: Complete synthesis of L
23
.  
 
The initial step in the synthetic scheme outlined above involved the mono-alkylation of 
the protected cyclen derivative, 1. It was decided that the best way to proceed would be 
via the mono-alkylated species 3. This is because it is known that di-alkylation of 1 with 
tert-butyl bromoacetate is facile, with the reaction between these two species being 
2 
4 
3 
L
23 
6 
1 
5 
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utilised in the synthesis of a frequently used cyclen derivative known as DO2A.
141
 
Hence, preferential formation of the mono-alkylated species would require extremely 
well-tuned reaction conditions. It was thought that the comparatively increased steric 
bulk of the glutarate derivative 2 may facilitate selective formation of a mono-alkylated 
species. The chiral arm was therefore introduced under standard conditions (CH3CN, 
K2CO3), with the SN2 nucleophilic substitution reaction giving 3 in moderate yield. 
Competitive formation of the di-alkylated species did not appear to be yield-limiting 
and in a subsequent attempt at this reaction, it was found that the yield was not 
improved if the reaction was left for a longer time period.  
 
Following purification of 3 by column chromatography, the second alkylation was 
carried out with tert-butyl bromoacetate. The reaction was carried out in a small volume 
of acetonitrile in order to maximise the rate and extent of reaction. The benzyl 
protecting groups were subsequently cleaved by hydrogenolysis using a heterogeneous 
catalyst, which was removed from the product, 5, by filtration through celite. Before the 
azaxanthone chromophores could be coupled onto the cyclen ring it was necessary to 
reprotect the carboxylate group of the chiral pendant arm, this time as a methyl ester. 
This was achieved in an acid-catalysed reaction in methanol, which was monitored by 
mass spectrometry. The final step in the preparation of L
23
 involved another alkylation 
reaction. This time, 2-bromomethyl-1-azaxanthone was coupled onto the cyclen ring 
twice, again via an SN2 nucleophilic substitution reaction carried out under standard 
conditions. The reaction was checked by TLC to confirm that the brominated starting 
material had been completely consumed, before being worked up.  
 
An attempt was made to purify the crude product L
23
 by column chromatography on 
silica gel. However, it did not prove possible to achieve the separation of the desired 
product using this method. The decision was made to continue with the synthesis of (R)-
[Ln.L
23
]
+
 using the crude sample of L
23
, anticipating that (R)-[Ln.L
23
]
+
 could later be 
purified by preparative HPLC.   
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2.2.4 Lanthanide complex formation and purification 
 
Formation of the lanthanide complex required two further steps (Scheme 2.4). 
 
 
 
Scheme 2.4: Formation of the lanthanide complex, (R)-[Ln.L
23
]
+
. 
 
Initially, attempts were made to monitor the removal of the tert-butyl protecting groups 
using TFA by 
1
H NMR spectroscopy. However, solubility issues in both MeOD and 
CDCl3 hampered these attempts. This problem was resolved by instead using LCMS to 
monitor the progress of the deprotection reaction. Once the cleavage was complete, it 
was possible to proceed to the second stage of the reaction scheme. Metal complexation 
was confirmed, prior to isolation of each of the complexes, by removing a sample of the 
reaction mixture and obtaining its emission spectrum in water. In each case, the 
characteristic emission spectra expected for europium and terbium were visible, 
following excitation of the azaxanthone chromophore at 336 nm.  
 
Once the complexes had been isolated, samples were submitted for HPLC. For both the 
europium and terbium complexes, this analysis revealed the presence of two major 
luminescent species in roughly equal abundance. Further analysis using LCMS revealed 
the identity of these luminescent species, with both of the samples being found to be 
mainly comprised of a mixture of the desired complex and its hydrolysed analogue, (R)-
[Ln.L
24
].  
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Figure 2.2: HPLC trace obtained for (R)-[Tb.L
23
]
+
 following complexation of crude L
23
. 
 
Since there was no evidence of the ligand L
24
 being present in the crude ligand sample 
used for complexation, it was inferred that the hydrolysis of the methyl ester occurred 
during the complexation procedure. This is not an unreasonable theory as both acidic 
and basic conditions were used at different stages of this procedure, potentially leading 
to hydrolysis. Preparative HPLC was used to obtain pure samples of (R)-[Ln.L
23
]
+
 and 
(R)-[Ln.L
24
] (Ln = Tb
3+
, Eu
3+
).  
 
2.3 Characterisation and structural analysis 
 
The purified europium and terbium complexes of L
23
 were characterised using various 
techniques, some of which served simply to verify the identity of the isolated 
complexes. For example, high resolution mass spectrometry allowed the determination 
of accurate masses. Due to the fact that inner sphere water molecules are typically not 
observed in mass spectrometric analyses, it was necessary to employ emission 
spectroscopic techniques to estimate the hydration state of the complexes, q'. The results 
of this characterisation are discussed in the following section. 
 
 
 
 
 
(R)-[Tb.L
23
]
+
 (R)-[Tb.L
24
] 
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2.3.1 Estimation of the complex hydration state, q' 
 
For a given europium or terbium complex, the diminution of the metal-based emission 
intensity over time will always occur more slowly in D2O than in water, reflecting the 
poorer efficiency of energy transfer from the lanthanide excited state to XD oscillators, 
in comparison to XH oscillators.
55
 The excited state decay data presented in Figure 2.3
i
 
serves to illustrate this.  
 
  
Figure 2.3: Excited state decay profiles for europium emission at 620 nm from solutions of (R)-[Eu.L
23
]
+
 
as a function of delay time in D2O (red) and H2O (blue). The gradient of Ln(intensity) vs. delay time 
gives the radiative decay constant. It should be noted that the lifetime of the emission is the reciprocal of 
this value. 
 
As is shown in Figure 2.3
ii
, manipulation of the excited state decay data collected for a 
given lanthanide complex can allow determination of rate constants for the depopulation 
of the excited state in both water and D2O. If determination of such rate constants is 
possible, the number of water molecules bound to the metal centre when a europium or 
terbium complex is in solution may be estimated using equations 11 and 12, where n is 
the number of proximate carbonyl-bound amide groups.
55
 
 
                                     
                                                     (eqn. 11) 
 
                                                 
                                                     (eqn. 12) 
 
In order to calculate the q' value of the europium and terbium complexes of L
23
 the 
decay of the intensity of the lanthanide emission was initially recorded in water. Next, 
following lyophilisation, the complex samples were re-dissolved in D2O and left 
overnight to facilitate the displacement of any coordinated water molecules by D2O 
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molecules. Finally, the D2O was removed under vacuum and replaced with fresh D2O 
before the emission decay was again measured.  In each case, a monoexponential decay 
was observed, meaning the rate constants for the depopulation of the lanthanide excited 
state could be calculated for each complex in both of these media. Appropriate 
substitution of the values obtained into equations 11 and 12 allowed estimation of the 
hydration state for each of the complexes. 
 
Table 2.1: Experimentally determined radiative rate constants and derived values of q' (± 20%) for 
europium and terbium complexes of L
23
 (295 K, pH 5.5). 
 
Complex      / ms
-1
      / ms
-1 q' 
(R)-[Eu.L
23
]
+ 
2.13 0.75 1.36 
(R)-[Tb.L
23
]
+
 0.55 0.32 0.85 
 
As can be seen from Table 2.1, analysis of the data obtained in the measurements 
outlined above led to the conclusion that there is one water molecule located in the inner 
coordination sphere of the europium and terbium complexes of L
23
. This was an 
unexpected result, as the q' value given in the literature for the racemic parent complex 
[Ln.L
22
]
+
 was ~ 0 for both the europium and terbium analogues.
137
 The reproducibility 
of this literature result was subsequently investigated; using the methodology outlined 
for the complexes of L
23
, appropriate rate constants were determined and the hydration 
state of the europium and terbium complexes of L
22
 was estimated using these values 
(Table 2.2).  
 
Table 2.2: Experimentally determined radiative rate constants and derived values of q' (± 20%) for 
europium and terbium complexes of L
22
 (295 K, pH 5.5). Literature data is taken from reference 137. 
 
Complex 
Literature data Experimental data 
     / ms
-1
      / ms
-1
 q'      / ms
-1
      / ms
-1 q' 
[Eu.L
22
]
+ 
1.02 0.65 0.14 2.08 0.61 1.46 
[Tb.L
22
]
+
 0.43 0.36 0.05 0.66 0.48 0.60 
 
As can be seen from the data presented in Table 2.2, the experimentally determined rate 
constants for the depopulation of the lanthanide excited state of the complexes of L
22
 
were not found to be in agreement with the literature data. A hydration state of ~ 1 was 
calculated for both the europium and terbium complexes. The agreement of the 
experimentally determined values with those observed for complexes of L
23
 suggests 
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that the      and      values given in the literature for europium and terbium 
complexes of L
22
 may be erroneous. It was concluded that the lanthanide complexes 
adopt the structures shown below when in solution. 
 
[Ln.L
22
(OH2)]
+ 
(R)-Ln.L
23
(OH2)]
+
 
Ln = Eu
3+
, Tb
3+
 
 
Having determined the hydration state of the europium and terbium complexes of L
23
, a 
number of other characterisation techniques were employed to facilitate the completion 
of a detailed structural analysis of these complexes. This structural analysis was carried 
out with reference to data collected for the racemic parent system and is discussed in 
detail in the following sections, which focus on individual methods of characterisation 
and highlight relevant observations and conclusions. 
 
2.3.1 Emission spectroscopy 
 
Emission spectra were obtained for [Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
 (Ln = Tb
3+
, 
Eu
3+
) in aqueous solution (Figure 2.4). In each case, minimal ligand fluorescence was 
seen, consistent with observations made previously for other cyclen-based lanthanide 
complexes including 1-azaxanthone derivatives as the sensitising moiety.
138
 The 
emission spectral profile observed for the two europium complexes was extremely 
similar, with slight differences apparent in the relative intensity of the various emission 
bands, particularly within the hypersensitive ΔJ = 2 and ΔJ = 4 manifolds. Meanwhile, 
for the terbium complexes, the spectral form of the metal-based emission was found to 
show a striking resemblance. These observations suggested that the coordination 
environment of the lanthanide ion bears a high degree of similarity in complexes of both 
L
22
 and L
23
. It was therefore anticipated that the analyte binding capabilities initially 
observed for [Eu.L
22
(OH2)]
+
 in the presence of HSA would be preserved in this newly 
synthesised analogue.   
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Figure 2.4: Emission spectra of [Ln.L
22
(OH2)]
+
 (left) and (R)-[Ln.L
23
(OH2)]
+
 (right) in water after 
excitation at 336 nm. Europium spectra are shown at the top and terbium at the bottom (295 K, pH 7.4, 
0.1 M NaCl). 
 
Inspection of the form of the ΔJ = 1 manifold within the emission spectra obtained for 
[Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+ 
revealed further information about the solution 
structures of the two complexes. Due to the fact that the 
5
D0 excited state of europium is 
singly degenerate, a maximum of three bands should be visible within this manifold if 
there is only one luminescent species present in solution, corresponding to A1-A2, A1-E1 
and A1-E2 transitions.
26
 Within this limit, the number of separate bands observed is 
influenced by the symmetry of the complex. For europium complexes of high 
symmetry, such as Cn, simpler emission spectra with fewer bands within each manifold 
are typically observed. With respect to the ΔJ = 1 manifold the three transitions 
mentioned above are typically closer or identical in energy for complexes of higher 
symmetry, leading to the observation of less than three bands in this manifold. In cases 
where two or three bands are observed within the ΔJ = 1 manifold, it is possible to 
calculate the splitting between the A1-A2 and A1-E1,2 components, which is directly 
proportional to the second-order crystal field coefficient,   
 .
142 
Given that this 
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parameter is determined primarily by the local symmetry and donor polarizability, 
analysis of the splitting between the A1-A2 and A1-E1,2 components of the ΔJ = 1 
manifold can prove informative in the comparison of lanthanide complexes derived 
from structurally related ligands.  
 
The ΔJ = 1 manifold of both [Eu.L22(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+ 
was found to be 
composed of three main bands, implying that both complexes adopt structures of low 
symmetry in solution. For the racemic complex [Eu.L
22
(OH2)]
+
, the second and third 
bands visible within the ΔJ = 1 manifold appeared to show further splitting, implying 
the presence of multiple luminescent species in solution. Meanwhile, for (R)-
[Eu.L
23
(OH2)]
+
 no such additional splitting was evident and the splitting between the 
A1-A2 and A1-E1,2 components was determined as approximately 308 cm
-1
.  
 
If it is assumed that the multiple species present in solution in the case of 
[Eu.L
22
(OH2)]
+
 are different stereoisomers of the complex (i.e. SAP and TSAP species), 
then these observations lend support to the idea that the inclusion of a stereogenic centre 
in the ligand framework of (R)-[Ln.L
23
(OH2)]
+ 
favours the existence of a single 
diastereomer in solution. Additional methods of structural analysis were subsequently 
employed in order to gain more information with regard to the number and identity of 
species present in solution for both [Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
. 
 
2.3.2 
1
H NMR spectroscopy 
  
The utility of 
1
H NMR spectroscopy in the structural analysis of cyclen-based 
lanthanide complexes is well recognised, with this method of analysis having been 
found to be of value in determining the relative distribution of SAP and TSAP 
stereoisomers in solution for a given DOTA-derived lanthanide complex (see Section 
1.4.2 of Chapter 1). Generally speaking, the chemical shift range of the resonances 
arising as a result of the presence of the SAP stereoisomer in solution will be larger than 
that of the TSAP stereoisomer, for such complexes.
30
  
 
In light of the facts outlined above, it was decided that 
1
H NMR studies could prove 
valuable in the gathering of more information about the number and identity of species 
present in solution for both [Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
. Owing to the fact 
that line broadening is typically more apparent for terbium complexes than their 
europium analogues, 
1
H NMR spectra were obtained for [Eu.L
22
(OH2)]
+
 and (R)-
[Eu.L
23
(OH2)]
+ 
only. Spectra were recorded in D2O at 400 MHz.  
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Figure 2.5: 
1
H NMR spectra obtained for [Eu.L
22
(OH2)]
+
 (top) and (R)-[Eu.L
23
(OH2)]
+
 (bottom) (D2O, 
295 K, 400 MHz), * indicates solvent resonances. 
 
Two sets of proton resonances were clearly discernible in the 
1
H NMR spectrum 
obtained for [Eu.L
22
(OH2)]
+
, consistent with the presence of multiple species in 
solution. The relative intensity of the observed sets of resonances was roughly 4:1. For 
the major species, the chemical shift range extended from around +54 ppm, for the most 
shifted axial ring resonance, to -35 ppm. Meanwhile, the chemical shift range was 
smaller for the minor species, extending from approximately +34 to -30 ppm. It was 
concluded that the observed sets of resonances were most likely indicative of a 4:1 
distribution of 9-coordinate SAP and TSAP stereoisomers in solution, each with one 
inner sphere water molecule. Unfortunately, the linewidth of the 
1
H NMR signals 
observed for [Eu.L
22
(OH2)]
+
 was found to be too broad for any 2D NMR studies to be 
carried out, even when the sample was cooled down to 273 K. This precluded 
verification of the above hypothesis by methods such as EXSY. It should be noted that, 
although the observation of such a large change in chemical shift range is unusual for 
complexes of this type, it is not without precedent, having been observed in europium 
complexes of  tetra-glutarate ligands.
81
 
 
In the case of (R)-[Eu.L
23
(OH2)]
+
 only a small amount of material was available, 
meaning that the quality of the 
1
H NMR spectrum obtained was relatively poor. 
*    * 
* 
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Importantly, the appearance of the spectrum was consistent with the presence of only 
one species in solution. The range of chemical shifts for the observed resonances 
stretched from roughly +58 to -39 ppm, indicating that the species present in solution 
adopted the same SAP geometry as the major species visible in the 
1
H NMR spectrum 
of  [Eu.L
22
(OH2)]
+
.  
 
2.3.3 CPL spectroscopy 
 
CPL spectra for [Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
 (Ln = Tb
3+
, Eu
3+
) in D2O were 
recorded with the assistance of Dr R. D. Peacock at Glasgow University. As anticipated, 
no circularly polarized emission was observed for [Ln.L
22
(OH2)]
+
, providing 
confirmation of the fact that this complex exists as a racemic mixture in solution. In 
contrast, the presence of circularly polarized emission for (R)-[Ln.L
23
(OH2)]
+
 provided 
further evidence for the theory that the introduction of a stereogenic centre at a position 
α to the ring N in this complex leads to the formation of one diastereomeric species in 
solution. 
 
  
Figure 2.6: Representative CPL spectra showing the circularly polarized emission of (R)-[Eu.L
23
(OH2)]
+ 
(left) and (R)-[Tb.L
23
(OH2)]
+ 
(right) in D2O (295 K). 
 
As was outlined in Section 1.2.2 of Chapter 1, a quantitative assessment of the 
information contained in CPL spectra is possible by calculation of emission 
dissymmetry factors, which were devised by Emeis and Oosterhoff and can be defined 
using equation 1.
13
 
 
                                                           
      
    
                                                   (eqn. 1) 
 
Emission dissymmetry factors for selected transitions in the spectra displayed in Figure 
2.6 are given overleaf in Table 2.3.  
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Table 2.3: Selected emission dissymmetry factors for (R)-[Eu.L
23
(OH2)]
+
 and (R)-[Tb.L
23
(OH2)]
+ 
calculated using the data shown in Figure 2.6. 
 
Complex 
gem 
ΔJ = 1 (λ) ΔJ = 2 (λ) 
(R)-[Eu.L
23
(OH2)]
+ 
-0.17       
(597) 
+0.04    
(605) 
+0.03      
(624) 
-0.04     
(631) 
 ΔJ = 1 (λ) 
(R)-[Tb.L
23
(OH2)]
+ 
-0.09             
(546) 
+0.03            
(554) 
-0.04             
(559) 
 
In terms of the sign and sequence of the transitions, the CPL signature of (R)-
[Eu.L
23
(OH2)]
+
 is similar to the spectrum previously reported for (RRR)-[Eu.L
25
]
3+
.
132 
The absolute configuration of this complex was assigned based on the similarities of its 
CPL spectrum to that of (RRRR)-[Eu.L
26
]
3+
, whose absolute configuration has been 
verified by X-ray crystallography.
86 
This suggests that (R)-[Eu.L
23
(OH2)]
+
 adopts a 
square antiprismatic Λ(δδδδ) configuration, with a right-handed ring conformation and 
left-handed helicity in the layout of the pendant arms. This conclusion is in agreement 
with the hypothesis made previously on the basis of 
1
H NMR spectral data obtained for 
this complex in solution.  
 
  
(RRR)-[Eu.L
25
]
3+
 (RRRR)-[Eu.L
26
]
3+ 
 
2.4 Preliminary investigations into interactions with proteins 
 
Having completed a thorough structural analysis of the newly synthesised complex (R)-
[Ln.L
23
(OH2)]
+
 and confirmed that it appears to adopt a similar structure in solution to 
[Ln.L
22
(OH2)]
+
, attention was turned to carrying out an assessment of the potential of 
this enantiopure complex as a responsive CPL probe. In order for a complex to be of 
any utility in such a role, it must show selectivity for the desired analyte in a 
competitive environment. Hence, it was decided that the binding of the complexes 
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[Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
 with a selection of proteins should be 
investigated. A total of six proteins were chosen, all of which are relatively abundant in 
human serum.
143
 Table 2.4 gives the normal range of these proteins in human serum, 
along with their pI values. It is important to note that several of the proteins selected 
belong to a class of proteins known as 'acute phase proteins'. These proteins can be 
defined as those whose plasma concentration increases (positive acute-phase proteins) 
or decreases (negative acute-phase proteins) by more than 25% in response to 
inflammation.
144 Both α1-AGP and α1-AAT can be described as positive acute phase 
proteins, whilst serum albumin and transferrin are negative acute phase proteins. The pI 
value of a protein is the pH at which it will carry an overall neutral surface charge.  
 
Table 2.4: Abundance and pI values for the six selected serum proteins. 
 
Protein Normal Range / µM pI 
Serum albumin 500-750 4.7 – 5.1 
γ-Immunoglobulin-G 50-120 6.4 - 9 
α1 -Antitrypsin 40-80 4.9 – 5.1 
apo-Transferrin 25-40 6.5 
α1 -Acid glycoprotein 12-32 2.7 – 3.1 
Fibrinogen 6-14 5.6 
 
At this point it may also be noted that of the proteins selected, both serum albumin and 
α1-AGP are known to be important drug-binders.
145, 146
 It may therefore be anticipated 
that  both complexes should demonstrate an ability to bind to α1-AGP, with the binding 
event likely to be indicated by well-defined changes in spectral form, as was previously 
noted for [Eu.L
22
(OH2)]
+
 in the presence of HSA.  
 
2.4.1 Examining changes in emission spectral form 
 
Six pairs of titrations were carried out monitoring the luminescence emission intensity 
of [Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+
 in gradually increasing amounts of each 
protein. These initial investigations utilised the europium complexes rather than their 
terbium analogues because for europium the emissive 
5
D0 excited state is non-
degenerate, meaning that the emission spectra are comparatively simple and their 
interpretation relatively straightforward.
147
 In addition, as has been outlined previously, 
the emission spectra of europium complexes are more sensitive to changes in the 
lanthanide coordination environment than their terbium counterparts.  
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Incremental additions of protein were made to 1 mL samples of each complex, which 
had been dissolved in aqueous solution at pH 7.4 containing 0.1 M NaCl, to give 
solutions where the concentration of complex was 30 µM. Additions were halted when 
the relevant physiological concentrations of the proteins had been reached. The pH, 
temperature and ionic strength of the samples were kept constant for each experiment, 
with pH adjustment being carried out after each addition of protein, using conc. HCl(aq) 
and conc. NaOH(aq). The emission spectral profile was recorded between 400 nm and 
720 nm. This allowed changes in the intensity of fluorescence from the azaxanthone 
chromophore, a broad band between roughly 400 and 500 nm, to be monitored, along 
with metal-based emission.  
 
In every case, some increase in the fluorescent emission intensity in the region between 
400 and 550 nm was apparent. The most considerable change in fluorescence in this 
region was observed in the case of HSA and γ-immunoglobulin-G, which were 
examined at higher concentrations than the other proteins due to their higher abundance 
in human serum. It is therefore reasonable to attribute this to fluorescence from the 
protein itself, which contains fluorescent moieties, such as the amino acids tyrosine and 
tryptophan. Meanwhile, in terms of the metal-based emission, a variety of responses 
were observed. Figure 2.7 shows the variation in the metal-based emission of 
[Eu.L
22
(OH2)]
+
 upon addition of α1-AGP. 
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Figure 2.7: Variation of the emission spectral profile of [Eu.L
22
(OH2)]
+
 upon addition of α1-AGP (295 K, 
pH 7.4, 0.1 M NaCl, 30 µM complex). Inset: Calibration curve showing variation of the observed 
emission intensity versus [α1-AGP]. The line shows the fit to the experimental data obtained using a non-
linear least squares fitting algorithm, assuming 1:1 binding stoichiometry. 
 
Although some alteration of spectral form was observed in the majority of cases, the 
dramatic changes in the emission profile that are apparent in Figure 2.7 were not typical 
of every system examined. When considering changes in the metal-based emission, apo-
transferrin proved particularly exceptional. Neither complex showed any significant 
change in its spectral fingerprint when in the presence of this protein, although some 
quenching of the emission intensity was apparent. Meanwhile for fibrinogen, significant 
quenching of the emission intensity was observed for each complex. This was 
accompanied by minor changes in spectral form, which were more apparent for the 
complex [Eu.L
22
(OH2)]
+
 and were only induced when the concentration of protein was 
at the upper limit of its normal range in human serum. These observations are perhaps 
unsurprising, as neither of these proteins is known to exhibit drug-binding 
characteristics. 
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Figure 2.8: Europium emission spectral changes following addition of human apo-transferrin (left, 40 
µM) and bovine fibrinogen (right, 15 µM) to [Eu.L
22
(OH2)]
+
 (blue = initial, red = final, 295 K, 0.1 M 
NaCl, pH 7.4, 30 µM complex).   
 
The remaining proteins gave more significant changes in spectral form, meaning that a 
1:1 binding isotherm could be fitted to the data collected using non-linear least squares 
iterative analysis. By doing this it was possible to estimate the binding affinity (Table 
2.5). It is important to note that the values given in Table 2.5 can only be treated as 
estimates of the binding affinity, as the stoichiometry of the binding interaction was not 
determined experimentally. Nevertheless, it is still useful to quantify the binding 
interactions in this manner as it enhances the comparative analysis that can be carried 
out for the systems studied. 
 
Table 2.5: Comparison of the experimentally determined apparent binding constants for [Eu.L
22
(OH2)]
+
 
and (R)-[Eu.L
23
(OH2)]
+
. Standard deviation errors associated with data fitting are shown in brackets. 
 
Complex 
logK 
HSA α1-AGP α1-AAT γ-Ig-G 
[Eu.L
22
(OH2)]
+ 
4.00 (± 0.02) 5.73 (± 0.06) 4.72 (± 0.01) 3.91 (± 0.02) 
(R)-[Eu.L
23
(OH2)]
+ 
3.91 (± 0.01) 5.84 (± 0.05) 4.58 (± 0.01) 3.58 (± 0.03)  
 
In the case of HSA, α1-AGP and α1-AAT, well-defined spectral transformations were 
observed over the physiological range for each complex, with limiting spectra being 
attained. For γ-immunoglobulin-G the spectral fingerprint remained relatively 
unchanged over the physiological range of protein, particularly in the case of the 
complex (R)-[Eu.L
23
(OH2)]
+
. More significant variation in the emission spectral form 
was apparent at concentrations exceeding the normal range. The limiting spectra for 
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each complex in the presence of HSA, α1-AGP and α1-AAT are shown below, along 
with the originally recorded emission spectra. 
 I II 
A 
  
B 
  
C 
  
D 
  
 
Figure 2.9: Representative emission spectra showing the metal-based emission of [Eu.L
22
(OH2)]
+
 (I) and 
(R)-[Eu.L
23
(OH2)]
+
 (II): (A) complex only; (B) complex + 0.7 mM HSA; (C) complex + 0.03 mM α1-
AGP; (D) complex + 0.07 mM α1-AAT (295 K, pH 7.4, 0.1 M NaCl, 30 µM complex). 
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As can be seen from the spectra presented in Figure 2.9 and the values given in Table 
2.5, the complexes tended to mimic each other's behaviour in the presence of protein. 
The appearance of the limiting spectra in the presence of HSA is almost identical and 
the spectra obtained in the presence of α1-AGP and α1-AAT show a marked similarity, 
with minor differences occurring in the hypersensitive ΔJ = 2 and ΔJ = 4 bands. 
Meanwhile, the equilibrium binding constants are comparable in each of these cases. 
These results suggest that the protein binding interactions do not involve the ligand 
glutarate substituent.  
 
In each of the cases depicted in Figure 2.9, the addition of protein to the aqueous 
samples of the complexes led to a dramatic change in spectral form. The emission 
spectra obtained in the presence of these proteins are characterised by a large increase in 
the relative intensity of the ΔJ = 2 band, suggesting a change in the axial donor 
polarizability. This may be attributed to the replacement of a neutral N donor with a 
polarizable charged oxygen donor, which could take the form of an aspartic or glutamic 
acid side chain carboxylate group. It is interesting to note that in some cases the metal-
based emission intensity was found to show an overall increase when in the presence of 
protein. For example, the quantum yield of [Eu.L
22
(OH2)]
+
 was found to double when in 
the presence of α1-AGP at a concentration of 50 µM, increasing from 4% to 8%. 
 
Although the general changes discussed above are characteristic of all three of these 
proteins, it is apparent that the more detailed form of the limiting spectra seems to 
depend on the protein that is present. It is interesting to note that closer inspection of the 
limiting spectra shown in Figure 2.9 reveals that for both complexes in the presence of 
HSA there are two components visible within the ΔJ = 0 band. Meanwhile, for the α1-
AGP and α1-AAT bound species only one component is visible within this band. The 
number of components in this band correlates directly to the number of chemically 
distinct emissive species that are present, which are not undergoing exchange on the 
millisecond timescale. Additional differences exist in the pattern of splitting within the 
ΔJ = 1 manifold. In the presence of HSA there are at least four components visible 
within this manifold, whilst for the α1-AGP and α1-AAT bound species three well-
defined components are visible. The presence of more than three components within 
this manifold is another indicator that there is more than one chemically distinct species 
present in the HSA-bound sample. 
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Figure 2.10: Representative emission spectra showing the ΔJ = 0 and ΔJ = 1 manifolds of the europium 
emission for (R)-[Eu.L
23
(OH2)]
+
 in the presence of 0.7 mM HSA (left) and 0.03 mM α1-AGP (right) (295 
K, pH 7.4, 0.1 M NaCl, 30 µM complex). 
 
At this point it is important to note that significant differences exist between the 
structures and known drug binding characteristics of HSA and α1-AGP. For example, 
studies have indicated that human serum albumin has multiple sites for ligand binding 
whilst α1-AGP has a single ligand binding site. A crystal structure obtained for α1-AGP 
has shown that there is one ligand pocket, which has three separate lobes.
146
 Two of 
these lobes are negatively charged and smaller in size than the deep main lobe, which is 
completely nonpolar. In contrast, the two major binding sites in serum albumin are 
known to have cationic residues near the surface, including Arg257, Arg222, Lys199 
and Lys195.
148
 Taking these differences into consideration, it is perhaps unsurprising 
that the complexes appear to be bound in a different manner by these two proteins. 
 
In contrast to HSA and α1-AGP, α1-AAT is not a known drug binder and the dramatic 
changes in spectral form that were observed for each complex in the presence of this 
protein were therefore somewhat unexpected. The identical nature of the emission 
spectra obtained for each complex in the presence of α1-AGP and α1-AAT is intriguing 
and suggests identical coordination environments around the metal centres. Although 
some homology does exist in the DNA sequence of the genes coding for these proteins, 
the only conserved region is located in the 5'-untranslated region and therefore does not 
yield any homology in the amino-acid sequences.
149 
 
 
The identical nature of the emission spectra for each complex in the presence of α1-AGP 
and α1-AAT, which are both characterised by a large increase in the relative intensity of 
the ΔJ = 2 band, prompted an investigation into the structural similarity of these two 
proteins. Protein structural alignment studies were carried out by Dr J. Sanderson 
(Durham University) using the FATCAT  algorithm for representative PDB entries for 
α1-AGP (3KQ0) and α1-AAT (9API).
150, 151
 It became apparent that although there was 
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very little overall structural similarity between the two proteins, some common features 
were present. Of particular significance was the location of two sets of glutamic acid 
residues. Firstly Glu-36, which is located over the entrance to the binding pocket in α1-
AGP, was found to be in close proximity to Glu-152 of α1-AAT in the modelled 
structure. In addition, Glu-64, which is located in the hydrophobic binding pocket of α1-
AGP, was found to lie in close proximity to Glu-206 of α1-AAT. These results support 
the hypothesis that the binding event is associated with the coordination of a polarizable 
charged oxygen donor to the metal centre in an axial position. 
 
 
 
Figure 2.11: Structural superposition using FATCAT.  In each case, α1-AGP (3KQ0) is shown in blue, 
α1-AAT (9API) is shown in green.  (A) and (B), orthogonal views of the superposition of E36 of α1-AGP 
(magenta) with E152 of α1-AAT (orange); (C), showing the position of E64 of α1-AGP (yellow) and E206 
of α1-AAT (magenta). 
 
2.4.2 Determining the hydration state of the protein-bound complexes 
 
In order to provide more insight into the mode of protein binding, studies were carried 
out to determine q' values for the protein-bound complexes, using an analogous method 
to that outlined in Section 2.3.1. In the case of the HSA-bound complexes, the presence 
of multiple species in solution gave rise to a biexponential decay of the emission 
intensity over time. Hence, it was not possible to determine rate constants for the 
depopulation of the europium excited state for either complex in the presence of this 
protein. 
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Table 2.6: Experimentally determined radiative rate constants and derived values of q' (± 20%) for 
europium complexes (295 K, pH 5.5) and in the presence of α1-AAT (0.1 mM) and α1-AGP (0.05 mM) 
(295 K, pH 7.4, 0.1 M NaCl, 30 µM complex). 
 
Complex Protein      / ms
-1
      / ms
-1
 q' 
[Eu.L
22
(OH2)]
+ 
- 2.08 0.61 1.46 
α1-AAT 1.19 0.70 0.29 
α1-AGP 0.96 0.70 0.01 
(R)-[Eu.L
23
(OH2)]
+ 
- 2.13 0.75 1.36 
α1-AAT 0.98 0.74 0 
α1-AGP 1.09 0.89 0 
 
In each of the cases for which data is shown in Table 2.6, it was found that the rate of 
decay of the excited state of the complexes in water was decreased in the presence of 
protein. Meanwhile, no significant change occurred in the rate of decay of the excited 
state emission recorded in D2O. Generally speaking, it is normally the case that for 9-
coordinate complexes possessing one bound water molecule it is very difficult to 
substitute the water molecule in aqueous media.
63
 However, in this case the q' value was 
consistently calculated to tend to zero in the presence of protein. Hence, it can be 
concluded that in each of these instances, protein binding is accompanied by the 
displacement of the bound water molecule from the metal centre.  
 
2.4.3 Probing the mode of protein binding for α1-AGP 
 
In the case of α1-AGP further investigations into the mode of protein binding were 
carried out. Both the emission spectral form and lifetime data suggest the presence of 
one major species in solution for each complex when in the presence of this protein. In 
addition, the binding affinity for the interaction between α1-AGP and each complex was 
determined to be an order of magnitude higher than any of the other proteins that were 
considered. 
 
 
2.4.3.1 Considering a structurally similar complex 
 
The complex [Eu.L
27
(OH2)]
+ 
is an isomer of [Eu.L
23
(OH2)]
+
, differing only in the 
constitution of the tricyclic sensitising group. A control experiment was performed in 
which the emission spectrum of a 1 mL sample of [Eu.L
27
(OH2)]
+
 was recorded in the 
presence and absence of α1-AGP.  
 
CHAPTER TWO: A CHIRAL PROBE FOR ACUTE PHASE PROTEINS 
- 74 - 
 
Figure 2.12: Europium emission spectral variation following addition of human α1-AGP (50 µM) to 
[Eu.L
27
(OH2)]
+
 (blue = initial, green = final, 295 K, 0.1 M NaCl, pH 7.4, 20 µM complex).   
 
As can be seen from Figure 2.12, the behaviour observed differed completely to that 
found for the other two complexes in the presence of this protein. Namely, the addition 
of α1-AGP to the solution containing [Eu.L
27
(OH2)]
+ 
resulted in neither a change in 
spectral form nor any variation in lifetime, consistent with retention of the metal 
coordination environment and hydration state of the complex. This observation suggests 
that the protein binding interaction of [Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+
 with α1-
AGP must involve the azaxanthone chromophore.  
 
It is apparent from the emission spectral form observed for [Eu.L
27
(OH2)]
+ 
in aqueous 
solution that the ligand field of this complex is somewhat different to that of 
[Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+
. Only two bands are visible in the ΔJ = 1 
manifold suggesting that this complex adopts a structure of higher symmetry in 
solution. In addition, the splitting between the A1-A2 and A1-E1,2 components of this 
manifold is smaller, at only 198 cm
-1
. As was previously stated, the splitting between 
these components of the ΔJ = 1 manifold is influenced by the second-order crystal field 
coefficient,   
 . This is also true of the range of chemical shifts observed for a given 
lanthanide complex in its 
1
H NMR spectrum. Hence, the existence of differences in the 
ligand field between [Eu.L
27
(OH2)]
+
 and [Eu.L
22
(OH2)]
+
 is also apparent if comparison 
is made between their 
1
H NMR spectra, the former of which has been published in the 
literature.
152
 As for [Eu.L
22
(OH2)]
+
, this complex was found to exist in solution as a 
mixture of SAP and TSAP stereoisomers. However, the range of chemical shifts 
observed for the resonances associated with the two isomers were very similar, with all 
resonances falling between +28 and -25 ppm. This is in agreement with the observation 
of a reduced splitting between the A1-A2 and A1-E1,2 components of the ΔJ = 1 manifold 
in the emission spectrum of [Eu.L
27
(OH2)]
+
, outlined above. 
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Figure 2.13: 
1
H NMR spectrum obtained for [Eu.L
27
(OH2)]
+
 (D2O, 295 K, 400 MHz), * indicates solvent 
resonances.
152
 
 
When considering the origin of these differences in ligand field between [Eu.L
27
(OH2)]
+ 
and [Eu.L
22
(OH2)]
+
, it may be observed that the constitution of the azaxanthone 
chromophore in the complex [Eu.L
27
(OH2)]
+
 leads to a reduced steric demand around 
the metal centre in comparison to [Eu.L
22
(OH2)]
+
. In addition, the pyridyl nitrogen is a 
weaker donor in the case of [Eu.L
22
(OH2)]
+
 due to its location in an α-position relative 
to the σ-polarizing oxygen. Hence, in the case of [Eu.L22(OH2)]
+
 and (R)-
[Eu.L
23
(OH2)]
+
, an interaction may be envisaged in which protein binding is not only 
accompanied by displacement of the coordinated water molecule, but also by 
dissociation of one of the coordinated azaxanthone chromophores.  
 
2.4.3.2 Studies using circular dichroism 
 
As was previously mentioned, α1-AGP is an important drug binding protein, showing 
particular affinity for apolar and basic drugs.
153-155
  Up until recently, the X-ray crystal 
structure of this protein had not been resolved,
146
 meaning that it was necessary to use 
alternative methods to attempt to characterise the drug binding interactions. Circular 
dichroism spectra induced by the binding of achiral drug molecules to the asymmetric 
binding site of α1-AGP have proven useful in this respect.
156
 Hence, it was suggested 
that it may be possible to exploit circular dichroism as a tool to probe in absorption the 
chiral environment of the azaxanthone chromophore for the complex [Eu.L
22
(OH2)]
+
 in 
the presence and absence of α1-AGP. Circular dichroism studies were carried out by 
Samuele Lo Piano under the supervision of Dr Lorenzo Di Bari (Università di Pisa). 
*      * 
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Figure 2.14: UV absorption spectra for [Eu.L
22
(OH2)]
+
 (41 µM) in the absence (dotted) and presence 
(dashed) of 1 equivalent of α1-AGP. The ECD spectrum in the presence of 1 equivalent of bovine α1-AGP 
is also shown (green). The ECD spectrum was normalised (Δε') to the total concentration of complex.  
 
The absorption spectrum of the azaxanthone chromophore in the absence of protein was 
found to show two main bands, centred at 290 and 330 nm. In the presence of one 
equivalent of α1-AGP, it was still possible to discern the two absorption bands, which 
showed a marked variation in their relative intensity. As was anticipated, the complex 
exhibited no electronic circular dichroism (ECD) signal in the absence of protein. In 
contrast to this, a strong ECD signal was recorded for the complex in the presence of 1 
equivalent of protein, confirming the formation of a stereodefined adduct between the 
protein and complex. The signal consists of two negative Cotton effects, each associated 
with one of the main transitions of the azaxanthone chromophore. Partially resolved fine 
structure is apparent, typical of a relatively rigid environment with little or no solvation 
dynamics. Closer inspection of the induced ECD spectrum reveals the presence of two 
partially resolved CD bands within each transition, implying that the two azaxanthone 
chromophores may be in slightly different local chiral environments. This lends support 
to the hypothesis that the protein binding interaction involves displacement of one of the 
azaxanthone chromophores from the europium centre, whilst the other remains 
coordinated. 
 
In order to gather further information about the site of the binding interaction and origin 
of the induced ECD signal, competition experiments were carried out using three known 
AGP-binders: progesterone, chlorpromazine and amitriptylene. A recent publication has 
described the computational docking of progesterone into the ligand binding pocket of 
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α1-AGP, whilst X-ray crystal structures of the latter two species co-crystallised with α1-
AGP were recently published.
146, 157
 Initial experiments were attempted in which the 
emission from a sample containing the α1-AGP bound complex [Eu.L
22
(OH2)]
+
 was 
monitored as a function of increasing amounts of each competitive binder. It was 
hypothesised that displacement of the europium complex from its binding site on the 
protein by any one of these species would result in a change of spectral form, ultimately 
regenerating the emission spectrum observed in the absence of protein. The addition of 
progesterone and amitriptylene was found to cause no variation in the emission spectral 
signature of the protein-bound species. In contrast, the addition of chlorpromazine 
appeared to yield some alteration of the spectral form, although an apparent quenching 
of the emission intensity made it difficult to discern the exact nature of the variation. To 
clarify this result a second circular dichroism experiment was carried out, based on a 
similar premise to the luminescence experiment outlined above.  
 
Incremental addition of chlorpromazine (0 to 1.25 equivalents) to a sample containing 
the α1-AGP bound complex [Eu.L
22
(OH2)]
+
 (1:1, 21 µM) was found to result in a 
progressive reduction of the induced CD signal associated with the azaxanthone 
chromophore, suggesting the displacement of the europium complex from its protein 
binding site. Prior CD studies examining the binding of chlorpromazine to α1-AGP have 
attributed the observation of an induced CD signal (a positive band, centred around 258 
nm) to an exciton coupling interaction with the electric-dipole allowed transitions of a 
proximate tryptophan residue (Trp-25).
156
 
 
 
Figure 2.15: Variation in the induced ECD spectrum of [Eu.L
22
(OH2)]
+
 (21 µM) in the presence of 1 
equivalent of α1-AGP upon addition of CPZ (up to 1.25 equivalents). 
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2.4.3.3 A proposed mode of binding 
 
Based on the information outlined in the preceding sections of this discussion, it is 
possible to propose a tentative model for the structure of the α1-AGP-bound complexes, 
involving the displacement of one chromophore and the coordinated water molecule 
from the metal centre. Taking into account the nature of the observed emission spectral 
changes and the results of the FATCAT structural analysis, which aimed to discern the 
apparently identical mode of binding for the europium complexes in the presence of α1-
AGP and α1-AAT, it seems probable that the binding interaction involves coordination 
of a  polarizable charged oxygen donor to the metal centre in the axial position; this 
could take the form of a glutamic acid side chain carboxylate group (e.g. Glu 64 for α1-
AGP). The enhanced binding affinity of both complexes for α1-AGP in comparison to 
the other proteins examined can be attributed to favourable hydrophobic interactions 
between the azaxanthone sensitising moiety and the protein drug-binding pocket. 
 
 
 
 
 
 
 
 
 
Relaxivity studies utilising the gadolinium analogue of the complex [Ln.L
22
(OH2)]
+
 
provided support for the proposed α1-AGP bound structure. The gadolinium complex 
was synthesised according to previously described methods.
137 
Complexation was 
confirmed by mass spectrometry prior to working up the reaction. The complex was 
then purified by preparative HPLC and isolated as an off-white solid.  
 
In order to facilitate the preparation of samples of an exact concentration for use in 
relaxivity studies, the concentration of gadolinium in the isolated sample was 
determined using a method demonstrated by Peters et al.
158
 A sample of the complex 
[Gd.L
22
(OH2)]
+ 
was dissolved in an aqueous 1% tert-butyl alcohol solution and 300 µL 
was placed in an NMR tube. An inner reference tube containing aqueous 1% tert-butyl 
alcohol solution was inserted into the NMR tube. Using 
1
H NMR spectroscopy, it was 
possible to observe two resonance signals from the methyl protons of the tert-butyl 
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alcohol. The frequency shift of these two resonance signals represents the bulk magnetic 
susceptibility shift caused by the presence of the paramagnetic gadolinium complex.  
 
 
Figure 2.16: 
1
H NMR spectrum showing the frequency shift between two resonance signals from the 
methyl protons of the tert-butyl alcohol induced by the presence of [Gd.L
22
(OH2)]
+
. 
 
The observed BMS shift is related to the concentration of the gadolinium complex, c, by 
equation 13 where s is a constant dependent on the shape of the sample and its position 
in the magnetic field, T is the absolute temperature and µeff is the effective magnetic 
moment of the lanthanide in question. 
 
                                                 
    
 
 
    
    
 
 
                                              (eqn. 13) 
 
Having determined the concentration of the bulk solution by this method, it was 
possible to prepare a 0.5 mmol solution of the complex in 0.1 M NaCl by dilution.  
Titrations were conducted using samples of this 0.5 mmol solution monitoring the 
longitudinal relaxation time, T1, of the bulk water as a function of α1-AGP and HSA 
concentration at 37 
o
C. Incremental additions of protein were made to 500 µL samples 
of the solution, which were adjusted to pH 7.4. Additions were halted when a limiting 
value of T1 appeared to have been reached. The pH of the sample was monitored over 
the course of each titration and adjustments carried out using conc. HCl(aq) and conc. 
NaOH(aq) when necessary. Using the data gathered it was possible to calculate relaxivity 
data. 
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Figure 2.17: Variation in relaxivity as a function of added protein for an aqueous solution of 
[Gd.L
22
(OH2)]
+
 (0.5 mmol complex, 0.1 M NaCl, pH 7.4, 310 K). 
 
As can be seen from Figure 2.17, the addition of protein to the sample caused an 
increase in relaxivity for both α1-AGP and HSA. In the case of α1-AGP, the increase in 
relaxivity was relatively modest, with a limiting value being reached in the presence of 
roughly 1 equivalent of α1-AGP. This result suggests specifically that only one complex 
is binding per protein. Meanwhile, in the presence of HSA the increase in relaxivity was 
larger and a limiting value was reached at a much lower concentration of added protein, 
supporting a hypothesis that the binding of the complex by this protein occurs at 
multiple sites.   
 
The large increase in relaxivity observed in the presence of HSA is in keeping with the 
results of analogous studies detailed in the literature.
134
 This effect can be attributed to 
the large molecular size of the protein adduct resulting in a slowing down of the 
molecular motion and elongation of the rotational correlation time, τr, which is a 
limiting factor in the relaxivity of small Gd(III) chelates.
159
 Meanwhile, the modest 
enhancement in relaxivity that was observed in the presence of α1-AGP can be 
rationalised as a mixture of two opposing effects. For the α1-AGP adduct it appears that 
the paramagnetic effect is not transmitted towards the bulk solvent as well as it is for 
HSA, an effect which on its own would be expected to cause a decrease in r1. The 
observed changes in relaxivity are therefore consistent with a model of protein binding 
in which the coordinated water molecule is displaced and bulk water is excluded more 
effectively from the site where the complex is bound for α1-AGP than for HSA. This 
supports the theory that the binding of [Ln.L
22
(OH2)]
+
 by α1-AGP occurs within a 
relatively hydrophobic drug-binding pocket.  
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2.5 CPL spectroscopy studies 
 
The original hypothesis suggested in this work was that the synthesis of an analogue of 
[Ln.L
22
(OH2)]
+
 based on an enantiomerically pure ligand framework may yield a 
complex for which the binding of an analyte could be probed by CPL spectroscopic 
techniques. However, in accordance with the discovery that it was possible to record an 
induced circular dichroism spectrum for the complex [Eu.L
22
(OH2)]
+
 in the presence of 
α1-AGP, it was envisaged that the protein binding interactions that have been discussed 
in this work may also be coupled to a new phenomenon, namely induced CPL caused 
by a change in the constitution of a racemic complex. Therefore, the utility of both 
[Ln.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
 as responsive CPL probes was investigated in a 
series of CPL spectroscopy studies.  
 
CPL spectra were initially obtained for the europium analogues of [Ln.L
22
(OH2)]
+
 and 
(R)-[Ln.L
23
(OH2)]
+
 in the presence of HSA, γ-immunoglobulin-G, α1-AGP and α1-
AAT. Appropriate concentrations of protein were chosen on the basis of the preliminary 
results outlined in the preceding sections. The spectra obtained in the presence of these 
proteins are shown in Figure 2.18, along with those recorded in the absence of any 
additive. For a given complex, the CPL spectral signature in the presence of α1-AGP 
and α1-AAT was found to be almost identical, in agreement with observations made 
previously. Therefore, only the CPL spectral fingerprints for [Eu.L
22
(OH2)]
+
 and (R)-
[Eu.L
23
(OH2)]
+
 in the presence of α1-AAT are shown. 
 
As is apparent from the data presented in Figure 2.18, it was indeed possible to observe 
the induction of circularly polarized emission through protein binding for 
[Eu.L
22
(OH2)]
+
. The CPL spectra recorded for this complex in the presence of HSA, α1-
AAT/α1-AGP and globulin were found to differ in form, suggesting that the observed 
signal cannot simply be attributed to a perturbation of the racemic equilibrium either in 
the ground or excited state. Instead, it appears that the helicity at the metal centre is 
being determined by the manner of protein binding and not the inherent conformation of 
the complex. This is consistent with the formation of an adduct in which the 
coordination environment around the metal centre is altered and is therefore in 
agreement with previously discussed results. For (R)-[Eu.L
23
(OH2)]
+ 
the CPL spectral 
signature was found to be altered in the presence of each protein, also suggesting an 
altered metal coordination environment. Particularly well defined spectra were obtained 
in the presence of HSA and α1-AAT/α1-AGP.   
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Figure 2.18: Representative CPL spectra showing the circularly polarized emission of [Eu.L
22
(OH2)]
+
 (I) 
and (R)-[Eu.L
23
(OH2)]
+
 (II): (A) complex only (295 K, pH 5.5); (B) complex + 0.7 mM HSA; (C) 
complex + 0.3 mM γ-immunoglobulin-G; (D) complex + 0.1 mM α1-AAT (295 K, pH 7.4, 0.1 M NaCl, 
30 µM complex). 
 
Emission dissymmetry factors for selected transitions in the various spectra displayed in 
Figure 2.18 are given overleaf in Table 2.7.  
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Table 2.7: Selected emission dissymmetry factors calculated using the data displayed in Figure 2.18. 
 
Complex Protein 
gem 
ΔJ = 1 (λ) ΔJ = 2 (λ) ΔJ = 3 (λ) ΔJ = 4 (λ) 
[Eu.L
22
(OH2)]
+ 
- 0 0 0 0 0 
HSA 
-0.13 
(598) 
+0.03  
(619) 
-0.02 
(624) 
0 0 
γ-Ig-G 
+0.04  
(598) 
-0.02 
(619) 
-0.02 
(624) 
-0.05 
(657) 
-0.02 
(691) 
α1-AAT 
-0.21 
(599) 
-0.03 
(619) 
+0.05   
(623) 
+0.10  
(658) 
+0.04  
(692) 
α1-AGP 
-0.23 
(598) 
-0.02 
(618) 
+0.05  
(623) 
+0.08  
(657) 
+0.02  
(690) 
(R)-[Eu.L
23
(OH2)]
+ 
- 
-0.17 
(597) 
0       
(619) 
+0.03  
(624) 
0 +0.02  
(688) 
HSA 
-0.16 
(598) 
+0.07  
(619) 
-0.02 
(624) 
0 +0.03  
(689) 
γ-Ig-G 
-0.07 
(598) 
0       
(619) 
+0.02  
(624) 
-0.02 
(658) 
+0.01  
(689) 
α1-AAT 
-0.22 
(597) 
+0.04  
(619) 
+0.12  
(623) 
+0.15  
(656) 
+0.03  
(689) 
α1-AGP 
-0.07 
(597) 
+0.04  
(619) 
+0.07  
(623) 
+0.14  
(656) 
+0.02  
(690) 
 
It is apparent from the data shown in Table 2.7 that in all cases the largest emission 
dissymmetry factor was associated with the ΔJ = 1 transition, occurring between 585 
and 600 nm. This is in agreement with established theory on the topic of lanthanide-
based CPL phenomena, which allows the emission dissymmetry factor to be related to 
size and relative orientations of the electric and magnetic dipole transition moments, µ 
and m, associated with a given transition (see Section 1.2.2).
92
 This relationship is 
expressed in equation 8, where τ is the angle between the magnetic and electric 
transition dipole moments. 
  
                                                               
    
   
                                               (eqn. 8) 
 
This relationship suggests that the largest dissymmetry factors will be associated with 
magnetic-dipole allowed transitions that also have weak electric-dipole character. For 
europium, the 
5
D0
 → 7F1 transition is the only transition that obeys the formal selection 
rules relating to the total angular momentum quantum number, J (i.e. ΔJ = 0, ± 1 
excluding 0 ↔ 0), and therefore it is the only transition that is strictly magnetic-dipole 
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allowed. Hence, the largest emission dissymmetry factor can be expected to be 
associated with this transition.  
 
The data presented in Figure 2.18 and Table 2.7 reveals that protein binding does not 
appear to affect the enantiopure complex (R)-[Eu.L
23
(OH2)]
+
 in such a manner as to 
induce a significant change in the helicity at the metal centre. Generally speaking, the 
emission dissymmetry factor at a selected wavelength for the protein-bound adduct was 
found to retain its sign in comparison with the complex in absence of protein. This was 
particularly true of the circularly polarized emission associated with the magnetic dipole 
allowed ΔJ = 1 transition. These results are in contrast to a previous example from the 
literature, where it was found that the helicity of a DOTA-based lanthanide complex 
became inverted upon binding to serum albumin.
133
 In addition, it was also noted that in 
many cases the emission dissymmetry factors characterising the emission from (R)-
[Eu.L
23
(OH2)]
+ 
were diminished in the presence of protein. From these observations it 
may be inferred that the dynamically racemic complex, [Ln.L
22
(OH2)]
+
, may actually 
prove to be of more use as a chiral probe exploiting CPL than its analogue (R)-
[Ln.L
23
(OH2)]
+
.  
 
In order to further characterise the binding of [Ln.L
22
(OH2)]
+ by α1-AGP, a titration was 
carried out in which the 'switching on' of the CPL signal from the europium analogue of 
this dynamically racemic system was monitored in the presence of increasing amounts 
of bovine α1-AGP. The method employed was analogous to that used for the titrations 
previously described, in which the total emission spectral change was monitored. It is 
important to note that the changes in total emission spectral form in the presence of 
bovine α1-AGP had been found to be extremely similar to those observed with human 
α1-AGP, which have been presented earlier in this report. In agreement with this, the 
CPL spectral signature of [Eu.L
22
(OH2)]
+
 in the presence of 50 µM bovine α1-AGP was 
also found to mimic the form of the CPL spectrum in the  presence of 50 µM human α1-
AGP, with some difference in the hypersensitive ΔJ = 2 band around 620 nm.  
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Figure 2.19: Europium emission spectral changes following addition of bovine α1-AGP (left, 50 µM) to 
[Eu.L
22
(OH2)]
+
 (blue = initial, dark green = final) shown alongside the europium emission spectrum (dark 
green) and CPL spectrum (light green) of [Eu.L
22
(OH2)]
+
 in the presence of 50 μM bovine α1-AGP. The 
scale used in the CPL figure refers to (IL+ IR) and is on a scale of x 40 with respect to (IL - IR). (295 K, 0.1 
M NaCl, pH 7.4, 40 µM complex). CPL spectra are not red corrected. 
 
By plotting the variation in the magnitude of the emission dissymmetry factor at 600 nm 
as a function of the concentration of added protein it was possible to estimate a binding 
constant for the association between [Eu.L
22
(OH2)]
+
 and bovine α1-AGP. A 1:1 binding 
isotherm was fitted to the data using non-linear least squares iterative analysis, giving a 
value of logK = 5.9 (± 0.1). This was in fairly good agreement with the estimate made 
on the basis of total emission spectral changes. 
 
 
 
 
Figure 2.20: CPL spectral changes following addition of bovine α1-AGP to [Eu.L
22
(OH2)]
+
. Inset: 
Variation in gem at 600 nm with concentration of bovine α1-AGP (295 K, 0.1 M NaCl, pH 7.4, 40 µM 
complex).  
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The CPL spectra of [Tb.L
22
(OH2)]
+
 in the presence of HSA, γ-immunoglobulin-G, α1-
AGP and α1-AAT were also recorded. Preliminary studies monitoring the variation in 
total emission intensity and form of the terbium spectra in the presence of HSA, γ-
Immunoglobulin-G, α1-AGP and α1-AAT revealed quenching of the emission intensity 
in each case but no significant change in spectral form. In the case of HSA and γ-Ig-G 
this quenching effect was particularly significant, with an overall loss of more than 90% 
of the signal intensity in the presence of 0.5 mM HSA and 80% in the presence of 
0.5mM γ-immunoglobulin-G. The measurement of CPL for the terbium complex in the 
presence of either of these proteins yielded only poor quality spectra, presumably due to 
lack of signal intensity. In the case of HSA, it was found that a slightly better quality 
spectrum could be obtained at lower concentrations of added protein. A spectrum was 
collected at [HSA] = 0.2 mM as changes in the europium emission spectral form had 
previously been observed to manifest themselves at this concentration. For α1-AGP and 
α1-AAT slightly more of the signal intensity was retained in the presence of protein and 
CPL spectra of higher quality were obtained. 
 
A 
 
B 
 
C 
 
D 
 
Figure 2.21: Representative CPL spectra showing the circularly polarized emission of [Tb.L
22
(OH2)]
+
: 
(A) complex + 0.2 mM HSA; (B) complex + 0.3 mM γ-immunoglobulin-G; (C) complex + 0.05 mM α1-
AGP; (D) complex + 0.1 mM α1-AAT (295 K, pH 7.4, 0.1 M NaCl, 30 µM complex). 
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As can be seen from Figure 2.21, the CPL spectra recorded for [Tb.L
22
(OH2)]
+ 
in the 
presence of protein all took on the same general form; a large CPL signal was 
associated with the 
5
D4 → 
7
F5 transition, whilst no substantial circular polarization was 
associated with any of the other transitions. As would be expected from the results 
already obtained with the europium analogue of this complex, the CPL spectral 
signature of [Tb.L
22
(OH2)]
+
 in the presence of α1-AGP and α1-AAT was identical. 
Emission dissymmetry factors were calculated and are displayed in Table 2.8.  
 
Table 2.8: Selected emission dissymmetry factors calculated using the data displayed in Figure 2.21. 
 
Complex Protein 
gem 
ΔJ = 1 (λ) 
[Tb.L
22
(OH2)]
+ 
HSA 0 -0.03 (546) 0 +0.01 (552) 
γ-Ig-G 0 -0.04 (546) -0.01 (550) +0.01 (552) 
α1-AAT +0.06 (543) -0.13 (546) +0.05 (549) -0.02 (552) 
α1-AGP +0.06 (544) -0.13 (547) +0.05 (549) -0.03 (553) 
 
Much of the current research in the area of lanthanide complexation chemistry is 
focussed on the development of emissive europium complexes as ratiometric probes for 
biological analytes.
31, 131, 160, 161
 The sensitivity of the europium emission spectral form 
to the metal coordination environment is key to these advances and terbium is often 
overlooked. This example illustrates nicely how the use of CPL spectroscopy may be 
able to facilitate the use of terbium complexes as emissive probes, where changes in gem 
at a given wavelength could be used to indicate the presence of a given analyte. 
 
2.6 Investigating protein binding in a background of human serum 
 
As was previously stated, for a complex to be of any utility as a responsive CPL probe, 
it must show selectivity for the desired analyte in a competitive biological environment. 
Hence, it was decided that the binding of the complex [Ln.L
22
(OH2)]
+
 to the acute phase 
protein α1-AGP should be investigated in a background of human serum. Serum 
contains a complex mixture of proteins, along with electrolytes and a variety of other 
biomolecules such as antibodies and antigens.  
 
In order to allow for the construction of a calibration curve to characterise the spectral 
response of the complex in the presence of increasing amounts of α1-AGP, it was first 
necessary to assess the α1-AGP content of the human serum sample. This was achieved 
using a commercially available solid-phase ELISA assay, purchased from R&D 
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systems. A stock solution of the serum sample was created by carrying out a 10,000-
fold dilution of a raw sample. The concentration of α1-AGP present in this sample was 
then estimated by comparison with a series of standard solutions, having α1-AGP 
concentrations ranging between 200 and 3.13 ng/mL.  
 
 
Figure 2.22: A standard curve generated to facilitate calculation of the α1-AGP concentration in a sample 
of human serum. 
 
Using the standard curve that was generated, it was possible to estimate the 
concentration of α1-AGP in the human serum sample as being 0.62 mg/mL (≈ 15 µM), 
which is at the lower end of the normal concentration range in plasma.
162
 Having 
estimated the concentration of α1-AGP present in the serum sample, a preliminary 
titration was carried out in which incremental additions of a concentrated α1-AGP stock 
solution were made to a sample of the complex [Eu.L
22
(OH2)]
+
 that had been dissolved 
in human serum. Associated spectral changes were monitored using total emission 
spectroscopy.  
 
As was previously mentioned, serum albumin is the most abundant plasma protein and 
on this basis it may have been anticipated that the initial spectral form of the complex in 
serum would resemble the HSA-bound species. However, as was shown previously, the 
binding affinity that characterised the interaction between the complex and serum 
albumin was actually surpassed by other proteins, even within the relatively small 
sample size of 6 proteins. Hence, it was presumed likely that the initial spectral form in 
serum would not mimic any of the spectra recorded to date. This was indeed found to be 
the case, with the initial spectral form bearing some resemblance to that of the HSA-
bound complex suggesting that although a mixture of adducts are present when the 
complex is dissolved in serum, this is the major contributor to the speciation. 
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Figure 2.23: Europium emission spectral changes following addition of α1-AGP (left, 50 µM) to 
[Eu.L
22
(OH2)]
+
 in human serum (blue = initial, green = final) shown alongside a calibration curve 
depicting the variation in the emission intensity ratio of selected europium emission bands over the course 
of the titration (295 K, pH 7.4).  
 
Over the course of the titration the emission spectral signature was found to change, 
eventually reaching a limiting form which bore close resemblance to that observed for 
the α1-AGP bound complex. A total of 50 µM of α1-AGP was added to the serum 
sample, reflecting a four-fold increase in the initial serum concentration in order to 
mimic an inflammatory response. Analysis of the change in the emission intensity ratio 
comparing the integrated emission intensity over part of the ΔJ = 2 band in comparison 
to part of the ΔJ = 1 band from the total emission spectrum allowed a calibration curve 
to be generated, which is shown in Figure 2.23. 
 
A control experiment was carried out in order to assess the effect of α1-AAT addition on 
the total emission spectral form observed from the serum sample. As was shown in 
Section 2.4.1, the complex [Eu.L
22
(OH2)]
+
 was also found to have a higher affinity for 
this protein than for HSA. It is therefore perhaps unsurprising that an analogous titration 
carried out with this protein gave rise to changes in spectral form and an increase in the 
emission intensity ratio that was similar to that induced by α1-AGP. It can be concluded 
that the elevation in serum levels of either of these acute phase proteins may be used to 
signal the onset of inflammation in biologically relevant systems through the use of the 
dynamically racemic complex [Eu.L
22
(OH2)]
+
.  
 
Attempts were subsequently made to record the CPL spectrum of [Eu.L
22
(OH2)]
+ 
in 
samples of human serum with and without added α1-AGP. As was expected on the basis 
of the results outlined above, the spectral form of the CPL signal for the complex in 
serum in the absence of added α1-AGP was not found to resemble that of any one of the 
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protein-bound species. When 50 µM of bovine α1-AGP was added to the serum sample 
a modulation of the CPL output was induced, with the resulting spectral fingerprint 
bearing some resemblance to that recorded for the α1-AGP adduct in a non-competitive 
media. Unfortunately, these changes in CPL spectral form were much less well-defined 
than those observed in total emission and a high background signal meant that the 
generation of a calibration curve that could be used for determining α1-AGP 
concentration in biologically relevant samples was not possible using CPL data. 
  
Figure 2.24: The europium emission spectrum and CPL spectrum of [Eu.L
22
(OH2)]
+
 in human serum in 
the absence (left) and presence (right) of 50 μM added bovine α1-AGP (295 K, pH 7.4). The scale used on 
the y axis refers to (IL+ IR) and is on a scale of x 40 with respect to (IL - IR). Spectra are not red corrected. 
 
2.7 Conclusions 
 
A chiral lanthanide complex, (R)-[Ln.L
23
(OH2)]
+
 was synthesised and characterised and 
a structural analysis carried out in comparison to the related complex [Ln.L
22
(OH2)]
+
. 
The emission spectral form of the europium complexes was examined and found to be 
similar in general. Slight differences in the splitting of the ΔJ = 1 band suggested that 
[Eu.L
22
(OH2)]
+
 existed in solution as a mixture of species. Proton NMR studies gave 
further evidence for this, revealing the presence of two species in solution, in a ratio of 
4:1. It was proposed that the complex was present in solution as a mixture of SAP and 
TSAP stereoisomers. Further NMR studies were hindered by broad linewidths. In the 
case of (R)-[Eu.L
23
(OH2)]
+
 the amount of material available for study limited the scope 
of the NMR studies. A 
1
H NMR spectrum was obtained (D2O, 295 K, 400 MHz) and 
appeared to show the presence of only one species in solution. The range of chemical 
shifts observed was similar to that seen for the major isomer of [Eu.L
22
(OH2)]
+
, 
suggesting that (R)-[Ln.L
23
(OH2)]
+
 adopts a SAP geometry in solution. CPL spectra 
obtained for the two complexes confirmed that although [Ln.L
22
(OH2)]
+
 exists in 
solution as a racemic mixture, this is not the case for (R)-[Ln.L
23
(OH2)]
+
. For this 
complex, the inclusion of an asymmetric carbon centre in a position α to a ring nitrogen 
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yielded the predominant formation of what is tentatively assigned as a (R)-Λ(δδδδ) 
diastereoisomer. 
 
Comparative investigations were carried out to assess the effect of protein binding on 
the emission profile of [Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+
. A total of six proteins 
were investigated, chosen on the basis of their abundance in human serum. In the case 
of fibrinogen and apo-transferrin, no significant change in emission spectral form was 
noted for either complex and no further analysis was carried out using these proteins. 
Meanwhile, changes in the total emission spectral fingerprint were noted for both 
complexes in the presence of HSA, α1-AGP, α1-AAT and γ-Ig-G. This suggests that a 
binding interaction is able to occur between the complexes and each of these proteins, 
involving a change in complex constitution. Apparent binding constants were calculated 
for these interactions based on the assumption of 1:1 association.  
 
It was found that for both complexes the most well-defined spectral response over the 
physiological concentration range of protein was observed in the case of HSA, α1-AGP 
and α1-AAT. In every case, the total emission spectrum of the complex in the presence 
of protein had the same general form, with the relative intensity of the ΔJ = 2 band 
found to be much larger in comparison to spectra obtained in the absence of protein. 
This suggests that a binding interaction is occurring in which the complex constitution 
is changed in such a manner that the axial donor polarizability is increased. In some 
cases, the metal-based emission intensity was found to show an overall increase when in 
the presence of protein, suggesting very effective exclusion of quenching XH oscillators 
from the primary and secondary coordination spheres. 
 
In the case of each of these three proteins, the complexes were found to mimic each 
other's behaviour, both in terms of observed changes in emission spectral form and 
calculated affinity constants. In samples containing HSA the observation of multiple 
components in the ΔJ = 0 band implies the presence of more than one chemically 
distinct lanthanide containing species. For α1-AGP and α1-AAT similar analysis 
suggests the presence of only one species. It can be concluded that the complexes 
occupy more than one binding site on HSA, with a different local coordination 
environment at europium. With α1-AGP and α1-AAT one binding site is occupied. 
 
For both europium complexes, observed changes in spectral form in the presence of α1-
AAT were identical to those seen in the presence of α1-AGP. The origin of this result 
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was probed by carrying out protein structural alignment studies on representative PDB 
entries for α1-AGP and α1-AAT. Although very little overall structural similarity was 
apparent for the two proteins, some commonality was found in the location of two sets 
of glutamic acid residues. This supports a hypothesis that the binding event is associated 
with the coordination of a polarizable charged oxygen donor from a glutamic acid side 
chain to the metal centre in an axial position. 
 
It was possible to estimate the inner sphere hydration number for the systems where the 
form of the emission spectrum indicated the presence of only one major emissive 
species in solution. In all cases, q' was found to tend to zero in the presence of protein. 
This was consistent with previous observations of changes in the metal-based emission 
intensity in the presence of protein, which suggested very effective exclusion of 
quenching XH oscillators from the primary and secondary coordination spheres. 
 
The nature of the interaction between the complexes and α1-AGP was investigated more 
thoroughly using a variety of techniques. The emission spectral form of the complex 
[Eu.L
27
(OH2)]
+
, an isomer of [Eu.L
22
(OH2)]
+
 in which the constitution of the 
azaxanthone chromophore is altered, showed no change in the presence of α1-AGP. This 
indicates that the interaction of [Eu.L
22
(OH2)]
+
 and (R)-[Eu.L
23
(OH2)]
+
 with α1-AGP 
must involve the sensitising moiety. Further investigations were carried out using CD 
spectroscopy, with the observation of a strong induced ECD signal for [Eu.L
22
(OH2)]
+
 
in the presence of α1-AGP suggesting the formation of a stereodefined adduct between 
the protein and complex. The presence of two partially resolved CD bands within each 
observed transition supports a hypothesis that the two azaxanthone chromophores may 
be in slightly different local chiral environments in the protein adduct. The site of 
protein binding was also probed in a series of competitive binding studies with known 
α1-AGP drug binders. It was concluded that the protein binding interaction involves 
displacement of one of the azaxanthone chromophores from the europium centre, whilst 
the other remains coordinated.  
 
Taking into account all of the observations outlined above, a tentative model for the 
structure of the  α1-AGP-bound complexes was proposed, involving the displacement of 
one chromophore and the coordinated water molecule from the metal centre. It was also 
concluded that the binding interaction involves coordination of a  polarizable charged 
oxygen donor to the metal centre in the axial position. It was suggested that this could 
take the form of a glutamic acid side chain carboxylate group (e.g. Glu 64 for α1-AGP). 
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The enhanced binding affinity of both complexes for α1-AGP in comparison to the other 
proteins examined was attributed to favourable hydrophobic interactions between the 
azaxanthone sensitising moiety and the protein drug-binding pocket. Relaxivity studies 
carried out using [Gd.L
22
(OH2)]
+
 supported these conclusions. 
 
Further assessment of the protein binding interactions was carried out using CPL 
spectroscopy. For HSA, α1-AGP, α1-AAT and γ-Ig-G protein binding caused a helical 
structure to be adopted by [Eu.L
22
(OH2)]
+
, resulting in strong induced CPL. In the case 
of (R)-[Eu.L
23
(OH2)]
+ 
some change in the CPL spectral signature was observed in the 
presence of each protein but it was apparent from comparison of gem values that protein 
binding did not cause a major change in the helicity at the metal centre in any case. It 
was concluded that the racemic complex, [Ln.L
22
(OH2)]
+
, showed more promise with 
respect to its development as a responsive CPL probe. For [Ln.L
22
(OH2)]
+
 (Ln = Eu
3+
 or 
Tb
3+
) CPL spectra obtained in the presence of α1-AGP and α1-AAT were identical. This 
was in agreement with observations of the changes exhibited in total emission, detailed 
above. A titration was carried out in which the 'switching on' of a CPL signal from the 
dynamically racemic complex [Eu.L
22
(OH2)]
+
 was monitored in the presence of 
incremental amounts of bovine α1-AGP. It was shown that by monitoring changes in gem 
a binding constant for the interaction could be calculated which was in agreement with 
the binding constant calculated using total emission data. It was concluded that 
[Ln.L
22
(OH2)]
+
 showed potential for development as a chiral probe for the acute phase 
proteins α1-AGP and α1-AAT. 
 
A titration in which incremental amounts of α1-AGP were added to a solution of 
[Eu.L
22
(OH2)]
+
 in human serum was carried out. Spectral changes remained well 
defined in total emission, with the limiting spectral form mimicking that observed in 0.1 
M NaCl. This allowed a calibration curve to be generated. In addition, it was shown that 
identical changes in the emission spectral fingerprint could be generated by addition of 
α1-AAT to the serum solution. Unfortunately, the same could not be said for the CPL 
spectral response. Hence, although this complex does show promise as a probe for these 
acute phase proteins in biological media, it seems unlikely that it will be possible to 
signal the presence of these proteins by CPL methods. 
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3.1 Introduction 
 
The work described in Chapter 2 demonstrated the induction of circular polarization in 
the luminescence output of the racemic lanthanide system [Ln.L
22
(OH2)]
+
 as a result of 
a change in complex constitution. Although the induction of CPL from a racemic 
lanthanide system via this mechanism has not before been exemplified in the literature, 
the observation of induced CPL from such a system is in itself not a new phenomenon; 
such an effect has previously been demonstrated for [Ln(DPA)3]
3-
 complexes. As was 
discussed in Chapter 1, the detection of induced CPL from these complexes has been 
achieved in the presence of a variety of chiral additives, with the observation of the 
effect generally being attributed in part to the occurrence of outer sphere associative 
mechanisms.  
 
Several studies conducted using [Ln(DPA)3]
3-
 complexes have highlighted the fact that 
the observation of induced CPL from these systems typically allows discrimination 
between enantiomeric compounds and therefore may facilitate the determination of 
enantiomeric excess in mixtures of pure enantiomers.
110
 Owing to the abundance of 
chirality in nature and its importance in the manufacture of pharmaceuticals, the 
development of techniques aiding chiral analysis is of great significance. At present, 
discrimination between enantiomeric compounds is typically achieved using methods 
such as NMR spectroscopy, HPLC or GC. The former method employs chiral shift 
solvating or derivatising agents and the latter two require the use of a chiral stationary 
phase, which is often derived from a complex biomolecule.
163-165
 Each of these methods 
is relatively time-consuming and requires the use of expensive and complex 
instrumentation. The discovery of alternative methods, by which chiral detection can be 
achieved, therefore has great appeal. 
 
This chapter describes investigations carried out in order to assess the utility of racemic 
lanthanide systems based on macrocylic ligands for chiral detection, in which an 
induced CPL effect is observed as a result of a change in complex constitution. The 
work presented concerns studies carried out using [Ln.L
22
(OH2)]
+ 
(Ln = Eu
3+
, Tb
3+
).
 
Although the induction of circular polarization in the luminescence output of this 
complex was only demonstrated in the presence of proteins in Chapter 2, it was 
envisaged that the binding of a number of other chiral substrates to the lanthanide centre 
may also be coupled to a change in complex constitution, and therefore could yield 
further induced CPL effects.  
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3.2 Preliminary investigations into anion binding 
 
Owing to the fact that there exist many chiral anions where both enantiomers are 
readily-available, it was decided that these species were promising substrates for use in 
the investigations. The binding of anionic species by lanthanide complexes derived 
from ligands based on a DOTA framework is a well-recognised phenomenon, with the 
mechanism of binding typically involving the displacement of bound water molecules 
from a coordinatively unsaturated lanthanide centre.
166
 Many examples of anion 
responsive systems exist in the literature based on such a framework, including the 
bicarbonate responsive complexes discussed in Section 1.5.3.1 of Chapter 1. As has 
been previously noted (Section 2.4.2, Chapter 2), the displacement of the single water 
molecule from the primary coordination sphere of a monohydrated lanthanide complex 
derived from an octadentate ligand has typically been found to be prohibited. In 
accordance with this, it would be reasonable to predict that the binding of anions at the 
lanthanide centre in [Ln.L
22
(OH2)]
+
 should not be possible. However, it was anticipated 
that such binding may be facilitated for this complex by the weakness of the binding 
interaction with the pyridine nitrogens of the azaxanthone chromophores.  
 
3.2.1 Verifying the occurrence of anion binding at the lanthanide centre 
 
As was shown in Chapter 2, the sensitivity of europium emission to the metal 
coordination environment allows any binding event occurring at the metal centre to be 
easily visualised and a binding affinity to be calculated.  Hence, in order to verify the 
hypothesis that anion binding may occur at the lanthanide centre in [Ln.L
22
(OH2)]
+
, a 
preliminary titration was carried out in which the emission intensity of [Eu.L
22
(OH2)]
+ 
was monitored in the presence of gradually increasing amounts of the achiral chelating 
anion bicarbonate. The binding of bicarbonate to a coordinatively unsaturated 
lanthanide centre is a well-known phenomenon and is thought to occur in a stepwise 
manner, ultimately yielding a complex in which the anion acts as a bidentate ligand.  
 
 
Figure 3.1: Schematic diagram of a plausible mechanism of hydrogencarbonate chelation at a 
coordinatively unsaturated lanthanide centre.
57
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Incremental additions of a freshly prepared, concentrated sodium bicarbonate stock 
solution were made to a 1 mL sample of [Eu.L
22
(OH2)]
+
, which had been dissolved in 
aqueous solution at pH 7.4 containing 0.1 M NaCl, to give a solution where the 
concentration of complex was 30 µM. The pH of the sample was allowed to rise over 
the course of the titration, such that the concentration of bicarbonate could be accurately 
known, and the experiment was halted when the concentration of bicarbonate in 
solution was 29 mM. Figure 3.2 shows the variation in europium emission upon 
addition of the stock solution, along with separate plots showing the initial and limiting 
spectral signatures. Ratiometric analysis of the data gathered generated values to which 
a 1:1 binding isotherm could be fitted, therefore allowing the binding affinity to be 
estimated. The binding interaction between [Eu.L
22
(OH2)]
+
 and bicarbonate was found 
to be characterised by a value of logK = 2.42 (± 0.02). 
 
  
 
Figure 3.2: Variation of the emission spectral profile of [Eu.L
22
(OH2)]
+
 upon addition of bicarbonate. 
The initial spectral form and limiting spectral form (10 mM bicarbonate) are highlighted in separate plots 
(295 K, pH 7.4, 0.1 M NaCl, 30 µM complex).  
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The dramatic change in spectral form observed upon addition of bicarbonate was 
reminiscent of that observed previously in the presence of protein, consistent with the 
occurrence of a binding interaction between the anion and the lanthanide centre, 
involving a similar change in the constitution of the complex. Again, a large increase in 
the relative intensity of the ΔJ = 2 band was apparent, suggesting a change in the axial 
donor polarizability.
29, 30
 As before, this could possibly be attributed to the replacement 
of the neutral N donor of the azaxanthone chromophore with a polarizable charged 
oxygen donor from the chelating anion. Meanwhile, using an analogous method to that 
outlined in Section 2.3.1 of Chapter 2, the hydration state of the complex in the 
presence of 29 mM bicarbonate was found to be reduced in comparison to the free 
complex (Table 3.1), suggesting displacement of the coordinated water molecule from 
the lanthanide centre. Overall these results are consistent with a mode of binding 
involving displacement of both the coordinated water molecule and one of the 
azaxanthone chromophores from the lanthanide centre. 
 
Table 3.1: Experimentally determined radiative rate constants and the derived value of q' (± 20%) for 
[Eu.L
22
(OH2)]
+
 (295 K, pH 5.5) and in the presence of sodium bicarbonate (29 mM) (295 K, 0.1 M 
NaCl). 
 
Complex Anion      / ms
-1
      / ms
-1
 q' 
[Eu.L
22
(OH2)]
+
 
- 2.08 0.61 1.46 
Bicarbonate 1.51 0.72 0.65 
 
The reversibility of the binding interaction between [Eu.L
22
(OH2)]
+ 
and bicarbonate was 
probed in a simple experiment. Firstly, a 1 mL sample of [Eu.L
22
(OH2)]
+
 was prepared, 
as outlined above, and a sample of concentrated sodium bicarbonate stock solution was 
added to give a bicarbonate concentration of 29 mM. The pH of the sample was then 
gradually lowered and the total emission output monitored. Upon acidification of the 
sample, the emission spectral form changed. The experiment was halted at pH 3 and 
argon was bubbled through the sample in order to facilitate the removal of carbonic acid 
as carbon dioxide. The spectral fingerprint observed at this pH bore close resemblance 
to that of the starting aqua complex, suggesting that the binding interaction and 
associated changes in complex constitution are indeed reversible.  
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3.2.2 Examining changes in emission spectral form  
 
Having verified that reversible anion binding is able to occur at the lanthanide centre in 
[Ln.L
22
(OH2)]
+
, several additional investigations were carried out to assess and 
characterise the binding of a number of chiral anions. It was anticipated that such an 
analysis would allow the identification of the chiral anions that would be most suitable 
for use in CPL studies, aimed at demonstrating the scope and utility of [Ln.L
22
(OH2)]
+ 
in chiral detection.  
 
Titrations were carried out in which the emission intensity of [Ln.L
22
(OH2)]
+
 (Ln = Eu
3+
 
or Tb
3+
) was monitored in the presence of a gradually increasing amount of each chosen 
anion. In every case, incremental additions of a freshly prepared, concentrated anion 
stock solution were made to a 1 mL sample of [Ln.L
22
(OH2)]
+ 
(Ln = Eu
3+
 or Tb
3+
), 
which had been dissolved in aqueous solution at pH 7.4 containing 0.1 M NaCl. The pH 
of each anion stock solution was adjusted to 7.4 using conc. HCl(aq) and conc. NaOH(aq) 
prior to additions being carried out, in order to minimise changes in the pH of the 
lanthanide complex solution over the course of each titration. Generally speaking, it was 
found that changes in spectral form for [Eu.L
22
(OH2)]
+
 only occurred at relatively high 
concentrations of added anion. In accordance with this, the titrations were typically 
carried out over the concentration range 0 - 75 mM for both the europium and terbium 
analogues of the complex, unless significant quenching of signal intensity was found to 
occur or a limiting spectral form was attained prior to this endpoint. Representative 
structures of the anions investigated are shown below.  
 
 
 
 
pKa's:       0.94, 6.11
167 
                                <1, 2.08, 5.65, 9.74
168 
                          1.6, 2.02, 5.65, 9.20
168 
 
 
 
         3.86
169 
                             3.41
170 
                             3.40, 5.20
169                      
                 2.99, 4.40
169 
   L-Lactate                     L-Mandelate                           L-Malate                                  L-Tartrate 
      D-Glucose-6-phosphate                      O-Phospho-L-threonine                       O-Phospho-L-tyrosine  
 
α-Hydroxy acids: 
                  
Phosphorus(v) oxy-anions: 
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In the case of the chiral phosphorus(v) oxy-anions, very little change in spectral form 
was observed upon addition of the anion stock solution to 1 mL samples of 
[Eu.L
22
(OH2)]
+
. For D-glucose-6-phosphate and O-phospho-L-threonine, slight 
variations in the emission spectral fingerprint first became apparent when the 
concentration of added anion was in excess of roughly 5 mM. These changes were 
similar in nature for the two anions and were particularly evident within the 
hypersensitive ΔJ = 2 manifolds of the emission spectra. Each titration was halted when 
the concentration of added anion reached roughly 75 mM, at which point a limiting 
spectrum was still not attained. In the case of O-phospho-L-tyrosine, quenching of 
signal intensity meant that the analogous titration was halted when the concentration of 
added anion was roughly 46 mM. No significant change in spectral form was observed 
for [Eu.L
22
(OH2)]
+ 
in the presence of this anion. Analogous titrations carried out with 
[Tb.L
22
(OH2)]
+
 showed only quenching of the signal intensity, which was particularly 
pronounced in the case of O-phospho-L-tyrosine, as was expected on the basis of the 
results obtained with [Eu.L
22
(OH2)]
+
.
 
  
 
  
Figure 3.3: Europium emission spectral changes following addition of O-phospho-L-threonine (left, 75 
mM) and O-phospho-L-tyrosine (right, 46 mM) to [Eu.L
22
(OH2)]
+
 (blue = initial, red = final, 295 K, 0.1 
M NaCl, pH 7.4, 15 µM complex).   
 
The observations outlined above were very different to the dramatic changes in spectral 
form observed for [Eu.L
22
(OH2)]
+ 
in the presence of bicarbonate, and provided limited 
evidence to support a mode of anion binding involving a change in complex 
constitution. Binding affinities were estimated where possible by fitting 1:1 binding 
isotherms to the data gathered using non-linear least squares iterative analysis. For each 
anion, the binding interaction with [Eu.L
22
(OH2)]
+ 
was found to be characterised by a 
value of logK ≤ 1.0 (± 0.1). Taking this into account, it is unsurprising that the changes 
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in spectral form observed in the presence of the phosphorus(v) oxy-anions were less 
dramatic than those seen with bicarbonate (logK = 2.42 (± 0.02)). Previous studies 
examining the binding of phosphorus(v) oxy-anions by coordinatively unsaturated 
lanthanide complexes have revealed that these anions tend to bind to the lanthanide 
centre of europium complexes in a monodentate manner.
50, 128
 This is in contrast to the 
chelating manner known to be favoured by bicarbonate (see Figure 3.1) and could 
perhaps in part explain the weaker affinity observed. 
 
In contrast to the results obtained with the phosphorus(v) oxy-anions, well-defined and 
dramatic changes in the emission spectral form were found to occur for [Eu.L
22
(OH2)]
+
 
in the presence of the α-hydroxy acids lactate, mandelate and malate. For the 
structurally-related chiral anion tartrate, some change in form was observed but the 
variation appeared incomplete over the concentration range examined. Limiting spectra 
attained in the presence of the former three anions are shown in Figure 3.4, along with 
the initially recorded emission spectrum.  
 
A 
 
B 
 
C 
 
D 
 
Figure 3.4: Representative emission spectra showing the metal-based emission of [Eu.L
22
(OH2)]
+
: (A) 
complex only; (B) complex + 69 mM L-lactate; (C) complex + 34 mM D-mandelate; (D) complex + 61 
mM L-malate (295 K, pH 7.4, 0.1 M NaCl, 15 µM complex). 
 
As can be seen from Figure 3.4, the limiting spectral fingerprint of the complex in the 
presence of lactate, mandelate and malate was very similar in form, suggesting a near 
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identical mode of binding at the lanthanide centre. In each case, a large increase in the 
relative intensity of the ΔJ = 2 band was apparent in comparison to the free complex, 
mimicking the variation which had previously been observed with bicarbonate. On the 
basis of this observation, it may be hypothesised that the mode of coordination of these 
α-hydroxy acids at the lanthanide centre again involves displacement of both the 
coordinated water molecule and one azaxanthone pyridine nitrogen from the lanthanide 
centre. In the presence of lactate, an overall increase in the emission intensity was 
observed, suggesting particularly efficient exclusion of quenching XH oscillators from 
the primary and secondary coordination spheres. For lactate and mandelate close 
inspection of the ΔJ = 1 manifold within the limiting emission spectral fingerprint 
revealed the presence of only three bands, consistent with the presence of a single 
emissive species in solution. In contrast, a similar analysis of the spectral fingerprint 
obtained in the presence of malate suggested the existence of multiple emissive species 
in solution, implying the presence of several different ternary complexes in solution (see 
Section 3.3.1 for further discussion). 
  
  
Figure 3.5: Representative emission spectra showing the ΔJ = 0 and ΔJ = 1 manifolds of the europium 
emission for [Eu.L
22
(OH2)]
+
 in the presence of 69 mM L-lactate (left) and 61 mM L-malate (right) (295 
K, pH 7.4, 0.1 M NaCl, 15 µM complex). 
 
As expected, for [Tb.L
22
(OH2)]
+
 the changes in spectral form observed in the presence 
of the chiral α-hydroxy acids discussed above were much less pronounced. Generally 
speaking, for this complex the overall emission intensity was found to decrease in the 
presence of each anion, with no significant variation in the relative intensity of the 
emission within the various manifolds. Substantial quenching of the emission intensity 
was observed in the presence of mandelate and the titration was halted when the 
concentration of added anion was 17 mM. In every other case, less quenching was 
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observed and the titrations were carried out over the concentration range 0 - 75 mM. 
The variation in metal-based emission of [Tb.L
22
(OH2)]
+
 upon addition of lactate is 
shown in Figure 3.6. 
 
 
Figure 3.6: Variation of the emission spectral profile of [Tb.L
22
(OH2)]
+
 upon addition of L-lactate. Inset: 
Calibration curve showing variation of the observed emission intensity versus [L-lactate] (295 K, pH 7.4, 
0.1 M NaCl, 30 µM complex). 
 
Attempts were made to estimate binding affinities for each of the α-hydroxy chiral 
anions with [Ln.L
22
(OH2)]
+
  (Ln = Eu
3+
, Tb
3+
). First, a ratiometric analysis of the data 
collected at each concentration of added anion was carried out. A 1:1 binding isotherm 
was then fitted to the resulting data points using non-linear least squares iterative 
analysis, allowing the determination of binding constants. For the titrations carried out 
using the europium complex, the ratiometric analysis of the data generated was carried 
out by comparing the integrated emission intensity of the ΔJ = 2 band to that of the ΔJ = 
1 band. As is evident from the data presented in Table 3.2, the binding constant 
associated with the interaction between [Eu.L
22
(OH2)]
+
 and tartrate was much weaker 
than those characterising the interaction between this complex and the other α-hydroxy 
acids. Meanwhile, of the other three anions, the highest binding constant was associated 
with the interaction between [Eu.L
22
(OH2)]
+ 
and mandelate. In light of previous studies 
of interactions between coordinatively unsaturated DOTA-derived lanthanide 
complexes and phosphorus(v) oxy-anions, which demonstrated a chemoselectivity for 
(O-P-Tyr)
2-
 over (O-P-Ser)
2-
, this latter result was not unexpected and may reasonably 
be attributed to the lower degree of hydration experienced by mandelate in aqueous 
media, in comparison to lactate and malate.
128, 171
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Table 3.2: Comparison of the experimentally determined binding constants for [Eu.L
22
(OH2)]
+
 in the 
presence of various anions. Standard deviation errors associated with data fitting are shown in brackets. 
 
Complex 
logK 
Lactate Mandelate Malate Tartrate 
[Eu.L
22
(OH2)]
+ 
1.94 (± 0.02) 2.39 (± 0.03) 1.81 (± 0.01) 0.88 (± 0.01) 
 
Attempts to perform ratiometric analyses of the data obtained over the course of 
titrations carried out with [Tb.L
22
(OH2)]
+
 using a method of the type described above 
did not generate data that was amenable to further analysis. By instead analysing the 
variation in emission intensity at a pair of individual emission wavelengths a set of data 
points to which a 1:1 binding isotherm could be fitted was generated in the case of 
lactate, and an affinity constant of logK = 1.70 (± 0.01) was calculated. This was a 
surprising result, owing to the fact that terbium is slightly more charge dense than 
europium and one may therefore anticipate that for a given anion a higher affinity 
constant is expected to be associated with its interaction with the terbium analogue of a 
chosen complex.  
 
3.2.3 Determining the hydration state of the anion-bound complexes 
 
In order to gain further evidence in support of the hypothesis that the binding of lactate, 
mandelate and malate to [Ln.L
22
(OH2)]
+ 
(Ln = Eu
3+
, Tb
3+
) is associated with the 
displacement of both the coordinated water molecule and one of the azaxanthone 
chromophores from the lanthanide centre, experiments were undertaken to facilitate the 
determination of the hydration state, q', of the complex in the presence of these anions. 
The method used was analogous to that outlined in Section 2.3.1 of Chapter 2, with 
suitable concentrations of each anion being decided on the basis of previously obtained 
results. In all cases, a mono-exponential decay of the emission intensity was observed in 
both H2O and D2O, facilitating the determination of radiative rate constants and 
derivation of q' values.  
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Table 3.3: Experimentally determined radiative rate constants the derived value of the hydration state, q' 
(± 20%), for [Ln.L
22
(OH2)]
+
 (295 K, pH 5.5) and in the presence of lactate (106 mM), mandelate (44 mM 
for Eu
3+
, 17 mM for Tb
3+
) and malate (96 mM) (295 K, 0.1 M NaCl). 
 
Complex Anion      / ms
-1
      / ms
-1
 q' 
[Eu.L
22
(OH2)]
+
 
- 2.08 0.61 1.46 
Lactate 1.32 0.69 0.46 
Mandelate 1.38 0.72 0.49 
Malate 1.26 0.66 0.42 
[Tb.L
22
(OH2)]
+ 
- 0.66 0.48 0.60 
Lactate 0.56 0.42 0.40 
Mandelate 0.72 0.59 0.35 
Malate 0.57 0.46 0.25 
 
As can be seen from the data presented in Table 3.3, the hydration state of both the 
europium and terbium complexes of L
22
 was consistently found to tend towards zero in 
the presence of each added anion. The results obtained are therefore in support of the 
hypothesis that binding of lactate, mandelate and malate to [Ln.L
22
(OH2)]
+ 
(Ln = Eu
3+
, 
Tb
3+
) is associated with the displacement of both the coordinated water molecule and 
one of the azaxanthone chromophores from the lanthanide centre. It is interesting to 
note that, whilst in all other cases the rate of radiative decay of the lanthanide emission 
in water was found to decrease in the presence of anion, [Tb.L
22
(OH2)]
+ 
proved 
exceptional to this when in the presence of mandelate.  
 
3.3 CPL studies 
 
On the basis of the results outlined in the preceding sections, lactate, mandelate and 
malate were selected for use in a series of experiments aimed at evaluating the utility of 
[Ln.L
22
(OH2)]
+ 
(Ln = Eu
3+
, Tb
3+
) for chiral detection. In comparison to the proteins 
examined in Chapter 2, these chiral anions are much smaller entities and offer no 
possibility of secondary coordination effects, such as the inclusion of the azaxanthone 
sensitiser into the ligand binding pocket which was noted for α1-AGP. Hence, although 
it was clear from the results discussed previously that these chiral α-hydroxy acids are 
able to bind to the lanthanide centre in [Ln.L
22
(OH2)]
+ 
in a manner that is coupled to a 
change in complex constitution, it remained to be seen whether this would lead to the 
observation of an induced CPL effect in any of these cases. All CPL spectra reported in 
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this chapter were recorded at Durham University on a custom built spectrometer, which 
employed a laser driven light source with a spectral range of 170 to 2100 nm.    
 
3.3.1 Preliminary studies using [Tb.L
22
(OH2)]
+
 
 
An initial study was undertaken to establish whether any circular polarization was 
induced in the emission output of [Tb.L
22
(OH2)]
+ 
in the presence of lactate, mandelate 
or malate. A preliminary titration was performed in an attempt to monitor the 'switching 
on' of CPL in the emission output of this racemic complex, in the presence of gradually 
increasing amounts of L-lactate. The method employed was analogous to that used for 
the titrations previously described, in which the total emission spectral change was 
monitored. Unfortunately, the complex [Tb.L
22
(OH2)]
+
 was found to be extremely 
susceptible to photobleaching under the experimental conditions. The observed decrease 
in emission intensity presumably occurred as a result of photoreduction of the carbonyl 
group, facilitated by the high power of the laser driven excitation light source. This 
meant that the signal intensity was progressively depleted over the course of the 
titration. The experimental method was subsequently revised such that for each anion 
examined a number of separate 1 mL samples of the terbium complex was prepared as 
outlined previously. The total emission spectrum of each sample was recorded prior to 
and immediately after the acquisition of CPL spectral data, such that the extent of 
photobleaching could be monitored. Typically, each sample was analysed for its CPL 
output in the presence of a chosen concentration of anion and then discarded. As before, 
additions of the anions were made from freshly prepared, concentrated stock solutions, 
which had been adjusted to pH 7.4 using conc. HCl(aq) and conc. NaOH(aq). Between 
four and six different concentrations of each anion were examined, with appropriate 
ranges chosen on the basis of previously obtained results.  
 
In the case of both L-lactate and L-mandelate, the 'switching on' of a CPL signal was 
observed for [Tb.L
22
(OH2)]
+
 at various concentrations of added anion (Figure 3.7). As 
was anticipated based on the structural similarity of these anions, the spectral fingerprint 
of the induced CPL signal observed in the presence of their L enantiomers was identical 
in form. The CPL spectra were characterised by a large signal associated with the 
5
D4 
→ 7F5 transition, whilst little circular polarization was associated with any of the other 
transitions. This was reminiscent of the behaviour previously exhibited by this complex 
in the presence of protein (see Section 2.5, Chapter 2). 
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Figure 3.7: Representative CPL spectra showing the circularly polarized emission of [Tb.L
22
(OH2)]
+
 in 
the presence of 10 mM L-lactate (left) and 0.5 mM L-mandelate (right) (295 K, 0.1 M NaCl, pH 7.4, 15 
µM complex). 
 
In contrast to the results outlined above, CPL spectra recorded for [Tb.L
22
(OH2)]
+
 in the 
presence of L-malate did not show any circular polarization of the emission. Samples 
were analysed at 4 different concentrations of added anion, ranging between 5 and 45 
mM. Unfortunately it was not possible to gather data at higher concentrations owing to 
quenching of signal intensity. The lack of induced CPL observed in the presence of 
malate provides clear evidence to support a hypothesis that the mode of binding of this 
anion at the metal centre in [Ln.L
22
(OH2)]
+ 
differs to that of lactate and mandelate. 
 
Previous studies examining the binding of lactate to lanthanide centres in complexes 
based on ligands derived from DOTA have shown that the binding of this anion 
typically occurs via the formation of a 5 membered chelate, involving the hydroxy 
group and the α-carboxylate.127 However, it may be envisaged that the formation of a 
chelated adduct involving a lanthanide centre and this or other α-hydroxy acids may 
also occur via the carboxylate moiety, either exclusively or in part. In addition, for 
hydroxy acids such as malate where there is a second carboxylate moiety present in a β-
position relative to the hydroxy group, a coordination mode involving cooperative 
carboxylate binding may be anticipated. 
 
 
 
Scheme 3.1: Possible modes of chelation for α-hydroxy acids at a lanthanide centre. 
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A series of control titrations was carried out using an identical method to that outlined 
in the previous section, in an attempt to ascertain further information regarding the 
mode of binding of lactate, mandelate and malate at the europium centre in 
[Eu.L
22
(OH2)]
+
. The variation in the emission spectral output of [Eu.L
22
(OH2)]
+ 
was 
examined in the presence of gradually increasing amounts of acetate, alanate, succinate 
and citrate. As before, titrations with these ions were halted when the concentration in 
solution reached roughly 75 mM. With citrate, significant quenching of the signal 
intensity was observed, which precluded analysis of changes in spectral form. 
Meanwhile, for alanate very little change in spectral form was found to occur, 
suggesting that this zwitterion is unable to form a ternary complex in solution with 
[Eu.L
22
(OH2)]
+ 
over the concentration range examined. More significant changes in 
spectral form were seen with acetate and succinate. The observed variations in the 
emission spectral profile of [Eu.L
22
(OH2)]
+ 
in the presence of these anions are shown in 
Figure 3.8. A limiting spectral form was not attained, in either case, over the 
concentration range examined, suggesting that the binding of lactate and mandelate to 
the europium centre in [Eu.L
22
(OH2)]
+ 
must occur predominantly in a classical manner, 
via the formation of 5 membered chelates involving the hydroxy group.
127
 Meanwhile, 
results obtained with succinate suggest that the ternary complexes formed by 
[Eu.L
22
(OH2)]
+
 in the presence of malate may involve coordination of the anion via one 
or both of the carboxylate moieties. The chiral centre is therefore located more remotely 
in relation to the lanthanide ion and induced CPL is not observed.  
 
  
Figure 3.8: Europium emission spectral changes following addition of acetate (left, up to 80 mM) and 
succinate (right, up to 78 mM) to [Eu.L
22
(OH2)]
+
, shown with the structures of the anions (295 K, 0.1 M 
NaCl, pH 7.4, 15 µM complex). The emission spectrum obtained at the endpoint of each titration is 
shown in bold.  
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The CPL data gathered for [Tb.L
22
(OH2)]
+
 in the presence of L-lactate and L-mandelate 
was used to determine emission dissymmetry factors  in accordance with equation 1, as 
defined in Section 1.2.2 of Chapter 1.
13 
 
                                                           
      
    
                                                   (eqn. 1) 
 
For both anions, the highest emission dissymmetry factor was found to be associated 
with the transition centred at 541.5 nm. Figure 3.9 shows a plot of the variation in the 
emission dissymmetry factor at this wavelength as a function of L-lactate concentration. 
For this anion the emission dissymmetry factor was found to reach its maximum 
between 6 and 10 mM. Meanwhile, in the case of mandelate it was found that a lower 
concentration of added anion was required in order for a maximal emission 
dissymmetry factor to be reached at 541.5 nm, with the highest value of gem being 
obtained in the presence of between 0.5 and 1 mM L-mandelate. This was not 
unexpected given the relative affinity of [Eu.L
22
(OH2)]
+
 for these anions, which had 
already been calculated on  the basis of total emission spectral changes (see Table 3.2).  
 
 
Figure 3.9: A plot of the variation in gem at 541.5 nm with concentration of L-lactate for [Tb.L
22
(OH2)]
+
 
(295 K, 0.1 M NaCl, pH 7.4, 15 µM complex). 
 
As can be seen from Figure 3.9, the CPL signal associated with the ternary complex 
formed between L-lactate and [Tb.L
22
(OH2)]
+
 was characterised by a maximal gem value 
of roughly +0.1 at 541.5 nm. Surprisingly, it was found that there was a significant 
difference in magnitude between this and the equivalent value observed in the presence 
of L-mandelate, with the latter figure being around +0.05. On the basis of these figures, 
it was concluded that the utility of [Tb.L
22
(OH2)]
+
 for chiral detection would be best 
demonstrated in the presence of lactate, where it was hoped that the higher emission 
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dissymmetry factor would facilitate the collection of data for mixtures of stereoisomers 
containing only a slight excess of one enantiomer. 
 
3.3.2 Demonstrating the utility of [Tb.L
22
(OH2)]
+
 in chiral detection 
 
Prior to undertaking further CPL studies aimed at demonstrating the utility of 
[Tb.L
22
(OH2)]
+ 
in chiral detection, a preliminary titration was carried out monitoring the 
variation in total emission intensity of [Eu.L
22
(OH2)]
+
 as a function of D-lactate 
concentration. The data gathered facilitated the determination of a binding constant for 
the formation of a ternary complex between these species in accordance with the 
method outlined in Section 3.2.2. As was anticipated, the changes in spectral form 
observed in the presence of D-lactate were found to mimic those seen with the 
enantiomeric anion, and the binding affinity was found to be 1.97 (± 0.02) compared to 
1.94 (± 0.02) for L-lactate, i.e. the same within error (Figure 3.10 and see also Table 
3.2). 
 
 
 
 
Figure 3.10: Variation of the emission spectral profile of [Eu.L
22
(OH2)]
+
 upon addition of D-lactate (295 
K, pH 7.4, 0.1 M NaCl, 15 µM complex). Inset: Calibration curve showing variation of the observed 
emission intensity versus [D-lactate] and the fit (line) to the observed data.  
 
Subsequent CPL experiments carried out using the methods outlined in the previous 
section demonstrated that the addition of D-lactate to a 1 mL sample of [Tb.L
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(OH2)]
+ 
in 0.1 M NaCl at pH 7.4 also led to the induction of circular polarization in the emission 
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was a mirror image of that seen in the presence of L-lactate and the variation in gem at 
541.5 nm followed an identical pattern as the concentration of added anion was raised. 
 
A final set of experiments was carried out in which scalemic samples of lactate of pre-
determined enantiomeric composition were added to 1 mL samples of [Tb.L
22
(OH2)]
+ 
in 
0.1 M NaCl at pH 7.4 to give a series of solutions where the overall concentration of 
lactate was 10 mM. A CPL spectrum was recorded for each sample and the data 
generated was used to calculate emission dissymmetry factors. It was found that it was 
possible to calibrate the observed emission dissymmetry factor at 541.5 nm to the 
enantiomeric purity of the lactate sample, with an approximately linear relationship 
being observed between the two variables (Figure 3.11). Such a relationship could 
facilitate the determination of enantiomeric purity in samples containing an unknown 
composition of lactate. 
 
  
 
Figure 3.11: Representative CPL spectra showing the circularly polarized emission of [Tb.L
22
(OH2)]
+
 in 
the presence of 10 mM lactate of varying enantiomeric composition shown alongside a plot 
demonstrating the correlation between gem at 541.5 nm and the enantiomeric composition of the solution 
(295 K, 0.1 M NaCl, pH 7.4, 15 µM complex).  
 
3.3.3 Studies using [Eu.L
22
(OH2)]
+ 
and an insight into the mechanism of binding 
 
Having demonstrated the utility of [Tb.L
22
(OH2)]
+
 for the chiral detection of lactate, 
attempts were made to carry out an analogous study using the europium analogue of this 
complex. Firstly, a set of experiments was undertaken to determine if an induced CPL 
signal could be observed for this complex in the presence of various concentrations of 
enantiopure samples of D- and L-lactate. The same method was used for these 
experiments as had previously been employed in the initial analysis of induced CPL 
from samples of [Tb.L
22
(OH2)]
+
 described in Section 3.3.1. Again, the total emission 
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spectrum of each sample was recorded prior to and immediately after the acquisition of 
CPL spectral data, such that the extent of photobleaching could be monitored. For each 
enantiomer, a total of five concentrations of lactate were examined, ranging between 6 
and 49 mM.  
 
As expected on the basis of CPL data acquired for the terbium analogue of this 
complex, it did indeed prove possible to observe induced circular polarization in the 
emission of [Eu.L
22
(OH2)]
+
 in the presence of enantiopure samples of D- and L-lactate. 
The signal was found not to be particularly well defined at concentrations lower than 
around 25 mM, which was somewhat surprising, given that this complex had been 
determined to have a higher affinity for lactate than its terbium analogue on the basis of 
previous analysis of changes in the total emission spectral output (see Section 3.2.2). 
Again, for a given concentration of L- or D-lactate mirror image spectra were observed, 
with differing degrees of circular polarization being associated with each of the 
transitions. 
 
 
Figure 3.12: Representative CPL spectra showing the mirror image circularly polarized emission of 
[Eu.L
22
(OH2)]
+
 in the presence of 49 mM of D- and L-lactate (295 K, 0.1 M NaCl, pH 7.4, 15 µM 
complex).  
 
A more in depth analysis of the CPL data gathered at each concentration of lactate was 
facilitated by the calculation of emission dissymmetry factors, which were found to be 
at a maximum when the concentration of lactate was between 30 and 50 mM. As can be 
seen from the data presented in Table 3.4, relatively modest values of gem were observed 
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in general, with the highest values occurring for transitions within the ΔJ = 1 and ΔJ = 2 
manifolds. 
 
Table 3.4: Selected emission dissymmetry factors calculated using the data displayed in Figure 3.12. 
 
  gem 
Complex Anion ΔJ = 1 (λ) ΔJ = 2 (λ) ΔJ = 4 (λ) 
[Eu.L
22
(OH2)]
+
 
- 0 0 0 0 0 
L-lactate +0.04   
(588) 
-0.03  
(618) 
+0.04   
(620) 
-0.02  
(623) 
+0.02   
(696) 
D-lactate -0.04  
(588) 
+0.03   
(618) 
-0.04  
(620) 
+0.02   
(623) 
-0.02  
(696) 
 
An inspection of the total emission spectral data recorded prior to and following the 
CPL data collection for each sample revealed an unexpected result, with it being found 
that, for a given sample, differences in form were apparent between the two spectra. As 
can be seen from Figure 3.13, changes in form were more evident for samples where the 
concentration of added lactate was low. However, some variation was still noted in 
samples where lactate was present at a concentration of 49 mM. In particular, the ΔJ = 1 
manifold appeared to become more well-defined, with the spectrum recorded following 
acquisition of CPL data clearly showing only three distinct bands within this manifold.  
 
  
Figure 3.13: Europium emission spectra for [Eu.L
22
(OH2)]
+
 in the presence of 6 mM (left) and 49 mM 
(right) L-lactate. In each case, spectra recorded prior to (green) and following (blue) CPL data acquisition 
are shown (295 K, 0.1 M NaCl, pH 7.4, 15 µM complex).   
 
Subsequent investigations were carried out in an attempt to determine the factors 
implicit in the observations outlined above. A 1 mL sample of [Eu.L
22
(OH2)]
+
 was 
prepared in 0.1 M NaCl at pH 7.4 and an aliquot of sodium L-lactate added from a 
freshly prepared stock solution in order to yield a sample in which the concentration of 
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anion was approximately 50 mM. The total emission of this sample was recorded twice, 
with a 30 minute interval between measurements. No significant difference in form was 
noted between the spectra generated by these measurements. In a separate experiment a 
second 1 mL sample of [Eu.L
22
(OH2)]
+ 
in the presence of 50 mM L-lactate was 
prepared using an identical method. The total emission spectrum of this sample was 
recorded ten times over the space of a 30 minute time period, such that the sample was 
under frequent irradiation. In this case, it was found that the emission spectral form did 
change over the 30 minute time period, with the observed changes found to be largely 
conserved when the sample was subsequently left at room temperature for one hour, 
without further irradiation (Figure 3.14). Similar results were subsequently noted in 
analogous experiments carried out with bicarbonate, malate and mandelate, suggesting 
that the mechanism of binding of these anions at the lanthanide centre in [Ln.L
22
(OH2)]
+
 
is photo-assisted, to some extent. It should be noted that, in the absence of added anion, 
no change in the emission spectral form of the complex was observed, under the 
experimental conditions outlined above. 
 
 
 
Figure 3.14: Europium emission spectral changes over the course of 30 minutes for [Eu.L
22
(OH2)]
+
 in the 
presence of 50 mM L-lactate when under constant irradiation. The inset shows the variation in spectral 
form within the ΔJ = 1 manifold, with the original spectrum depicted in blue and the final spectrum in 
red. The green spectrum was recorded 1 hour later (295 K, 0.1 M NaCl, pH 7.4, 15 µM complex).   
 
A tentative hypothesis regarding the nature of the photo-assistance proposed above can 
be made, based on the assumption that the binding mechanism involves rate-limiting 
dissociation of the azaxanthone pyridine nitrogen, followed by fast anion binding. 
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Assuming this is the case, then the results outlined above suggest that the population of 
the triplet state of the chromophore leads to a weakening of the interaction between the 
lanthanide centre and the azaxanthone pyridine nitrogen, meaning anion binding is 
facilitated in the excited state. 
 
A final set of CPL experiments was carried out in order to evaluate the utility of this 
europium complex for the chiral detection of lactate. Using an analogous method to that 
outlined for [Tb.L
22
(OH2)]
+
 a linear correlation between the emission dissymmetry 
factor at 620 nm and the enantiomeric purity of lactate was established for samples in 
which the overall lactate concentration was 50 mM. Again, it may be envisaged that 
such a relationship could facilitate the determination of enantiomeric purity in samples 
containing an unknown composition of lactate. However, it should be acknowledged 
that the larger values of gem observed for the terbium analogue of this complex in the 
presence of D- or L-lactate mean that [Tb.L
22
(OH2)]
+
 is inherently better suited to such 
an application. In either case, additional experiments would first need to be undertaken 
to determine the reliability of such measurements, particularly in light of the apparent 
photo-assisted nature of the anion binding process. 
 
 
 
Figure 3.15: A plot demonstrating the correlation between gem at 620 nm for [Eu.L
22
(OH2)]
+
 and the 
enantiomeric composition of a solution containing 50 mM lactate (295 K, 0.1 M NaCl, pH 7.4).  
 
3.4 Conclusions and future work 
 
The utility of the racemic europium and terbium complexes of L
22
 for chiral detection 
has been demonstrated through a series of experiments. Given their wide availability, 
chiral anions were identified as suitable targets in this proof of concept study. 
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Before undertaking any studies with chiral anions, the ability of [Ln.L
22
(OH2)]
+
 to form 
ternary complexes with anionic species was first verified in an initial experiment, 
monitoring changes in the emission spectral output of [Eu.L
22
(OH2)]
+
 in the presence of 
the achiral anion bicarbonate. Spectral changes were found to mimic those observed in 
the presence of protein and the hydration state of the complex was found to decrease in 
the presence of this anion, suggesting that anion binding is also accompanied by 
displacement of both the coordinated water molecule and one of the azaxanthone 
chromophores from the lanthanide centre. 
 
Having confirmed the possibility of anion binding at the lanthanide centre in 
[Ln.L
22
(OH2)]
+
, experiments were carried out monitoring the change in the emission 
spectral output of [Ln.L
22
(OH2)]
+
 (Ln = Eu
3+
, Tb
3+
) in the presence of seven different 
chiral anions, three phosphorus(v) oxy-anions and four α-hydroxy acids. In the case of 
the phosphorus(v) oxy-anions, only minor changes in spectral form were observed for 
the emission spectral output of [Eu.L
22
(OH2)]
+
 over the concentration range examined 
and binding affinities were found to be weak (logK ≤ 1.0 (±0.1)). The modest nature of 
the binding interaction observed with these anions was attributed to their preference for 
a monodentate binding mode. More dramatic changes in the emission spectral form of 
[Eu.L
22
(OH2)]
+ 
were generally observed in the presence of each of the chelating α-
hydroxy acids, with a large increase in the relative intensity of the ΔJ = 2 band being 
observed in all cases. Emission spectral changes for [Tb.L
22
(OH2)]
+
 were also 
monitored in the presence of these anions; although quenching of the signal intensity 
was consistently seen, no real change in spectral form was found to occur in any case. 
 
On the basis of the results obtained in the total luminescence studies outlined above, 
lactate, mandelate and malate were selected for study in a series of CPL experiments 
aimed at demonstrating the utility of [Ln.L
22
(OH2)]
+
 for chiral detection. Initially, an 
attempt was made to record an induced CPL spectrum for [Tb.L
22
(OH2)]
+
 in the 
presence of each of these anions. Whilst well-defined CPL spectra were observed in the 
presence of L-lactate and L-mandelate, the induction of CPL was not found to be 
apparent with L-malate. It was suggested that the mode of binding at the lanthanide 
centre may differ for this anion, with coordination predominantly occurring through the 
carboxylate moieties rather than by the formation of a 5 membered chelate, involving 
the hydroxy group and the α-carboxylate oxygen. Therefore, for malate it was proposed 
that the chiral centre was placed further away from the lanthanide ion in the ternary 
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complex, thus leading to a lack of induced CPL. Evidence was gathered in support of 
this hypothesis through a series of control experiments examining the changes in total 
luminescence spectral form for [Eu.L
22
(OH2)]
+
 in the presence of a number of achiral 
anions. 
 
Owing to the fact that the CPL signal observed in the presence of lactate was associated 
with larger emission dissymmetry factors than that seen with mandelate, it was decided 
that the former anion was more suited to further study. A preliminary titration was 
undertaken in which changes in the total emission of [Eu.L
22
(OH2)]
+
 were monitored in 
the presence of D-lactate, in order to verify that species was able to bind to the 
lanthanide centre in an identical manner to its enantiomer. This was indeed found to be 
the case. A final CPL study was then performed with [Tb.L
22
(OH2)]
+
 in order to 
establish a correlation between the enantiomeric composition of an aqueous solution 
containing a known overall concentration of lactate and the emission dissymmetry 
factor at 541.5 nm. A linear relationship was observed between these variables, clearly 
demonstrating the utility of [Tb.L
22
(OH2)]
+
 for analysis of enantiomeric purity and 
assignment of absolute configuration. 
 
Similar CPL experiments carried out with [Eu.L
22
(OH2)]
+ 
also led to promising results, 
although emission dissymmetry factors were found to be lower in the case of this 
complex, meaning that the signal to noise was lower than for the terbium analogue. An 
unexpected insight into the mechanism of binding at the lanthanide centre was gained 
through undertaking these experiments. It was observed that, for a sample of the 
complex with a given concentration of lactate, the binding event appeared to be photo-
assisted, with changes in spectral form being observed over the course of the CPL data 
acquisition. On the basis of these results, it was proposed that anion binding must occur 
via a mechanism involving rate-limiting dissociation of the azaxanthone pyridine 
nitrogen, which in turn must occur more readily in the excited state. 
 
The work detailed in this chapter has clearly demonstrated the potential offered by 
racemic lanthanide complexes based on macrocyclic ligands for chiral detection. 
However, it should be highlighted that the photo-assisted nature of the binding 
mechanism observed for [Ln.L
22
(OH2)]
+
 in the presence of anions perhaps does not lend 
itself to the development of this particular system as a reliable tool for such analyses. It 
may be envisaged that alternative racemic lanthanide systems could be developed based 
on heptadentate ligands derived from DOTA, where anion binding would simply 
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involve displacement of coordinated water molecules from the lanthanide centre. There 
are several examples of enantiopure lanthanide systems of this type in the literature, 
where anion binding has been demonstrated through monitoring changes in the total 
emission spectral output.
166
 In addition, racemic lanthanide complexes of ligands 
derived from alternative macrocylic frameworks could be examined. For example, 
recent work carried out at Durham has demonstrated the potential offered by europium 
complexes derived from ligands based on a 1,4,7-triazacyclononane framework for 
anion sensing.
172
 In this work it was shown that the complex, [Eu.L
28
(OH2)]
+
 is able to 
bind lactate at the europium centre, with coordination occurring through the carboxylate 
moiety rather than via the formation of 5 membered chelates. A series of CPL 
experiments using this complex were carried out in parallel to the studies detailed in this 
chapter by Brian McMahon and Robert Pal. Results showed that the observation of 
induced CPL was possible in the presence of lactate, with emission dissymmetry factors 
an order of magnitude lower than those observed for [Tb.L
22
(OH2)]
+
.
173
 This is 
presumably a reflection of the differing coordination mode at the lanthanide centre, with 
the observation of the CPL signal made possible due to the exceptional quantum yield 
of the complex (in contrast to results obtained for [Tb.L
22
(OH2)]
+ 
in the presence of 
malate). For this complex, a linear correlation was also established between the average 
emission dissymmetry factor at 621.5 nm and the enantiomeric purity of lactate. 
 
     
 
Figure 3.16: The structure of [Eu.L
28
(OH2)]
+ 
is shown alongside a plot displaying the variation of gem at 
621.5 nm with enantiomeric composition of D-lactate.
173
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4.1 Introduction 
 
The work outlined in Chapter 3 demonstrated the utility of constitutionally mobile 
racemic lanthanide complexes in chiral detection. The inspiration for this study came 
from a consideration of the results obtained in previous investigations of induced CPL 
effects from racemic lanthanide complexes. Prior to undertaking the work detailed in 
Chapter 2 and 3 of this thesis, two mechanisms had been identified by which the 
presence of a chiral additive could lead to the induction of circular polarization in the 
emission output of a racemic lanthanide complex (see Section 1.5.2 of Chapter 1). One 
of these mechanisms is enantioselective excited state quenching.  
 
Enantioselective excited state quenching is a phenomenon which can lead to the 
generation of an enantiomeric excess over time in the excited state of a racemic 
lanthanide complex. Provided that the rate of racemisation is slower than the rate of 
radiative decay, such an effect will yield the induction of circular polarization in the 
emission output of the complex. As outlined in Chapter 1, the observation of induced 
CPL from [Ln(DPA)3]
3-
 systems as a result of such chiral discrimination in the excited 
state has been demonstrated with a wide variety of chiral additives.
111, 112, 114, 122, 124, 125
 
However, this phenomenon has yet to be exemplified for lanthanide complexes of other 
structural motifs. This chapter details work carried out in an attempt to demonstrate 
enantioselective quenching of luminescence for a number of lanthanide complexes 
derived from macrocyclic ligands.  
 
4.2 Experimental methodology 
 
As mentioned in Section 1.5.2.2 of Chapter 1, the vast majority of enantioselective 
quenching effects reported to date have been identified and characterised by the 
measurement of time-resolved CPL spectral data. However, owing to lack of access to 
suitable instrumentation, it was necessary to employ alternative methods of 
investigation and analysis for the preliminary studies outlined in this chapter. Key to the 
choice of methods used was the hypothesis that enantioselective quenching phenomena 
may be exhibited in situations other than those involving chiral but racemic lanthanide 
complexes in the presence of small amounts of enantiomerically resolved chiral 
additives. Specifically, it was envisaged that examination of the quenching of an 
enantiopure lanthanide complex by enantiomerically pure samples of a given chiral 
species may reveal the occurrence of preferential quenching, through the use of Stern-
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Volmer analysis. It should be noted that, although uncommon, the investigation of 
enantioselective quenching phenomena through the use of Stern-Volmer analysis is not 
entirely without precedent; the utility of such analysis in the identification and 
characterisation of enantioselective quenching phenomena was highlighted in a 2002 
publication.
174 
 
4.2.1 Stern-Volmer analysis 
 
Broadly speaking, quenching mechanisms can be classified into two categories.
175
 Static 
quenching involves formation of a non-fluorescent complex between the quencher and 
the ground state emissive species. Meanwhile, dynamic (or collisional) quenching is 
effected through a diffusive encounter with the quenching species during the excited 
state lifetime of the emissive species. Quenching mechanisms belonging to the latter of 
these categories can be described by the Stern-Volmer equation, which relates the ratio 
of the emission intensity in the absence and presence of quencher, 
  
 
, to the rate 
constant for the bimolecular quenching process,   , and the excited state lifetime in the 
absence of quencher,   , as well as the concentration of quencher present in solution, 
   . 
                                              
  
 
                                                (eqn. 14) 
 
Data gathered through steady-state luminescence measurements of dynamic quenching 
processes is frequently used in the calculation of Stern-Volmer quenching constants, 
   
  , which signify the concentration of quencher required to reduced the emission 
intensity to 50% of its original value. As is apparent from equation 14, for a dynamic 
quenching process occurring via a single mechanism, a plot of 
  
 
 or 
  
 
 will give a 
straight line with gradient    .  
 
As outlined in Section 1.3.4 of Chapter 1, quenching of the lanthanide-based emission 
from a sensitised lanthanide complex can occur via a number of different mechanisms, 
each of which is dynamic in nature. In light of this fact, it was anticipated that the 
characterisation of any chiral discriminatory effect occurring in the quenching of the 
luminescence from an enantiopure lanthanide complex by enantiomerically pure 
samples of a given chiral species would be possible by the calculation and comparison 
of Stern-Volmer quenching constants.  It was hypothesised that for a given lanthanide 
complex these constants would differ in magnitude for each donor-acceptor pair, if an 
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enantioselective quenching effect was present. If successful, such an analysis would 
therefore facilitate the identification of quenchers suitable for use in subsequent CPL 
studies with structurally related racemic lanthanide complexes. 
 
4.3 Examining quenching of lanthanide emission for a cyclen-based system 
 
An enantiopure complex suitable for use in initial studies aimed at demonstrating chiral 
discrimination in the quenching of luminescence from lanthanide complexes based on 
macrocyclic frameworks was selected following an initial consideration of the various 
mechanisms by which the quenching of lanthanide-based emission from a sensitised 
complex is known to occur. To date, enantioselective quenching studies with 
[Ln(DPA)3]
3-
 complexes have typically been carried out with systems where quenching 
is assumed to occur via a short range electronic energy transfer process. On the basis of 
this, it was thought that it may prove worthwhile to explore systems in which quenching 
is known to occur via other mechanisms involving short range interactions.  
 
As discussed in Section 1.3.4.2 of Chapter 1, one mechanism by which charge-transfer 
quenching of emission from sensitised lanthanide complexes incorporating electron-
poor chromophores may occur involves the formation of an exciplex between the triplet 
excited state of the chromophore and the quenching molecule.
45, 46
 It was hypothesised 
that if a system could be identified in which quenching occurs via this mechanism, 
where the structure of the lanthanide complex was such that the approach of the 
quenching molecule could only occur selectively to one face of the chromophore, then 
the prospects of chiral discrimination in any observed quenching effect would be 
enhanced. On the basis of this hypothesis, the cyclen-based terbium complex (SSS)-Δ-
[Tb.L
20b
]
3+ 
was selected for use in the preliminary experiments detailed in this section. 
The unusual serum albumin binding properties of this complex and its europium 
analogue (see Section 1.5.3.2, Chapter 1) had previously prompted a variety of NMR 
studies to be carried out using its yttrium analogue, (SSS)-Δ-[Y.L20b]3+.134 Proton NMR 
spectra obtained for this complex in the absence of protein revealed that one face of the 
tetra-azatriphenylene moiety is blocked by a phenyl ring of the proximate (S)-α-
methylbenzylamide group. This was confirmed by an extended DFT structural 
calculation carried out by Dr. I. Kuprov (University of Southampton), which generated 
a structure showing intramolecular π-overlap between the sensitising chromophore and 
a phenyl ring (Figure 4.1).
136
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Figure 4.1: DFT calculated structure of (SSS)-Δ-[Y.L20b]3+, the lower face of the sensitising moiety can 
be seen to be blocked by a proximate phenyl ring.
136
 
 
4.3.1 Selecting the chiral quenchers 
 
Two electron-rich aromatic reductants of differing conformational rigidity were selected 
for use in a series of initial experiments aimed at assessing the occurrence of chiral 
discriminatory phenomena in the quenching of the luminescence output of (SSS)-Δ-
[Tb.L
20b
]
3+
. The catechol derivative, DOPA, was one of the quenching species 
employed in the original mechanistic studies which led to the deduction that exciplex 
formation is implicated in deactivation of lanthanide luminescence, in certain instances 
of charge-transfer quenching.
45
 Meanwhile, Trolox, a vitamin E analogue, is a well-
known reductant which is known to quench triplet excited states by electron transfer.
176
 
It was hypothesised that quenching of the emission intensity from (SSS)-Δ-[Tb.L20b]3+ in 
the presence of Trolox would also occur via a mechanism involving exciplex formation. 
It should be noted that the reduction potential of this latter species is known to be 0.48 
V and is therefore comparable to that of catechol, which is 0.53 V.
177, 178 
 
 
 
Support for the hypothesis that quenching of the emission intensity from (SSS)-Δ-
[Tb.L
20b
]
3+ 
in the presence of Trolox would occur via a mechanism involving exciplex 
formation was gained through an investigation carried out to assess the dependence of 
the quenching effect on solvent composition. Separate titrations were carried out in 
buffer solution and methanol and the modulation of the luminescence emission intensity 
from (SSS)-Δ-[Tb.L20b]3+ was monitored as a function of (S)-Trolox concentration. As 
(S)-Trolox L-DOPA 
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can be seen from Figure 4.2, although a quenching effect was apparent in both methanol 
and buffer solution, a considerable solvent effect was observed.  
 
 
Figure 4.2: Comparison of the variation in emission intensity from (SSS)-Δ-[Tb.L20b]3+ as a function of 
[(S)-Trolox] in both MeOH (red squares; 295 K, 20 µM complex) and buffer solution (blue diamonds; 
295 K, pH 7.4, 0.1 M HEPES, 0.1 M NaCl, 20 µM complex).  
 
The observation that quenching was much less efficient in methanol than in the buffer 
solution supports the theory that quenching is occurring by a mechanism involving 
exciplex formation. Such behaviour suggests that a hydrophobic effect plays a role in 
the quenching process i.e. exclusion of high energy water from the surface of the π-
moieties upon exciplex formation, which returns to the bulk where hydrogen bonding is 
facilitated.  
 
4.3.2 Investigations into enantioselective quenching 
 
To assess the occurrence of chiral discrimination in the quenching of the emission of 
(SSS)-Δ-[Tb.L20b]3+ in the presence of DOPA and Trolox, titrations were carried out in 
which the modulation of the luminescence emission intensity and lifetime of the 
complex was monitored as a function of quencher concentration, Q. Incremental 
additions of each enantiomer of both quenchers were made to 2 mL samples of (SSS)-Δ-
[Tb.L
20b
]
3+
 which had been dissolved in 0.1 M HEPES containing 0.1 M NaCl at pH 
7.4, to give solutions where the concentration of complex was 20 µM. The variation in 
I0/I as a function of [Q] is shown in Figure 4.3; plots of τ0/τ versus [Q] were similar in 
form in every case.  
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Figure 4.3: Comparison of the variation in emission intensity as a function of [DOPA] (left) and [Trolox] 
(right) for (SSS)-Δ-[Tb.L20b]3+ (295 K, pH 7.4, 0.1 M HEPES, 0.1 M NaCl, 20 µM complex). 
 
As is apparent from the Stern-Volmer plots presented in Figure 4.3, the emission 
intensity was found to decrease upon addition of each of the quenchers to solution 
samples of (SSS)-Δ-[Tb.L20b]3+. Whilst an approximately linear plot of I0/I versus [Q] 
was generated by analysis of titration data in the case of Trolox, the same could not be 
said for DOPA. The nature of the curvature observed in the plot of I0/I versus [Q] for 
this latter species was reminiscent of observations outlined in previous publications 
detailing charge transfer quenching by electron rich species involving exciplex 
formation.
45
  
 
The data gathered from both the lifetime and intensity measurements performed over 
the course of the titrations were used in the calculation of Stern-Volmer quenching 
constants (Table 4.1). In the case of Trolox, these values were calculated on the basis of 
analysis of data gathered over the full concentration range of each titration, 0 - 40 µM. 
Meanwhile, for DOPA, only the eight initial data points were used, which spanned the 
concentration range 0 - 3 µM. For a given quencher, agreement between the Stern-
Volmer constants calculated on the basis of intensity and lifetime data was good, 
suggesting that it is reasonable to attribute the reduction of emission intensity and 
lifetime from (SSS)-Δ-[Tb.L20b]3+ to the occurrence of a single dynamic mechanism. 
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Table 4.1: Stern-Volmer quenching constants for the dynamic quenching of emission from (SSS)-Δ-
[Tb.L
20b
]
3+ 
(295 K, pH 7.4, 0.1 M HEPES, 0.1 M NaCl, 20 µM complex). 
 
Complex Quencher 
   
   / µM 
Intensity data Lifetime data 
(SSS)-Δ-[Tb.L20b]3+ 
L-DOPA 7.7 7.5 
D-DOPA 7.0 6.7 
(S)-Trolox 3.1 3.8 
(R)-Trolox 3.1 3.6 
 
As is clear from the Stern-Volmer quenching constants shown in Table 4.1, charge-
transfer quenching was found to occur more efficiently in the presence of Trolox than in 
the presence of DOPA, notwithstanding their similar reducing power. This may in part 
be a reflection of the differing overall charge of the two quencher species when in 
buffer solution at pH 7.4. For Trolox, the overall charge is negative owing to the 
presence of the ionised carboxylate group, meaning that an attractive electrostatic 
interaction will exist with the positively charged terbium complex. Meanwhile, DOPA 
is zwitterionic and therefore no such electrostatic interaction is present.  
 
Unfortunately, the results presented in Table 4.1 did not provide strong evidence to 
suggest any involvement of chiral discrimination in the charge transfer quenching 
processes for either Trolox or DOPA, with results obtained with enantiomeric species 
giving almost identical Stern-Volmer quenching constants in each case. This result was 
not entirely unexpected in the case of DOPA, where it was anticipated that the 
conformational flexibility of the quencher may negate the possibility of an 
enantiodifferential effect. Meanwhile, in light of these disappointing results, a series of 
computational studies examining the interaction between (SSS)-Δ-[Tb.L20a]3+ and the 
two Trolox enantiomers was conducted by Dr. I. Kuprov (University of Southampton). 
Initially, representative minimum energy structures for the diastereomeric exciplex 
species were generated using DFT (Figure 4.4). Examination of these structures 
revealed some difference in the orientation of the Trolox enantiomers relative to the 
tetraazatriphenylene moiety of the lanthanide complex, with a greater amount of 
aromatic overlap apparent in the case of (S)-Trolox. However, the energy difference 
between the diastereomeric exciplexes was found to be small (6 kJ mol
-1
), suggesting 
that little enantioselectivity is likely to be apparent in the quenching interactions of 
these species. It should be noted that, although these initial calculations were carried out 
in the gas phase, subsequent calculations using implicit solvent also revealed little 
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energy difference. Such data therefore agrees with the experimental observations 
outlined above.  
 
      
 
Figure 4.4: Minimum energy structures for the interaction of  (SSS)-Δ-[Tb.L20a]3+ with (S)-Trolox (left) 
and (R)-Trolox (right) calculated using DFT structural calculations. 
 
In spite of these results, it was hypothesised that a difference between the quenching 
effect of the two enantiomers may yet be seen for Trolox, if the electrostatic interaction 
between the lanthanide complex and the quencher species could be removed. This 
electrostatic interaction is non-directional so will not favour the formation of one 
diastereomeric exciplex over another. In order to generate a system in which this 
electrostatic interaction would not be significant, the methyl ester analogues of Trolox 
were synthesised, using a straightforward acid-catalysed esterification reaction. 
Subsequent titrations were carried out using these ester species under the conditions 
previously outlined. However, it was found that it was necessary to use a trace of 
methanol (< 1 % by volume) in order to ensure that the quenching species were fully 
dissolved. Figure 4.5 shows the variation in I0/I as a function of quencher concentration 
for the (R)- and (S)- enantiomers of Trolox methyl ester, derived using data gathered in 
initial titrations.  
 
(S)-Trolox (R)-Trolox 
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Figure 4.5: Stern-Volmer plots derived from titrations measuring the modulation of the emission 
intensity of (SSS)-Δ-[Tb.L20b]3+ in the presence of (R)- (purple triangles) and (S)- (orange circles) Trolox 
(295 K, pH 7.4, 0.1 M HEPES, 0.1 M NaCl, trace MeOH, 20 µM complex).  
 
As can be seen from Figure 4.5, an approximately linear plot of I0/I versus [Q] was 
generated by analysis of the initial titration data, with the extent of quenching seemingly 
less than had been observed with the parent acids. Stern-Volmer quenching constants 
were calculated by analysis of the data obtained over the full concentration range of 
each titration. In the case of the (R) enantiomer, a value of 7.5 µM was obtained by this 
analysis. Meanwhile, for the (S) enantiomer a slightly higher value of 9.2 µM was 
determined, indicating that quenching was slightly less efficient for (S)-Trolox methyl 
ester than its enantiomer. It should be noted that subsequent attempts to reproduce these 
results were not entirely successful. Although a difference in quenching efficiency of 
this sense was consistently observed for the two enantiomers, the same could not be said 
regarding the magnitude of the enantioselectivity. As was discussed in Section 1.5.2.2 
of Chapter 1, the dependence of enantioselective quenching phenomena on sample 
conditions is a well-researched topic, with several studies having been carried out to 
assess the effect of variables such as ionic strength and solvent on the degree of 
enantioselectivity observed for a given system. In light of this and of the fact that the 
quenching interaction with Trolox had been found to shown significant solvent 
dependence (see Figure 4.2), a set of titrations was carried out in which the quenching 
of (SSS)-Δ-[Tb.L20b]3+ by (R)-Trolox methyl ester was monitored for solutions 
containing various trace amounts of methanol. However, no clear correlation was found 
to exist between the percentage of methanol present and the resulting Stern-Volmer 
quenching constants, suggesting that fluctuations in other sample conditions such as 
temperature may also play a role in the exact results obtained.  
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Despite the lack of reproducible results obtained in the experiments described above, a 
series of CPL studies was carried out to determine if the methyl ester derivative of 
Trolox could perturb the excited state racemic equilibrium of the neutral complex 
[Tb.L
29
]. This racemic complex was selected due to its structural similarity with 
[Ln.L
20
]
3+
, in terms of the common presence of the tetra-azatriphenylene chromophore 
structure. CPL spectra were obtained for the complex in the presence of each 
enantiomer of the quenching species. Unfortunately, no evidence was found for the 
generation of circularly polarized emission in either system. 
 
N N
NN
N
N
N
N
O
O
O
O
O
O
Tb
 
 
 
4.4 Examining quenching of lanthanide emission for complexes based 
on 1,4,7-triazacyclononane 
 
Notwithstanding the apparent lack of promise shown by the results outlined in the 
previous section, it was decided that efforts should be made to study the possibility of 
enantioselective quenching phenomena using lanthanide complexes derived from 
ligands based on a structurally related macrocyclic framework, 1,4,7-triazacyclononane. 
Scheme 4.1 shows representative structures of a selection of ligands derived from this 
framework, each of which incorporates sensitising chromophores and has been utilised 
in the synthesis of racemic emissive 9-coordinate lanthanide complexes with pseudo C3 
symmetry.
 
In complexes of L
2
, L
30 
and L
31
, the lanthanide centre is coordinated by the 
three nitrogen atoms of the 1,4,7-triazacyclononane core, along with the three pyridyl 
nitrogen donors and three carboxylate or phosphinate oxygen donors.
32, 179-181
 In 
contrast, for complexes of L
32
, the coordination requirements of the metal centre are 
satisfied solely by the tridentate chelating units incorporated into the pendant arms of 
the ligand structure.
182
  
 
[Tb.L
29
] 
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Scheme 4.1: Representative structures of nonadentate ligands based on a 1,4,7-triazacyclononane core. 
 
As for complexes derived from DOTA (see Section 1.4.2, Chapter 1), the chirality of 
lanthanide systems derived from L
30
 can be described in terms of two torsion angles, the 
N-C-C-N angle of the macrocyclic ring, which can be +60
o
 or -60
o
 (δ and λ 
respectively), and the N-C-C-Npy angle of the pendant arms. If this latter angle is 
positive a Δ helicity results, if it is negative then a Λ helicity is defined. The existence 
of four stereoisomeric species, related as two pairs of enantiomers, is therefore predicted 
(Figure 4.6). However, to date structural studies of lanthanide complexes of L
30
 in both 
the solid state and solution have consistently revealed the existence of a single 
enantiomeric pair of complexes as a racemic mixture, which have been determined to 
have Δ(λλλ) and Λ(δδδ) helicity.179 Meanwhile, variable temperature 1H NMR 
spectroscopy experiments conducted using [Ln.L
30
] (Ln = Eu
3+
, Tb
3+
, Gd
3+
) have shown 
no evidence for the occurrence of dynamic processes, such as ring inversion and 
concerted arm rotation, suggesting high energy barriers for these processes.  
 
L
30 
 
 
 
                                                                       L
32 
 
 
 
L
2
 
R = Ph  
L
31
 
R = Me 
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Figure 4.6: Schematic representative of the four stereoisomers of [Ln.L
30
]. 
 
The chirality of lanthanide systems derived from L
2
 and L
31
 can be described in a 
similar manner to that outlined above. However, there is an extra element of chirality to 
consider for complexes of these ligands, owing to the fact that upon complexation a 
stereogenic centre is formed at phosphorus. In theory, cooperative binding of the three 
phosphinate moieties incorporated in the pendant arms of these ligands to a lanthanide 
centre could give rise to a mixture of diastereomeric species, where the configuration at 
phosphorus is (SSS)/(RRR) or (SRS)/(RSR). However, in the case of [Ln.L
2
] and 
[Ln.L
31
] the observation of a single phosphorus resonance in the 
31
P NMR spectra of 
both systems suggested that the formation of complexes with an (RSR)/(SRS) 
configuration at phosphorus does not occur.
32, 181
 In the case of [Ln.L
2
], this hypothesis 
was supported by solid state crystallographic analysis. Indeed, structural analysis of 
[Ln.L
2
] and [Ln.L
31
] complexes using the analytical techniques already mentioned, 
along with others such as 
1
H NMR spectroscopy, revealed the presence of a single 
enantiomeric pair of complexes as a racemic mixture, with (RRR)-Λ(δδδ) and (SSS)-
Δ(λλλ) configuration. As for [Ln.L30], no evidence for the occurrence of dynamic 
processes, such as ring inversion and concerted arm rotation, was obtained via variable 
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temperature 
1
H NMR spectroscopy. Separation of the enantiomeric (RRR)-Λ(δδδ) and 
(SSS)-Δ(λλλ) species was achieved for [Ln.L2] (Ln = Eu3+, Tb3+) using chiral HPLC. 
CPL spectra were subsequently recorded for the resolved complexes and were found to 
demonstrate high emission dissymmetry factors (see Figure 1.8, Chapter 1). 
 
4.4.1 Synthesis and characterisation of a series of enantiopure lanthanide 
complexes based on 1,4,7-triazacyclononane 
 
Before the methodology outlined in Section 4.2 of this chapter could be utilised for the 
study of enantioselective quenching phenomena for lanthanide complexes derived from 
ligands based on 1,4,7-triazacyclononane, it was first necessary to devise a means by 
which direct access to single enantiomeric species could be achieved. As discussed and 
exemplified in Section 1.4 of Chapter 1, the synthesis of enantiopure lanthanide 
complexes is typically achieved by the inclusion of asymmetric centres in the ligand. 
For ligands derived from macrocylic frameworks, asymmetry may be incorporated 
either directly onto the macrocycle or, alternatively, into the pendant arms. Although 
there are many examples of enantiopure lanthanide complexes synthesised using chiral 
DOTA-based ligands in accordance with this methodology, the same cannot be said for 
lanthanide complexes formed using ligands derived from the 1,4,7-triazacyclononane 
framework. The use of ligands derived from this framework is however much more 
widespread in transition metal coordination chemistry. Results of a recent study 
examining the synthesis and characterisation of a hexadentate copper complex, using 
the commercially available chiral ligand L
33
, provided evidence to suggest that it is 
possible to achieve the control of configuration for complexes derived from 1,4,7-
triazacyclononane by the use of similar methodology.
183
  
 
L
33 
 
In light of the results outlined above, it was hypothesised that adaptation of the ligand 
framework for L
2
 or L
31
 to include a single C-substitution in the macrocylic framework 
may lead to the preferential formation of one enantiomerically pure complex 
stereoisomer in solution. Owing to the fact that the pyridyl methylphosphinate ligand 
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L
31
 had been found to form complexes offering better water solubility, the complexes 
(R)- and (S)-[Ln.L
34
] (Ln = Eu
3+
, Tb
3+
) were chosen as the synthetic targets.  
 
 
 
4.4.1.1 Synthetic aspects 
 
Previously described methods were employed in the synthesis of the substituted 
complexes.
181, 184, 185 
The synthetic pathway for the preparation of the enantiomeric 
substituted macrocycles is shown in Scheme 4.2. 
 
 
Scheme 4.2: Synthetic pathway for the preparation of chiral 2-benzyl-1,4,7-triazacyclononane 
derivatives. 
 
With the exception of the tosylation reaction in step 3, where the occurrence of 
significant over-alkylation was found to limit the amount of desired product formed, 
yields greater than 70% were typically achieved in every stage of the synthesis. As 
expected, the yield of product in a given step was generally found to be similar, 
(R)-[Ln.L
34
]                                                                                        (S)-[Ln.L
34
] 
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regardless of which enantiomeric starting material was used. The detosylation of the 
ring nitrogens in the final stage of the synthesis was effected through the use of liquid 
ammonia and sodium, as opposed to lithium. Analysis of the product using 
1
H NMR 
spectroscopy typically revealed the presence of trace amounts of contaminating 
material, with the presence of alkene CH resonances at 5.5 and 5.7 ppm suggesting that, 
although largely avoided, partial reduction of the aromatic ring in the benzyl substituent 
had occurred to a small extent. Following characterisation, the product was used 
immediately for N-alkylation without further purification (see Scheme 4.5). 
 
The pyridyl methylphosphinate chromophore was prepared in parallel to the 
enantiomeric substituted macrocycles, in accordance with the synthetic pathway shown 
in Scheme 4.3.  
 
Scheme 4.3: Chromophore synthesis. 
 
As can be seen from Scheme 4.3, reactions were again found to be high yielding. The 
catalyst [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) was employed in 
the coupling reaction between 2-bromo-6-methylpyridine and ethyl methylphosphonite, 
which was found to afford a similar yield to that previously achieved in an analogous 
reaction using tetrakis(triphenylphosphine)palladium(0).
181
 Formation of the pyridyl N-
oxide was effected using MCPBA. Subsequent purification by column chromatography 
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on silica gel facilitated the removal of the benzoic acid side product. Conversion of this 
species to the final product shown in Scheme 4.3 was achieved in two stages. First, 
treatment with trifluoroacetic anhydride yielded a labile ester via a Boekelheide 
rearrangement, which was characterised by the presence of a singlet at ~ 5.5 ppm in its 
1
H NMR spectrum, corresponding to the methylene group protons. Subsequent 
hydrolysis in aqueous ethanol gave the final product, with 
1
H NMR spectroscopy 
revealing a shift in the methylene group protons to ~ 4.8 ppm (Figure 4.7).  
 
 
Figure 4.7: Comparison of 
1
H NMR spectra for ethyl[6-hydroxymethyl]pyridine-2-
yl](methyl)phosphinate and its ester precursor (CDCl3, 295 K, 400 MHz). 
 
In order to achieve ligand synthesis by alkylation of the previously described 1,4,7-
triazacyclononane derivatives, it was necessary to first convert the pyridyl 
methylphosphinate alcohol species to its mesylate ester. Mesylation was carried out 
using methanesulfonyl chloride and triethylamine in THF at 5 
o
C
 
(Scheme 4.4). This 
reaction was carried out multiple times, owing to the fact that it was necessary to 
prepare fresh samples of the mesylate for each alkylation reaction that was carried out. 
Each time, the reaction was monitored by TLC and typically found to be completed 
within 10  minutes. 
7 
7 
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Scheme 4.4: Mesylation of ethyl[6-(hydroxymethyl)pyridine-2-yl](methyl)phosphinate. 
 
Characterisation of the mesylate species was carried out using mass spectrometry and 
NMR spectroscopy. In most cases, some formation of an additional product was noted 
alongside the desired compound, which was identified as the chloromethyl species by 
analysis of the gathered spectroscopic data. The product was used for ligand synthesis 
without further purification, with alkylation of the previously described 1,4,7-
triazacyclononane derivatives being carried out under standard conditions (K2CO3, 
CH3CN) as shown in Scheme 4.5. Reactions were halted when complete consumption 
of the mesylated and chlorinated starting materials was apparent by TLC. The addition 
of a catalytic amount of potassium iodide was found to facilitate reaction of the latter 
species. 
 
 
Scheme 4.5: Synthesis of L
34
. 
 
As anticipated, the alkylation reaction depicted in Scheme 4.5 resulted in a mixture of 
products when either the (R) or (S) enantiomer of the macrocyclic starting material was 
used. Separation of these products was possible by column chromatography, facilitating 
the isolation of the desired triethyl ester protected ligands, (R)- and (S)-L
34
. Samples of 
the di-substituted ligand analogue, L
35
, were also isolated for both enantiomers. 
1
H 
NMR spectra obtained for the enantiomers of this latter species were consistent with the 
presence of a single regioisomer in solution, presumably that in which the ring nitrogen 
located in closest proximity to the C-substitution is not alkylated. Unfortunately, the 
amount of material available was not sufficient to carry out detailed NMR studies 
needed in order to verify this hypothesis. 
L
34 
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The formation of lanthanide complexes using (R)- and (S)-L
34
 was achieved in two 
further steps, shown in Scheme 4.6. Hydrolysis of the ethyl esters was confirmed by 
ESMS or 
31
P NMR spectroscopy before proceeding to the second stage of the reaction 
scheme. Metal complexation was confirmed prior to isolation of each of the complexes 
by removing a sample of the reaction mixture and obtaining its emission spectrum in 
water. In each case, the characteristic emission spectra expected for europium and 
terbium were visible, following excitation of the phosphinate chromophore at 268 nm. 
Once the complexes had been isolated, purification was carried out by short-path 
column chromatography on silica. The purity of each complex was verified using 
HRMS and reverse phase HPLC. 
 
 
 
Scheme 4.6: Preparation of [Ln.L
34
]. 
 
It should be noted that the preparation of terbium complexes of the heptadentate ligands 
(R)- and (S)-L
35
 was also achieved using similar methods to those shown in Scheme 4.6. 
However, owing to the charged nature of these di-substituted complexes, it was not 
possible to carry out purification via short-path column chromatography on silica. 
Analytical HPLC traces obtained for crude samples of both (R)- and (S)-[Tb.L
35
]
+
 
appeared to show the presence of two major species, with similar retention times. 
L
35 
[Ln.L
34
] 
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Further analysis of both samples using LCMS revealed that for each complex the two 
major species present were of the same mass, which corresponded to the expected mass 
of [Tb.L
35
]
+
. The removal of trace impurities from these complexes was subsequently 
achieved using preparative HPLC, though the method used did not allow isolation of 
separate samples of the isomeric species. Unfortunately, the amount of complex isolated 
was not sufficient to facilitate a structural analysis of the complexes formed. 
 
4.4.1.2 Photophysical characterisation of (R)- and (S)-[Ln.L
34
]  
 
Insight into the lanthanide ion environment in the purified europium and terbium 
complexes of the tri-substituted ligands (R)- and (S)-L
34 
was gained using a number of 
photophysical techniques. Characterisation was carried out with reference to results 
previously reported for the europium and terbium complexes of the achiral parent ligand 
L
31
.  
 
The hydration state of the newly synthesised complexes was determined using the 
methodology outlined in Section 2.3.1 of Chapter 2. Experimentally determined 
radiative rate constants for the deactivation of the lanthanide excited state were found to 
be independent of the configuration at the substituted carbon centre in the macrocylic 
ring. Rates were determined in both H2O and D2O, therefore allowing the derivation of 
the hydration state, q', of each complex. Table 4.2 shows the experimentally determined 
data along with comparable data taken from the literature for [Ln.L
31
] (Ln = Eu
3+
, 
Tb
3+
).
181
  
  
Table 4.2: Experimentally determined radiative rate constants and derived values of q' (± 20%) for 
europium and terbium complexes of (R)- and (S)-L
34
 as well as literature data for the europium and 
terbium complexes of L
31
 (295 K, pH 5.5).
181
 
 
Complex      / ms
-1      / ms
-1 q' 
[Eu.L
31
] 0.64 0.63 0.0 
(R)- or (S)-[Eu.L
34
] 0.75 0.63 0.0 
[Tb.L
31
] 0.39 0.34 0.0 
(R)- or (S)-[Tb.L
34
] 0.38 0.37 0.0 
 
As can be seen from Table 4.2, the values obtained in the investigations outlined above 
were extremely similar to those previously recorded for the europium and terbium 
complexes of L
31
, indicating that the lanthanide ions are in similar environments in 
complexes of these ligands. Comparison of the form of the emission spectral fingerprint 
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for the europium and terbium complexes of these ligands provided further evidence in 
support of this. As can be seen from Figure 4.8, not only was the form of the emission 
spectrum found to be identical for complexes of (R)- and (S)-L
34
, but an extremely high 
degree of similarity was seen in comparison with spectra previously reported in the 
literature for lanthanide complexes formed using L
31
. 
 
  
  
Figure 4.8: Emission spectra of the europium (top) and terbium (bottom) complexes of L
34
 (left) and L
31
 
(right) in water, after excitation at 268 nm (295 K, pH 7.4, 0.1 M NaCl, 0.1 M HEPES).  
 
4.4.1.3 Chiral analysis 
 
As stated above, initial photophysical characterisation of the [Ln.L
34
] complexes 
provided evidence to suggest a broad similarity between the immediate lanthanide ion 
coordination environment in comparison to analogous complexes of L
31
. However, 
significant differences between the overall symmetry and chirality of the complex 
structures were revealed by the use of additional characterisation methods. Further 
analysis of the solution structure of the [Ln.L
34
] complexes was carried out using NMR 
spectroscopic techniques. These methods not only allowed insight to be gained into the 
overall symmetry of the complexes, but also facilitated a more detailed examination of 
the nature of the relationship between the structure of complexes derived using (R)- and 
(S)-L
34
 for a given lanthanide ion. 
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As was mentioned in Section 4.4, 
31
P NMR spectra obtained for the europium and 
terbium complexes of the achiral ligand L
31
 showed a single phosphorus resonance, 
suggesting that the arrangement of the ligand around the lanthanide ion gave rise to a 
structure with pseudo C3 symmetry, in which the phosphorus centres adopt an 
(SSS)/(RRR) configuration. The disruption of this symmetry in europium and terbium 
complexes derived using the substituted ligand enantiomers (R)- and (S)-L
34
 was 
immediately apparent from 
31
P NMR spectra obtained, which were each characterised 
by the presence of three peaks of equal intensity, consistent with the non-equivalence of 
the P atoms of the phosphinate moieties. The absence of rotational symmetry in the 
europium and terbium complexes of L
31 
was also apparent from their 
1
H NMR spectra. 
Representative spectra are shown in Figure 4.9, which compares the 
31
P and 
1
H NMR 
spectra recorded for (S)-[Eu.L
34
] to those previously reported for [Eu.L
31
].  
 
A 
 
B 
 
C 
 
 
 
 
 
 
 
D 
 
Figure 4.9: 
31
P and 
1
H NMR spectra obtained for (S)-[Eu.L
34
] (B and D respectively) in comparison to 
those previously reported for [Eu.L
31
] (A and C) * indicates solvent resonances (CD3OD, 400 MHz). 
* 
* 
* 
* 
* 
Me 
Me Me Me 
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As can be seen from Figure 4.9, the appearance of the 
1
H and 
31
P
 
NMR spectra obtained 
for (S)-[Eu.L
34
] were consistent with the presence of only one species in solution, with 
less than 4% of any minor species. This was also found to be the case for the terbium 
analogue of this complex. For a given lanthanide ion, the NMR spectra recorded for the 
complexes derived using (R)- and (S)-L
34
 were found to be almost identical in form, 
implying that the complexes formed using these ligands were enantiomeric in nature. 
Figure 4.10 shows a comparison of 
1
H NMR spectra recorded for (R)- and (S)-[Tb.L
34
] 
in MeOD at room temperature. The broader linewidth apparent in these spectra in 
comparison to the 
1
H NMR spectra shown in Figure 4.9 is due to faster transverse 
relaxation rates, which arise due to the high magnetic susceptibility of the terbium ion. 
 
 
 
Figure 4.10: Comparison of 
1
H NMR spectra recorded for samples of (R)- (top) and (S)- (bottom) 
[Tb.L
34
] * indicates solvent resonances (CD3OD, 400 MHz).  
 
Based on the assumption that racemisation of the chiral centre in the ligand framework 
did not occur during the synthesis of these complexes, the results outlined above 
provided clear evidence to suggest that the incorporation of the ring substitution was 
successful in favouring the formation of a single enantiopure species in solution. In 
order to further substantiate this hypothesis, the enantiopurity of the complexes was 
probed using chiral HPLC. HPLC traces were obtained for samples of (R)- and (S)-
* * 
* * 
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[Eu.L
34
] using a CHIRALPAK-ID column with an isocratic elution of methanol (Figure 
4.11). 
 
 
Figure 4.11: Chiral HPLC traces of (R)- and (S)-[Eu.L
34
] (bottom and top respectively) run on a 
CHIRALPAK-ID column (MeOH, 1 mL min
-1, λ = 268 nm, 290 K). 
 
As can be seen from Figure 4.11, the HPLC traces obtained using (R)- and (S)-[Eu.L
34
] 
confirmed the presence of one major species in solution for both complexes; the amount 
of minor species present was found to be less than 5%. The differing retention times of 
the major species provided evidence to suggest opposing chirality. CPL spectra 
subsequently recorded in Durham for samples of (R)- and (S)-[Ln.L
34
] in D2O showed a 
mirror image relationship in the case of both the terbium and europium complexes, 
providing confirmation of the hypothesis that an enantiomeric relationship exists 
between the complexes (Figure 4.12).  
 
 
A B 
B A 
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Figure 4.12: Circularly polarized emission spectra for (R)- (red) and (S)- (blue) [Ln.L
34
]
 
(Ln = Eu
3+
, left 
and Tb
3+
, right). 
 
Emission dissymmetry factors were calculated for the enantiomeric complexes (Table 
4.3). As expected from the appearance of the CPL spectra, the values of gem at a chosen 
wavelength were found to be approximately equal and opposite for complexes of a 
given lanthanide ion derived from (R)- and (S)-L
34
. The magnitude of the calculated gem 
values was comparable to results previously found for enantiopure samples of the 
structurally related phenylphosphinate complex [Ln.L
2
], which had been obtained 
following resolution of the complex by chiral HPLC (see Section 4.4).
32
 
 
Table 4.3: Selected emission dissymmetry factors calculated using the data displayed in Figure 4.12. 
 
Complex 
gem 
ΔJ = 1 ΔJ = 2  ΔJ = 3  ΔJ = 4 
(591.5 nm) (595 nm) (615 nm) (654 nm) (701.5 nm) (708 nm) 
(S)-[Eu.L
34
] +0.08 -0.09 -0.03 +0.19 -0.19 +0.39 
(R)-[Eu.L
34
] -0.08 +0.09 +0.03 -0.22 +0.17 -0.38 
 ΔJ = 2  ΔJ = 1 ΔJ = 0  ΔJ = -1 
(489.5 nm) (544 nm) (548.5 nm) (587 nm) (620 nm) (623 nm) 
(S)-[Tb.L
34
] -0.07 +0.17 -0.19 -0.06 -0.15 +0.23 
(R)-[Tb.L
34
] +0.07 -0.18 +0.20 +0.05 +0.17 -0.26 
 
Comparison of the data displayed in Figure 4.12 and Table 4.3 to CPL spectral data 
previously reported for complexes of L
2
 allowed the helicity of the (R)- and (S)-[Ln.L
34
] 
complexes to be assigned. In terms of the sign and sequence of the observed transitions, 
it was found that the CPL spectral signature of the europium and terbium complexes 
derived using (R)-L
34 
showed a distinct similarity to the CPL spectra of the (SSS)-Δ-
(λλλ) enantiomers of [Ln.L2] (Ln = Eu3+, Tb3+). Meanwhile, a marked resemblance was 
also observed between the CPL spectral signature of the europium and terbium 
complexes derived using (S)-L
34
 and the CPL spectra of the (RRR)-Λ-(δδδ) enantiomers 
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of [Ln.L
2
] (Ln = Eu
3+
, Tb
3+
). Rationalisation of this observed stereoselectivity in 
complex formation was achieved through examination of the X-ray crystal structures 
obtained for the (SSS)-Δ-(λλλ) and (RRR)-Λ-(δδδ) enantiomers of another structurally 
related methylphosphinate complex, [Eu.L
36
], synthesised by Dr Nicholas Evans. The 
structure of this complex is shown in Figure 4.13, alongside the X-ray crystal structure 
of its (SSS)-Δ-(λλλ) enantiomer.186  
 
 
 
 
Figure 4.13: Structure of [Eu.L
36
] shown alongside the X-ray crystal structure of its (SSS)-Δ-(λλλ) 
enantiomer.
186
 
 
A detailed consideration of the crystal structure shown in Figure 4.13 revealed that for 
this enantiomer substitution of either of the pseudo-equatorial ring hydrogen atoms 
would give an (R) configuration, whereas an (S) configuration would result from 
substitution of either of the pseudo-axial ring hydrogens (Figure 4.14
a
). The observation 
that complexes derived using (R)-L
34 
adopt an (SSS)-Δ-(λλλ) configuration in solution 
may therefore be attributed to the fact that the ring substituent will preferentially occupy 
an equatorial position. The same logic applies for rationalisation of the fact that 
complexes derived using (S)-L
34 
adopt an (RRR)-Λ-(δδδ) configuration.  
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Figure 4.14: Views of the crystal structure of the (SSS)-Δ-(λλλ) enantiomer of [Eu.L36] illustrating (a) the 
pseudo-equatorial positions of the pro-(R) hydrogens on the ring, (b) the corner (filled arrow) versus side 
(dashed arrow) positions of the pro-(R) hydrogens and (c) the ring torsional angles; ‘corner’ carbons – 
those that fall between two gauche bonds – are marked with asterisks.186 
 
Further examination of the crystal structure allows an additional conclusion to be drawn 
regarding the likelihood of substitution at each possible ring carbon location. Figure 
4.14
b
 serves to illustrate the pseudo-equatorial positions of the pro-(R) hydrogens on 
both corner and side carbon atoms within the 1,4,7-triazacyclononane ring, which are 
distinguishable on the basis of the ring torsional angles (Figure 4.14
c
).
187
 As is apparent 
from Figure 4.14
b
, substitution in an equatorial position at a side carbon atom will 
generate a complex in which the ring substituent is directed towards the three pyridyl 
arms, therefore leading to a greater steric demand than if the substituent is located in an 
equatorial position at a corner carbon atom, directed away from the pyridyl arms. One 
may therefore anticipate that for the lanthanide complexes of (R)- and (S)-L
34
, the 
benzyl substituent will be located at a corner carbon position. Unfortunately, it did not 
prove possible to grow crystals of the [Ln.L
34
] complexes in order to confirm this 
hypothesis. 
 
Before moving on, it is important to highlight that, although the results outlined above 
were consistent with the absence of racemisation during complex synthesis, chiral 
analysis of europium complexes derived from ligand frameworks synthesised in 
analogous work carried out by Dr Nicholas Evans did not yield such favourable 
results.
186
 In the case of complexes derived using (S)-alanine and (S)-valine precursors, 
chiral HPLC analysis revealed the formation of complex enantiomers in a ratio between 
2:1 and 9:1. Subsequent NMR spectroscopic analysis of the amide species formed in the 
first stage of macrocycle synthesis (Scheme 4.2) revealed that racemisation is able to 
occur during the reaction of the ester starting material with ethylenediamine, if the 
temperature is too high. 
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4.4.2 Synthesis and characterisation of a transition metal based chiral quencher 
 
Having successfully achieved the synthesis of a set of enantiopure lanthanide complexes 
based on the 1,4,7-triazacyclononane macrocyclic framework, attention was turned to 
the identification of chiral quencher species suitable for use in preliminary studies of 
enantioselective quenching. Prior studies carried out in Durham by James Walton had 
revealed that a reduction in the signal intensity and lifetime of emission from the 
structurally related racemic complexes [Ln.L
2
] and [Ln.L
31
] (Ln = Eu
3+
, Tb
3+
) was 
observed in the presence of copper and manganese aqua ions, with preliminary 
investigations leading to the identification of energy transfer as the most likely 
quenching mechanism.
188
 It was therefore decided that efforts should be directed 
towards the identification of suitable transition metal-based chiral quenchers.  
 
As was mentioned in Section 1.5.2.2 of Chapter 1, the majority of studies of 
enantioselective quenching carried out to date have employed transition metal based 
complexes in the role of the chiral quencher. Although cobalt and ruthenium tris 
chelates have typically been the systems of choice in these studies, it was decided that 
the macrocyclic chiral cobalt complex [Co.L
37
] may provide a suitable alternative. The 
synthesis and characterisation of a structurally related system, [Co.L
38
], had previously 
been described in the literature and it was anticipated that the photophysical properties 
of [Co.L
37
] would closely resemble those of this species.
189
 Meanwhile, it was hoped 
that the introduction of a chiral substituent into the ligand framework for [Co.L
37
] 
would lead to the formation of a single complex isomer in solution, as had been found 
to occur for the structurally related hexadentate copper complex, discussed in Section 
4.4.1.  
 
 
4.4.2.1 Synthetic aspects 
 
The synthesis of (R)-L
37 
was achieved by alkylation of a sample of (R)-2-benzyl-1,4,7-
triazacyclononane, which had been prepared in accordance with Scheme 4.2, using tert-
[Co.L
37
] [Co.L
38
] 
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butyl bromoacetate under standard conditions (K2CO3, CH3CN). The progress of the 
reaction was monitored using LCMS. Metal complexation was subsequently carried out 
in two steps using previously described methodology (Scheme 4.7).
189
  
 
 
Scheme 4.7: Synthetic pathway for the preparation of (R)-[Co.L
37
]. The overall yield of complex was 
16%. 
 
In light of the fact that samples of enantiomeric lanthanide complexes had already been 
prepared, it was proposed that the occurrence of enantioselective quenching phenomena 
should be assessed using a slightly different methodology to that outlined in Section 4.2. 
Specifically, it was suggested that examination of the quenching of emission from an 
enantiomeric pair of lanthanide complexes by a single stereoisomer of a chiral quencher 
may allow identification of enantioselective quenching effects. Hence, the synthesis of 
(S)-[Co.L
37
] was not carried out. However, a sample of the achiral complex [Co.L
38
] 
was prepared for use in control experiments. To achieve this, the commercially 
available ligand 1,4,7-triazacyclononane-1,4,7-triacetic acid was used in a metal 
complexation reaction carried out in accordance with the methodology outlined in the 
second stage of Scheme 4.7. The identity of the complexes was verified following their 
isolation by use of high resolution mass spectrometry. 
 
4.4.2.2 Absorption properties 
 
Following their isolation, absorption spectra were recorded for samples of (R)-[Co.L
37
] 
and [Co.L
38
] in aqueous solution. As anticipated, the observed spectral profiles were 
found to bear close resemblance to each other. In each case, the longest wavelength 
absorption band was found to be centred at 512 nm and was assigned to a spin-allowed 
d-d transition. An additional absorption maximum was observed at 372 nm, along with 
significant absorption below 320 nm, attributed to a LMCT band. Such behaviour is in 
close agreement with data reported for [Co.L
38
] in the literature.
189
 For each complex 
the absorption spectrum was run at a variety of concentrations and a plot of absorbance, 
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A, against complex concentration, c, facilitated the determination of molar extinction 
coefficients, ε, at chosen wavelengths in accordance with the Beer-Lambert law 
(equation 15).
22 
 
                                                                                                                       (eqn. 15) 
 
Using the data gathered, an extinction coefficient of 348 dm
3
mol
-1
cm
-1
 was calculated 
for (R)-[Co.L
37
] at 512 nm (Figure 4.15). Meanwhile, a slightly lower value of 340 
dm
3
mol
-1
cm
-1
 was calculated for [Co.L
38
], in reasonable agreement with the literature 
value of 330 dm
3
mol
-1
cm
-1
.
189
 
 
  
Figure 4.15: Absorption spectra recorded for five aqueous solutions of (R)-[Co.L
37
] at differing 
concentrations (left) shown alongside a plot of the absorbance at 512 nm versus complex concentration. 
 
4.4.2.3 Chiral analysis 
 
Insight was gained into the structure adopted by (R)-[Co.L
37
] through the use of X-ray 
diffraction techniques. A preliminary search of the Cambridge Structural Database 
carried out by Dr Dmitry S. Yufit in April 2013 revealed no examples of crystal 
structures for triacetate derivatives of 1,4,7-triazacyclononane incorporating asymmetric 
centres into the ring framework. Hence, crystals of (R)-[Co.L
37
] suitable for analysis 
were isolated from aqueous solution, following recrystallisation of a sample of the 
originally isolated complex. Data collection and analysis was carried out by Dr Dmitry 
S. Yufit. Owing to the fact that [Co.L
38
] had previously been reported to crystallise 
isotypically with its chromium analogue, the structure of which could be accessed using 
the CSD, solid state structural analysis was not carried out for this second complex.
189
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Figure 4.16: Crystal structure of (R)-[Co.L
37
] (left) shown alongside the crystal structure of Δ-[Cr.L38] 
(right). The atoms shown are: C (grey), N (lilac), O (red), Co (dark blue) and Cr (light blue). 
 
As expected on the basis of the previously reported solid state structure of [Cr.L
38
], the 
structure of (R)-[Co.L
37
] was found to consist of monomeric, neutral molecules. Each 
cobalt ion was found to be coordinated by six donor atoms; the three ring nitrogens and 
three carboxylate oxygens (Figure 4.16). The complex crystallised in the space group 
P21, with four complexes in each monoclinic unit cell. Importantly, the solid state 
structural analysis revealed the presence of only one complex stereoisomer. This was in 
contrast to the solid state crystal structure of [Cr.L
38
] reported in the literature, where 
both Δ and Λ complex stereoisomers were seen. Examination of the N-C-C-N torsion 
angles within the ring structure revealed an average angle of -45
o
, consistent with a 
(λλλ) helicity. Meanwhile, the average N-C-C-O torsion angle for the acetate arms was 
found to be +18
o, consistent with a Δ helicity. This result was therefore in line with 
prior observations made in Section 4.4.1.3, pertaining to the [Ln.L
34
] systems. Further 
evaluation of the ring torsional angles allowed corner and side carbon atoms within the 
1,4,7-triazacyclononane ring to be distinguished and therefore facilitated verification of 
the hypothesis outlined in Section 4.4.1.3, which proposed that for the [Ln.L
34
] systems 
the ring substituent was more likely to be located at a corner carbon position, and 
therefore directed away from the coordinating arms of the complex (Figure 4.17). 
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Figure 4.17: Views of the crystal structure of (R)-[Co.L
37
] illustrating the ring torsional angles (as for 
Figure 4.14, ‘corner’ carbons are marked with asterisks) and the relative orientation of the ring substituent 
with respect to the coordinating arms of the complex. 
 
Having achieved an analysis of the structure of (R)-[Co.L
37
] in the solid state, attempts 
were made to probe the solution state structure of the complexes using circular 
dichroism spectroscopy. In light of results already outlined in this chapter, it was 
assumed that the number of isomers present for each complex in the solution state 
would mimic that found in the solid state. In accordance with this, it was predicted that 
a CD signal should only be observable for (R)-[Co.L
37
]. As can be seen from Figure 
4.18, this was indeed found to be the case. 
 
 
Figure 4.18: Electronic circular dichroism spectrum of (R)-[Co.L
37
] (blue) and [Co.L
38
] (red) in aqueous 
solution (295 K, pH 7.4). 
 
4.4.3 Preliminary investigations into enantioselective quenching 
 
A series of titrations was carried out to assess the quenching of the emission from (R)- 
and (S)-[Ln.L
34
] (Ln = Eu
3+
, Tb
3+
) in the presence of these complexes. Incremental 
additions of each cobalt complex were made from concentrated stock solutions to 1 mL 
samples of (R)- and (S)-[Ln.L
34
] (Ln = Eu
3+
, Tb
3+
), which had been dissolved in 0.1 M 
HEPES containing 0.1 M NaCl at pH 7.4, to give solutions where the concentration of 
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lanthanide complex was 20 µM. Owing to the fact that indirect excitation of the 
lanthanide complexes could only be achieved by irradiation at 268 nm and both the 
cobalt complexes had been found to exhibit significant absorption at this wavelength, 
lifetime measurements were used in place of emission intensity measurements to 
monitor the modulation of the luminescence output of each lanthanide complex over the 
course of the titrations. The variation in τ0/τ as a function of [Q] is shown for each 
enantiomeric pair of lanthanide complexes in Figure 4.19. 
 
 I II 
A 
  
B 
  
Figure 4.19: Comparison of the variation in emission lifetime as a function of [[Co.L
38
]] (I) and [(R)-
[Co.L
37
]] (II) for (R)- (red) and (S)- (blue) [Ln.L
34
] (A = Eu
3+
; B = Tb
3+
) (295 K, pH 7.4, 0.1 M HEPES, 
0.1 M NaCl, 20 µM complex). 
 
As is apparent from the plots presented in Figure 4.19, the lifetime data gathered in the 
titrations outlined above did not appear to provide any evidence to suggest the 
occurrence of enantioselective quenching phenomena. Whilst this result was in line with 
expectation in the case of experiments utilising [Co.L
38
] as the quenching species, the 
lack of chiral discrimination observed in experiments carried out with (R)-[Co.L
37
] was 
somewhat surprising. In the case of (R)- and (S)-[Tb.L
34
], the data presented in Figure 
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4.19 was used in the calculation of Stern-Volmer quenching constants (Table 4.4). 
Whilst a slight difference was apparent in the values associated with the quenching 
interactions of (R)- and (S)-[Tb.L
34
] with (R)-[Co.L
37
], convincing evidence of an 
enantioselective effect was not obtained.  
 
Table 4.4: Stern-Volmer quenching constants for the dynamic quenching of emission from (R)- and (S)-
[Ln.L
34
] by [Co.L
38
] and (R)-[Co.L
37
]  (295 K, pH 7.4, 0.1 M HEPES, 0.1 M NaCl, 20 µM complex). 
 
Complex Quencher    
   / µM 
(R)-[Tb.L
34
] 
[Co.L
38
] 
353 
(S)-[Tb.L
34
] 353 
(R)-[Tb.L
34
] 
(R)-[Co.L
37
] 
366 
(S)-[Tb.L
34
] 355 
 
In an effort to gain insight into the results outlined above, a consideration of the 
mechanism by which the quenching of the luminescence output occurred was 
undertaken. As was mentioned in Section 1.5.2.2 of Chapter 1, previous studies 
detailing chiral discrimination in quenching of the luminescence output from 
[Ln(DPA)3]
3-
 (Ln = Eu
3+
, Tb
3+
) by chiral quenchers had typically attributed quenching 
to energy transfer mechanisms, which generally require spectral overlap between the 
emission spectrum of the donor and the absorption spectrum of the acceptor. The 
occurrence of enantioselectivity in the quenching interactions studied was ascribed to 
differences in energy transfer efficiencies in homochiral versus heterochiral Ln 
*
- Q 
collisional complexes, thought to arise in part due to structural differences between 
these diastereomeric encounter complexes. Figure 4.20 shows an overlay of the 
absorption spectrum recorded for (R)-[Co.L
37
] in aqueous solution with representative 
emission spectra for [Ln.L
34
] (Ln = Eu
3+
, Tb
3+
). 
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Figure 4.20: Absorption spectrum of (R)-[Co.L
37
] (blue) as a function of wavelength (H2O, 295 K) 
overlaid with representative emission spectra for [Ln.L
34
] (Ln = Eu
3+
, right and Tb
3+ 
left). 
 
In light of the differing degree of overlap between the absorption band of [Co.L
38
] or 
(R)-[Co.L
37
] at 511 nm and the europium and terbium emission bands of (R)- and (S)-
[Ln.L
34
] as demonstrated in Figure 4.20, it can be concluded that the Stern-Volmer plots 
shown in Figure 4.19 provide evidence to suggest that quenching also occurs via an 
energy transfer mechanism for the systems under consideration in this study. However, 
the lack of enantioselectivity observed in the quenching of the luminescence output 
from (R)- and (S)-[Ln.L
34
]  by (R)-[Co.L
37
] reflects a high degree of similarity in the 
efficiency of energy transfer, perhaps indicating that in this case the observed quenching 
may be attributed mainly to long range energy transfer mechanisms. As can be seen 
from Table 4.4, the Stern-Volmer quenching constants associated with the quenching of 
(R)- or (S)-[Tb.L
34
] by [Co.L
38
] and (R)-[Co.L
37
] were relatively high, with values of 
approximately 350 µM being obtained in all cases. Although this may no doubt in part 
be attributed to the absence of electrostatic attraction between the lanthanide and cobalt 
complexes, which do not have any overall charge, it also suggests a lack of accessibility 
to the lanthanide centre. Indeed, analysis of data gathered in a titration performed using 
the cyclen-based system [Tb.L
22
(OH2)]
+
, featured in previous chapters of this thesis, in 
which the lanthanide centre is likely to be less shielded by the ligand framework, 
yielded a significantly lower Stern-Volmer quenching constant, with a value of 172 µM. 
 
4.5 Conclusions and future work 
 
The aim of the work outlined in this chapter was to identify macrocylic lanthanide 
complexes with potential utility in chiral quenching studies. Preliminary experiments 
focussed on the use of an enantiomerically pure cyclen-derived complex selected from 
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the literature, (SSS)-Δ-[Tb.L20b]3+. Previous structural studies of the yttrium analogue of 
this complex had revealed that one face of the tetraazatriphenylene moiety is blocked 
when the complex is in solution.  
 
The quenching of emission from (SSS)-Δ-[Tb.L20b]3+ was examined in the presence of 
two electron-rich chiral quenching species, Trolox and DOPA. The latter of these 
species had previously been shown to deactivate lanthanide luminescence by a 
mechanism involving formation of an exciplex with the triplet excited state of the 
chromophore. Support for the hypothesis that quenching of the emission intensity from 
(SSS)-Δ-[Tb.L20b]3+ in the presence of Trolox would also occur by such a mechanism 
was gained in a preliminary investigation comparing the efficiency of quenching in 
buffer solution to that in methanol. A much higher quenching efficiency was observed 
in buffer, suggesting the hydrophobic effect plays a role in the quenching process, by 
encouraging exciplex formation.  
 
Attempts were made to gather evidence for the occurrence of enantioselective 
quenching phenomena for (SSS)-Δ-[Tb.L20b]3+ using steady-state measurement 
techniques, in the presence of Trolox and DOPA. The utility of Stern-Volmer analysis 
in the identification and characterisation of enantioselective quenching phenomena had 
previously been highlighted in a 2002 publication.
174
 Unfortunately, only weak 
evidence of enantioselectivity was seen in the quenching interaction between (SSS)-Δ-
[Tb.L
20b
]
3+ 
and either Trolox or DOPA, with enantiomeric quenchers giving almost 
identical Stern-Volmer constants. It was concluded that the degree of conformational 
flexibility in DOPA may negate the possibility of an enantioselective effect. Meanwhile, 
in the case of Trolox, DFT calculations revealed very little energy difference between 
diastereomeric exciplexes, suggesting that the observation of enantioselectivity is 
unlikely. 
 
In spite of the results outlined above, it was hypothesised that in the case of Trolox, a 
difference between the quenching effect of the two enantiomers may be seen by 
removing the non-directional electrostatic component of the interaction with the terbium 
complex. The synthesis of the methyl ester analogues of Trolox was therefore 
undertaken, and titrations carried out using these species. Stern-Volmer analysis of the 
data gathered in these titrations revealed some evidence to suggest enantioselectivity in 
the quenching interaction. However, the results were not found to be entirely 
reproducible, presumably due to a high degree of sensitivity to sample conditions. A 
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series of steady-state CPL studies subsequently carried out using a structurally related 
racemic terbium complex, [Tb.L
29
], revealed no evidence for the induction of circular 
polarization in the emission output of this complex when in the presence of an 
enantiomerically pure sample of Trolox methyl ester. 
 
A second set of investigations was undertaken to study the possibility of 
enantioselective quenching phenomena using lanthanide complexes derived from 
ligands based on 1,4,7-triazacyclononane. Initially, the synthesis of a set of lanthanide 
complexes incorporating a chiral centre directly onto this macrocyclic framework, (R)- 
and (S)-[Ln.L
34
] (Ln = Eu
3+
, Tb
3+
), was undertaken. Chiral analysis of the complexes 
formed using techniques such as NMR spectroscopy, chiral HPLC and CPL suggested 
the presence of a single complex stereoisomer in each case, the overall helicity of which 
was found to be determined by the nature of the ring C substitution. Analysis of the X-
ray crystal structure for a related complex, [Eu.L
36
], allowed the origin of this chiral 
discrimination in complex formation to be identified. A chiral hexadentate cobalt 
complex based on a similar ligand framework, (R)-[Co.L
37
], was subsequently 
synthesised for use in studies of enantioselective quenching phenomena with these 
lanthanide complexes. Structural analysis of this complex was achieved in the solid 
state using X-ray crystallography. Meanwhile, circular dichroism spectroscopy revealed 
a racemic composition of the structurally related complex [Co.L
38
] in solution. 
 
Preliminary investigations into enantioselective quenching were carried out using (R)- 
and (S)-[Ln.L
34
] (Ln = Eu
3+
, Tb
3+
) and (R)-[Co.L
37
]. Unfortunately, no evidence for 
chiral discrimination was observed, despite the fact that quenching was found to occur 
via an energy transfer mechanism. It was hypothesised that long-range mechanisms may 
be responsible for the observed deactivation of the lanthanide luminescence, with the 
magnitude of Stern-Volmer quenching constants observed suggesting a high degree of 
shielding at the lanthanide centre. Although the exact origin of the enantioselective 
quenching phenomena previously detailed in the literature remains to some extent a 
curiosity,  it is generally thought to be the case that the effect may in part be attributed 
to structural differences between short range encounter complexes. Hence, it may be 
concluded that future work in this area should be directed towards the design and 
synthesis of macrocylic lanthanide systems in which short range energy transfer 
mechanisms with chiral quencher species may be encouraged by virtue of directional 
interactions such as hydrogen bonding. It is hoped that the construction of a CPL 
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spectrometer with time-resolved measurement capability at Durham will facilitate 
studies of such systems, as well as allowing verification of the results outlined in this 
chapter.  
 
Although the work detailed in this chapter did not lead to the successful identification of 
macrocylic lanthanide complexes with potential utility in chiral quenching studies, some 
noteworthy results were obtained. Particularly important was the demonstration that it is 
possible to achieve complete control of the stereochemistry of triazacyclononane-based 
lanthanide complexes by the inclusion of a single substitution on a ring carbon atom. 
Such methodology could prove to be of great utility in the synthesis of chiral probes for 
application in CPL spectroscopy and microscopy, particularly given that additional 
synthetic work carried out in parallel to the work detailed in this chapter showed that 
this chiral discrimination in complex formation is conserved when pyridyl bromine 
substituents are included in the ligand framework (see (S)-[Ln.L
39
] Section 5.2.2, 
Chapter 5).
186
 The inclusion of such substituents in the ligand framework leads to the 
generation of complexes that may be further derivatised by C-C or C-N 
functionalization, therefore facilitating access to enantiopure triazacyclononane based 
complexes where sensitised emission is possible through excitation at longer 
wavelengths. 
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5.1 General experimental 
 
5.1.1 Reagents and solvents 
 
Unless otherwise mentioned, all reagents were used as received from commercial 
suppliers (Acros, Alfa Aesar, CheMatech, Fischer Scientific, Merck, Sigma Aldrich and 
Strem). Solvents used were laboratory grade and were dried over appropriate drying 
agents when necessary. Air and water sensitive reactions were carried out under an 
atmosphere of dry argon. Water and H2O refer to high purity water obtained from the 
“Purite Neptune” purification system.  
 
5.1.2 Chromatography 
 
Thin layer chromatography was performed using neutral aluminium oxide plates 
(Merck Millipore 60 F254, neutral) or silica plates (Merck Millipore 60 F254) and 
visualised under irradiation at 254 nm or by staining with iodine or Dragendorff's 
reagent. Preparative column chromatography was carried out using silica (Fluorochem 
Silicagel LC60A, 40-63 micron) or neutral aluminium oxide (Merck Millipore 
Aluminium Oxide 90 active neutral, activity stage I, 70-230 mesh), which was soaked 
overnight in ethyl acetate prior to use.  
 
5.1.3 Spectroscopy 
 
NMR spectra (
1
H, 
13
C, 
31
P) were recorded on a Varian Mercury-400 (
1
H 399.95 Hz and 
31
P 161.90 MHz), Bruker Avance-400 (
1
H 400.07 MHz, 
13
C 100.60 MHz and 
31
P 
161.95 MHz), Bruker Avance-400 (
1
H 400.13 MHz and 
13
C 100.61 MHz), Varian 
Inova-500 (
1
H 499.71 MHz and 
13
C 125.65 MHz), Varian VNMRS-600 (
1
H 599.75 
MHz, 
13
C 150.82 MHz and 
31
P 242.78 MHz) or Varian VNMRS-700 (
1
H 699.73 MHz 
and 
13
C 175.95 MHz) spectrometer. Spectra were recorded in commercially available 
deuterated solvents and internally referenced to residual solvent signals.  
 
Electrospray mass spectra were obtained on a TQD mass spectrometer equipped with an 
Acquity UPLC, an electrospray ion source and an Acquity photodiode array detector 
(Waters Ltd, UK).  Methanol was used as the carrier solvent. For LCMS analyses a 2.1 
x 50 mm 1.7 micron Acquity UPLC BEH C18 column was used. The solvent system 
was H2O + 0.1% formic acid / MeOH (gradient elution, see Table 5.1). 
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Table 5.1: LCMS conditions. 
 
Step Time / min Flow / mL min
-1
 % H2O % MeOH 
0 0 0.6 95.0 5.0 
1 0.2 0.6 95.0 5.0 
2 4.0 0.6 5.0 95.0 
3 4.5 0.6 5.0 95.0 
4 5.0 0.6 95.0 5.0 
 
Accurate masses were recorded on a LCT Premier XE mass spectrometer or a QTOF 
Premier mass spectrometer both equipped with an Acquity UPLC, a lock-mass 
electrospray ion source and an Acquity photodiode array detector (Waters Ltd, UK). 
Methanol was used as the carrier solvent. 
 
5.1.4 Melting points 
 
Melting points were determined using a Sanyo Gallenkamp Melting Point Apparatus 
and are uncorrected.    
 
5.1.5 HPLC 
 
HPLC analysis was performed at 295 K using a Waters Mass Directed Auto Preparation 
(MDAP) system. The system consisted of a Waters 575 pump, Waters "System Fluidics 
Organizer", Waters 2545 "Binary Gradient Module", Waters 2767 "Sample Manager", 
Waters Fraction Collector III, Waters 2998 Photodiode Array Detector and Waters 3100 
Mass Detector. An XBridge C18 OBD 4.6 x 100 mm, i.d. 5 µM column was used. The 
solvent system was H2O +0.1% formic acid / MeOH +0.1% formic acid (gradient 
elution, see Table 5.2).  
 
Table 5.2: HPLC conditions used for the analysis of complexes. 
 
Step Time / min Flow / mL min
-1
 % H2O % MeOH 
0 0.0 1.0 90.0 10.0 
1 10.0 1.0 5.0 95.0 
2 13.0 1.0 5.0 95.0 
3 13.5 1.0 90.0 10.0 
4 16.5 1.0 90.0 10.0 
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Preparative HPLC for [Gd.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
 was performed at 295 K 
using the same Waters MDAP system. An XBridge C18 OBD 19 x 100 mm, i.d. 5 µM 
column was used. The solvent system was  H2O +0.1% formic acid / MeOH +0.1% 
formic acid (gradient elution, see Table 5.3). Fraction collection was automatically 
triggered by mass detection. 
 
Table 5.3: HPLC conditions used for the purification of [Gd.L
22
(OH2)]
+
 and (R)-[Ln.L
23
(OH2)]
+
.  
 
Step Time / min Flow / mL min
-1
 % H2O % MeOH 
0 0 17.0 90.0 10.0 
1 0.2 17.0 90.0 10.0 
2 0.7 17.0 90.0 10.0 
3 11 17.0 5.0 95.0 
4 14 17.0 5.0 95.0 
5 14.5 17.0 90.0 10.0 
6 16.5 17.0 90.0 10.0 
 
Preparative HPLC for (S)- and (R)-[Tb.L
35
] was performed at 295 K using a Shimadzu 
system consisting of a Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid 
Chromatograph (LC-20AP), a Prominence UV/Vis Detector (SPD-20A) and a 
Communications Bus Module (CBM-20A). An XBridge C18 OBD 19 x 100 mm, i.d. 5 
µM column was used. The solvent system was  H2O +0.1% formic acid / MeOH +0.1% 
formic acid (gradient elution, see Table 5.4). The UV detector was set at 268 nm and 
fraction collection was performed manually. 
 
Table 5.4: HPLC conditions used for the purification of (S)- and (R)-[Tb.L
35
].  
 
Step Time / min Flow / mL min
-1
 % H2O % MeOH 
0 0 17.0 90.0 10.0 
1 3.0 17.0 90.0 10.0 
2 13.0 17.0 0.0 100.0 
3 16.0 17.0 0.0 100.0 
4 17.0 17.0 90.0 10.0 
 
Chiral HPLC was performed at 290 K on a Perkin Elmer system consisting of a Perkin 
Elmer Series 200 pump, Perkin Elmer Series 200 auto-sampler and Perkin Elmer Series 
200 UV/Vis detector. A CHIRALPAK-ID 250 x 4.6 mm 5 µM column was used, with a 
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flow rate of 1.0 mL min
-1
 and a solvent system of MeOH (isocratic elution). The UV 
detector was set at an appropriate wavelength according to the species being analysed. 
 
5.1.6 Optical spectroscopy 
 
Unless otherwise specified, quartz cuvettes with a pathlength of 1 cm or disposable UV-
grade methacrylate cuvettes were used to contain all samples.   
 
UV/Vis absorbance spectra were measured on an ATI Unicam UV/Vis spectrometer 
(Model UV2) using Vision version 3.33 software. Molar extinction coefficients were 
determined by first dissolving a known amount of solid in a known amount of solvent to 
give a bulk solution. Five solutions of known concentration, with absorbances ranging 
between 0.05 and 0.5, were made up by dilution of the bulk solution. Molar extinction 
coefficients, ε, were calculated in accordance with the Beer-Lambert law (equation 
15),
22
 by plotting absorbance, A, against complex concentration, c. 
 
                                                                                                                       (eqn. 15) 
 
Absorbance measurements of 96-well plates were made on an Analytik Jena 
FLASHScan 530 using WinFLASH version 1.5 software. 
 
Emission spectra were recorded on an ISA Jobin-Yvon Spex Fluorolog-3 luminescence 
spectrometer using DataMax version 2.2.10 software. Unless otherwise stated, an 
integration time of 0.5 seconds, increment of 0.5 nm and excitation and emission slits of 
2.5 and 1.5 nm respectively were used.  
 
Quantum yields were determined by Dr L-O. Palsson at Durham University using a 
HORIBA Jobin-Yvon Fluorolog 3-22 Tau-3 fluorimeter with a Labsphere Optical 
Spectralon integrating sphere (diameter 100 mm, reflectance > 99% over 400 – 1500 
nm range) and a method developed by Porrés et al.
190
 Measurements were performed at 
295 K using solutions with absorbances of 0.15 at λmax, contained in a cylindrical quartz 
cuvette (8 mm diameter) fitted with a Teflon stopper. 
 
All of the CPL spectra shown in Chapter 2 were measured with the assistance of Dr R. 
D. Peacock, using a custom built (Glasgow University, UK) CPL spectrometer based on 
a Spex-Fluoromax-2-spectrofluorimeter. In all other cases, a custom built in-house CPL 
spectrometer was used. This consisted of a laser driven light source (Energetiq EQ-99 
LDLS, spectral range 170 to 2100 nm) coupled to an Acton SP2150 monochromator 
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(600 g/nm, 300 nm Blaze), allowing excitation wavelengths to be selected with a 6 nm 
FWHM band-pass. The collection of the emitted light (90 º angle set up) was facilitated 
by a Lock-In Amplifier (Hinds Instruments Signaloc 2100) and Photoelastic Modulator 
(Hinds Instruments PEM-90). The differentiated light was focused onto an Acton 
SP2150 monochromator (1200 g/nm, 500 nm Blaze) equipped with a high sensitivity 
cooled Photo Multiplier Tube (Hamamatsu 7155-01 red corrected).  Spectra were 
recorded using a 5 spectral average sequence with 0.5 nm spectral intervals 
and 500 s integration time. The recorded CPL spectra then underwent a 25% Fourier 
transformation smoothening protocol using Origin 8.0 Software (Origin Labs) to 
enhance visual appearance (all calculations were carried out using raw spectral data). In 
both cases samples were run at room temperature and indirect excitation at an 
appropriate wavelength was used. A schematic of the Durham CPL instrumentation is 
shown in Figure 5.1. 
 
 
Figure 5.1: Schematic diagram of Durham CPL instrumentation. 
 
Absorption and ECD spectra collected by Dr L. Di Bari at Pisa were acquired on a 
JASCO V650 spectrophotometer and a JASCO J715 spectropolarimeter respectively. 
Samples were run in cylindrical quartz cells at room temperature. The band width was 
set to 2.0 nm, response to 1 sec and scan speed to 50 nm/min. Up to 4 accumulations 
were averaged to improve S/N. In all cases the absorbance and dichroism data were 
scaled for the total concentration of complex to yield ε and Δε’ (the prime indicates that 
the real concentration of the ECD-active species is uncertain). 
 
ECD spectra for (R)-[Co.L
37
] and [Co.L
38
] were measured with the assistance of Lara 
Small on a JASCO J-810 CD Spectropolarimeter using Jasco's Spectra Manager
TM
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software. The band width was set to 1.0 nm, response to 2 sec and scan speed to 50 
nm/min. 
 
5.1.7 Lifetime measurements  
 
A Perkin Elmer LS55 luminescence spectrometer with FL Winlab Molecular 
Spectroscopy version 4.00.02 software was used to obtain lifetime measurements. 
Lifetime measurements were typically obtained by indirect excitation of the lanthanide 
(III) ion via the chromophore using a short pulse of light (at λmax) followed by 
monitoring the integrated intensity of the light emitted at a chosen wavelength (612-620 
nm for europium and 540-550 nm for terbium depending on the measured species) 
during a fixed gate time, tg, after a delay time, td. Measurements were made for a 
minimum of 20 delay times, covering 3 or more lifetimes. A gate time of 0.1 ms was 
used, and the excitation and emission slits were set to 10 and 5 nm respectively. The 
obtained decay curves were plotted in Microsoft Excel and fitted to equation 16. 
 
                                                            I = A0 + A1e
-kt
                                            (eqn. 16)                                                                        
 
I: intensity at time t following excitation 
A0: intensity when decay has ceased 
A1: pre-exponential factor 
k: rate constant for the depopulation of the excited state  
 
The excited state lifetime, τ, is the inverse of the radiative rate constant, k. 
 
5.1.8 Determination of inner sphere hydration number (q')
55  
 
The rate constant for the depopulation of a lanthanide excited state in water can be 
represented as a sum of three rate constants, denoting radiative decay (kr), non-radiative 
decay by energy transfer to XH oscillators (Σ kXH) and all other non-radiative decay 
(knr).  
                                                                                                                             (eqn. 17) 
 
Following D2O exchange, it is assumed that the exchangeable XH oscillators no longer 
contribute to the quenching. Hence, the expression can be simplified to contain only the 
first two terms. 
                                                                                                                                          (eqn. 18) 
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It follows that the difference between the rate constants in H2O and D2O can be 
expressed as being equal to the sum of all rate constants for non-radiative decay by 
energy transfer to XH oscillators. 
 
                                                                                                          (eqn. 19) 
 
If it is assumed that OH oscillators are the major contributor to the Σ kXH term, then the 
total number of water molecules located in the inner coordination sphere can be 
calculated using equation 20. 
                                                                                                                 (eqn. 20) 
 
Where A is a proportionality constant, defining the sensitivity of the lanthanide ion to 
vibronic quenching by OH oscillators. This takes a value of 1.2 ms for europium 
complexes and 5 ms for terbium complexes. Meanwhile, x is a correction factor, which 
allows for the effect of closely diffusing OH oscillators, taking a value of 0.25 ms
-1
 for 
europium complexes and 0.06 ms
-1
 for terbium complexes. For europium complexes it 
is also necessary to take into account proximal amide NH oscillators, with y taking a 
value of 0.075n ms
-1
 where n is the number of proximate carbonyl-bound amide groups. 
 
5.1.9 pH Measurements 
 
Adjustment of pH was performed using conc. NaOH(aq) and conc. HCl(aq) to prevent any 
considerable increase in sample volume. Measurements of pH were carried out using a 
Jenway 3510 pH meter with a Jenway combination electrode or a Jenway 3020 pH 
meter with an Aldrich glass combination pH electrode, both calibrated using buffer 
solutions of pH 4.00 ± 0.01, 7.00 ± 0.01 and 10.00 ± 0.01 (Sigma Aldrich). 
 
5.1.10 Luminescence titrations 
 
Luminescence titrations were carried out at pH 7.4 using solutions containing 0.1 M 
NaCl in order to maintain a constant ionic background. In most cases, volumetric 
addition of stock solutions was carried out, such that the increase in sample volume was 
kept to a minimum (<5%). In the case of HSA and γ-Ig-G, the protein was added 
directly to the solution as a lyophilised solid. For protein titrations, the pH was adjusted 
as necessary after each addition using conc. HCl(aq) and conc. NaOH(aq). All proteins and 
other analytes used were purchased from Sigma Aldrich. 
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5.1.11 Binding constant determination 
 
Apparent binding constants were calculated by fitting equation 21 to emission or 
lifetime data, using a non-linear least squares fitting algorithm in Microsoft Excel 2010, 
with the solver add-in.  
 
                     
 
         
            
   
       where         
      
      
            (eqn. 21) 
 
 
[X]: Total concentration of the selected analyte in solution 
[LnL]: Total concentration of the complex 
K: Binding constant 
F: Either intensity ratio of selected peaks or lifetime ratio 
F0: Initial ratio         
F1: Final ratio 
 
5.1.12 Relaxivity studies 
 
Relaxivity measurements for [Gd.L
22
(OH2)]
+
 were made in water at 37 
o
C and 60 MHz 
on a Bruker Minispec mq60 instrument. The mean value of three separate 
measurements was recorded, and values stated were corrected for the diamagnetic 
contribution of water (R1d = 0.25 at 60 MHz, 310 K). 
 
5.1.13 Single crystal X-Ray diffraction 
 
Data for the crystal of (R)-[Co.L
37
] were collected and processed by Dr D. S. Yufit. 
Data were recorded at 120 K on a Rigaku Saturn 724+ diffractometer at station I19 of 
the Diamond Light Source synchrotron (undulator,  = 0.6889 Å, -scan, 1.0°/frame) 
and processed using Bruker APEXII software. The temperature of the sample was 
maintained at 120 K by a Cryostream (Oxford Cryosystems) open-flow nitrogen 
cryostat. 6473 reflections were collected yielding 3721 unique data (Rint = 0.0541). The 
structure was solved by direct method and refined by full-matrix least squares on F
2
 for 
all data using SHELXTL
191
 and OLEX2
192
 software. All non-hydrogen atoms were 
refined with anisotropic displacement parameters, H-atoms were placed in calculated 
positions and refined in riding mode with Uiso(H) = 1.2 Uiso of corresponding parent 
atom. The absolute configuration of the compound has been established by 
measurements of anomalous dispersion effects (Flack parameter 0.06(4),
193
 Hooft 
parameter 0.07(2)
194
). The crystal data and further details of the refinement are listed 
later in Section 5.2.3 and in Appendix 1.  
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5.2 Synthetic experimental detail 
 
Ethyl [4-bromo-6-(hydroxymethyl)pyridin-2-yl](methyl)phosphinate was made by 
Nicholas Evans.
195
 [Ln.L
22
(OH2)]
+
 (Ln = Eu
3+
, Tb
3+
) was synthesised by Ga-Lai 
Law,
137
 [Eu.L
27
(OH2)]
+
 was prepared by James Walton
152, 188
 and (SSS)-Δ-[Tb.L20b]3+ 
was made by Craig Montgomery.
139
 
 
5.2.1 Cyclen-based complexes and precursors 
 
6-Methyl-2-phenoxynicotinic acid
138, 196 
 
 
 
A solution of NaOMe was prepared by dissolving sodium (840 mg, 36.5 mmol) in 
anhydrous methanol (20 mL). 2-Chloro-6-methylnicotinic acid (3 g, 17.5 mmol) and 
phenol (7.8 g, 83.2 mmol) were added to the NaOMe solution and the reaction mixture 
was stirred under an argon atmosphere for 15 min. The solvent was removed under 
reduced pressure yielding a yellow oil, which was heated to 180 
o
C for 3.5 h and 
subsequently allowed to cool to room temperature. The reaction mixture was dissolved 
in water (30 mL) and washed with ether (3 x 20 mL). The pH of the aqueous phase was 
adjusted to 4 by the addition of acetic acid, causing the product to precipitate as an off-
white solid that was collected by filtration and dried under high vacuum (2.58 g, 11.26 
mmol, 64%). m.p. 156-157 
o
C (lit.
196
 155-156 
oC); δH (400 MHz, CDCl3) 2.40 (3H, s, 
CH3), 7.03 (1H, d, J = 8.0 Hz, H
5
), 7.18 (2H, d, J = 7.5 Hz, H
2’
), 7.29 (1H, t, J = 7.5 Hz, 
H
4’
), 7.44 (2H, t, J = 7.5 Hz, H
3’
), 8.41 (1H, d, J = 8.0 Hz, H
4); δC (100 MHz, CDCl3) 
24.5 (1C, CH3), 110.5 (1C, C
3
), 119.3 (1C, C
5
), 121.8 (2C, C
2’
), 125.7 (1C, C
4’
), 129.7 
(2C, C
3’
), 143.6 (1C, C
4
), 152.6 (1C, C
1’
), 160.6 (1C, C
2
), 163.2 (1C, C
6
), 165.5 (1C, 
COOH); m/z (HRMS
+
) 230.0828 [M + H]
+
 (C13H12NO3 requires 230.0817).    
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2-Methyl-1-azaxanthone
138, 197 
 
 
Polyphosphoric acid (80 g) was added to 6-methyl-2-phenoxynicotinic acid (1.72 g, 
7.50 mmol) and the reaction mixture was heated at 120 
o
C for 20 h under argon with 
stirring. The light-brown liquid was allowed to cool to room temperature before pouring 
onto ice-water (250 mL) with stirring until a homogenous solution formed. The pH of 
the resulting solution was adjusted to 12 by the addition of KOH pellets and the aqueous 
solution was then extracted with dichloromethane (3 x 100 mL). The organic extracts 
were combined, dried over magnesium sulfate and filtered. Removal of the solvent 
under reduced pressure yielded the title compound as an off-white solid (1.26 g, 5.97 
mmol, 80%). m.p. 134–139 oC (lit.197 136-138 oC); δH (700 MHz, CDCl3) 2.61 (3H, s, 
H
10
), 7.20 (1H, d, J = 8.0 Hz, H
3
), 7.32 (1H, ddd, J = 8.0, 7.0, 1.0 Hz, H
7
), 7.49 (1H, dd, 
J = 9.0, 1.0 Hz, H
9
), 7.67 (1H, ddd, J = 9.0, 7.0, 1.5 Hz, H
8
), 8.19 (1H, dd, J = 8.0, 1.5 
Hz, H
6
), 8.47 (1H, d, J = 8.0 Hz, H
4); δC (100 MHz, CDCl3) 25.1 (1C, C
10
), 114.3 (1C, 
C
4’
), 118.5 (1C, C
9
), 121.2 (1C, C
3
), 121.7 (1C, C
6’
) , 124.6 (1C, C
7
), 126.7 (1C, C
6
), 
135.4 (1C, C
8
), 137.3 (1C, C
4
), 155.7 (1C, C
9’
), 160.0 (1C, C
1’
), 165.1 (1C, C
2
), 177.4 
(1C, C
5
); m/z (HRMS
+
) 212.0721 [M+H]
+
 (C13H10NO2 requires 212.0712). 
 
2-Bromomethyl-1-azaxanthone
138 
 
 
2-Methyl-1-azaxanthone (1.85 g, 8.73 mmol) was dissolved in carbon tetrachloride (25 
mL). A tungsten lamp was used to heat the reaction mixture prior to the addition of N-
bromosuccinimide (1.56 g, 8.73 mmol) and dibenzoyl peroxide (10 mg, 0.04 mmol), it 
was then left to stir under argon using the lamp for activation. The reaction was 
monitored by 
1
H NMR spectroscopy and TLC (SiO2, toluene-CH2Cl2-CH3OH, 49.5 : 
49.5 : 1) and stopped after 18 h. After cooling to room temperature, the mixture was 
filtered and the solvent was subsequently removed under reduced pressure. Purification 
CHAPTER FIVE: EXPERIMENTAL DETAILS 
- 165 - 
 
by column chromatography on silica gel (toluene-CH2Cl2, 1 : 1) gave the title 
compound as a white crystalline solid (301 mg,  1.04 mmol, 12%). m.p. 201-203 
o
C 
(lit.
138
 169-171 
o
C); Rf (SiO2, toluene-CH2Cl2-CH3OH, 49.5 : 49.5 : 1) : 0.28; δH (400 
MHz, CDCl3) 4.60 (2H, s, H
10
), 7.44 (1H, ddd, J = 8.0, 7.0, 1.0 Hz, H
7
), 7.56 (1H, d, J = 
8.0 Hz, H
3
), 7.61 (1H, dd, J = 8.5, 1.0 Hz, H
9
), 7.78 (1H, ddd, J = 8.5, 7.0, 1.5 Hz, H
8
), 
8.29 (1H, dd, J = 8.0, 1.5 Hz, H
6
), 8.70 (1H, d, J = 8.0 Hz, H
4); δC (100 MHz, CDCl3) 
32.0 (1C, C
10
), 115.8 (1C, C
4’
), 118.3 (1C, C
9
), 120.6 (1C, C
3
), 121.5 (1C, C
6’
), 124.7 
(1C, C
7
), 126.6 (1C, C
6
), 135.6 (1C, C
8
), 138.5 (1C, C
4
), 155.5 (1C, C
9’
), 159.6 (1C, 
C
1’
), 161.8 (1C, C
2
), 176.8 (1C, C
5
); m/z (HRMS
+
) 289.9807 [M + H]
+
 (C13H9
79
BrNO2 
requires 289.9817). 
 
1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester
141 
 
 
 
Disodium hydrogen phosphate (14 g, 98.62 mmol) was added to a solution of cyclen (5 
g, 29.02 mmol) in water:dioxane (50:20, 70 mL). The pH was then adjusted to between 
2.5 and 3 using conc. HCl(aq). Benzyl chloroformate (10.0 mL, 70.05 mmol) in dioxane 
(20 mL) was added dropwise to the reaction mixture over 2.5 h at room temperature and 
it was stirred for 18 h to yield a colourless solution containing a white precipitate. The 
solvent was removed from the crude mixture under reduced pressure to yield a viscous 
white gum, which was dissolved in water (100 mL). The pH of the resulting solution 
was then adjusted to 7 by the addition of conc. KOH(aq). The aqueous solution was 
washed with diethyl ether (3 x 50 mL) to facilitate the removal of reaction side 
products. This was followed by extraction of the product from the aqueous phase using 
dichloromethane (3 x 50 mL). The organic phase was then dried under reduced pressure 
to yield the product as a colourless viscous oil, which was redissolved in 
dichloromethane (5 mL). The addition of cold ether (60 mL) to the dichloromethane 
solution caused the product to precipitate, yielding a coarse white powder that was 
collected by centrifugation (8.03 g, 18.24 mmol, 63%). m.p. 121–124 oC (lit.198 113-116 
o
C); δH (400 MHz, CDCl3) 2.26 (2H, s br, 2 x NH), 2.83 – 3.09 (8H, m br, cyclen CH2), 
3.50 – 3.84 (8H, m br, cyclen CH2), 5.15 (4H, s, CH2Ph), 7.31 – 7.41 (10H, m, Ar); δC 
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(100 MHz, CDCl3) 49.0, 49.3, 49.6, 50.0, 50.1, 50.2, 50.6 (8C, cyclen CH2), 67.7, 67.8 
(2C, CH2Ph), 127.9, 128.0, 128.3, 128.4, 128.6, 128.7 (10C, Ar), 135.8, 135.9 (2C, 
Ar(q)), 156.0, 156.1 (2C, C=O); m/z (HRMS
+
) 441.2509 [M + H]
+
 (C24H33N4O4 requires 
441.2502). 
 
4,10-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-1,7-
dicarboxylic acid dibenzyl ester
139 
 
 
Caesium carbonate (2.2 g, 6.81 mmol) and tert-butyl bromoacetate (970 mg, 4.97 
mmol) were added to a solution of 1,4,7,10-tetraazacyclododecane-1,7-dicarboxylic 
acid dibenzyl ester (1 g, 2.27 mmol) in anhydrous acetonitrile (10 mL). The reaction 
mixture was stirred at reflux for 18 h under argon. After this time the reaction mixture 
was allowed to cool to room temperature and the solvent was removed under reduced 
pressure. The resulting residue was dissolved in dichloromethane (15 mL) and the 
organic solution was washed with water (3 x 10 mL), to facilitate the removal of 
caesium salts, before being dried over magnesium sulfate and filtered. Removal of the 
solvent under reduced pressure yielded the crude product, which was purified by 
column chromatography on silica gel (gradient elution: CH2Cl2 to 1% CH3OH-CH2Cl2) 
to give the title compound as a yellow oil (674 mg, 1.01 mmol, 44%). Rf (SiO2, CH2Cl2-
CH3OH, 95 : 5) : 0.59; δH (400 MHz, CDCl3) 1.41 (18H, s, 
t
Boc CH3), 2.87 (8H, br s, 
cyclen CH2), 3.11 – 3.50 (12H, m, cyclen CH2; CH2CO), 5.10 (4H, s, CH2Ph), 7.19 – 
7.39 (10H, m, Ar); δC (100 MHz, CDCl3) 28.1 (6C, 
t
Boc CH3), 46.6, 46.9, 54.0, 54.3 
(8C, cyclen CH2), 55.9 (2C, CH2CO), 66.8 (2C, CH2Ph), 80.8 (2C, 
t
Boc(q)), 127.8, 128.4 
(10C, Ar), 136.8 (2C, Ar(q)), 156.4 (2C,Cbz C=O), 170.4 (2C, 
t
Boc C=O); m/z 
(HRMS+) 669.3879 [M + H]+ (C36H53N4O8 requires 669.3863). 
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1,7-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
199
 
 
 
 
4,10-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylic 
acid dibenzyl ester (674 mg, 1.01 mmol) in EtOH (10 mL) was shaken in a Parr 
hydrogenation flask at 40 psi over Pd(OH)2/C (150 mg) for 18 h. The resulting mixture 
was filtered through celite to give a colourless solution. The solvent was removed under 
reduced pressure, yielding the desired product as a yellow oil (346 mg, 0.85 mmol, 
86%); δH (400 MHz, CDCl3) 1.32 (18H, s, 
t
Boc CH3), 2.70 (8H, br s, cyclen CH2), 2.84 
(8H, br s, cyclen CH2), 3.29 (4H, s, CH2CO); δC (100 MHz, CDCl3) 28.1 (6C, 
t
Boc 
CH3), 47.0, 51.4, 56.8, 57.8 (10C, cyclen CH2, CH2CO), 81.2 (2C, 
t
Boc(q)), 171.1 (2C, 
t
Boc C=O); m/z (HRMS+) 401.3122 [M + H]+ (C20H41N4O4 requires 401.3128). 
 
1,7-Bis-(tert-butoxycarbonylmethyl)-4,10-bis[2-methyl-1-azaxanthone]-1,4,7,10-
tetraazacyclododecane
137 
 
 
1,7-Bis-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (187 mg, 0.47 
mmol), 2-bromomethyl-1-azaxanthone (284 mg, 0.98 mmol) and caesium carbonate 
(305 mg, 0.94 mmol) were stirred in anhydrous acetonitrile (5 mL) at reflux under 
argon. The reaction was monitored by TLC to confirm that all the brominated starting 
material had been consumed. After  48 h the reaction mixture was allowed to cool to 
room temperature and the solvent was removed under reduced pressure. The resulting 
residue was dissolved in dichloromethane (10 mL) and the organic solution was washed 
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with water (3 x 10 mL), to facilitate the removal of caesium salts, before being dried 
over magnesium sulfate and filtered. Removal of the solvent under reduced pressure 
yielded the crude product, which was purified by column chromatography on silica gel 
(gradient elution: CH2Cl2 to 6% CH3OH-CH2Cl2) to give the title compound as an 
orange oil (53 mg, 0.07 mmol, 14%). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.29; δH (700 
MHz, CDCl3) 1.11 (18H, s, 
t
Boc CH3), 2.45-3.05 (20H, br m, cyclen CH2, CH2CO), 
3.98 (4H, br s, H
10
), 6.97 (2H, d, J = 8.5 Hz, H
9
), 7.25 (2H, m, H
7
), 7.45 (2H, ddd, J = 
8.5, 7.5, 1.5 Hz, H
8
), 7.50 (2H, d, J = 8.0 Hz, H
3
), 8.16 (2H, dd, J = 8.0, 1.5 Hz, H
6
), 
8.74 (2H, d, J = 8.0 Hz, H
4
); δC (100 MHz, CDCl3) 27.8 (6C, 
t
Boc CH3), 53.4, 58.0, 
59.5 (12C, cyclen CH2, CH2CO, C
10
), 82.1 (2C, 
t
Boc(q)), 115.6 (2C, C
4’
), 117.9 (2C, C
9
), 
121.2, 121.4 (4C, C
3
, C
6’
), 124.8 (2C, C
7
), 126.6 (2C, C
6
), 135.4 (2C, C
8
), 138.5 (2C, 
C
4
), 155.2 (2C, C
9’
), 160.4 (2C, C
1’
), 165.2 (2C, C
2
), 172.0 (2C, 
t
Boc C=O), 176.9 (2C, 
C
5
); m/z (HRMS+) 819.4099 [M+H]
+
 (C46H55N6O8 requires 819.4081).  
 
[Gd.L
22
(OH2)]
+
 
 
 
 
 
Trifluoroacetic acid (1 mL) was added to a solution of 1,7-bis-(tert-
butoxycarbonylmethyl) - 4,10 - bis[2-methyl-1-azaxanthone] - 1,4,7,10 -
tetraazacyclododecane (53 mg, 0.07 mmol) in dichloromethane (0.5 mL). The mixture 
was left stirring for 60 h at room temperature. The solvent was removed under reduced 
pressure and the resulting residue re-dissolved in dichloromethane three times to aid the 
removal of excess acid and tert-butyl alcohol. The product was checked by ESMS to 
confirm complete ester hydrolysis and was used immediately for complexation with 
gadolinium acetate.  
 
The ligand was dissolved in a mixture of methanol and water (1 : 2, 3 mL) and 
sonicated. The pH of the solution was raised to 5.5 by the addition of aqueous ammonia 
solution. Gadolinium acetate (32.7 mg, 0.098 mmol) was added and the reaction 
mixture was heated at 90 
o
C overnight. The reaction mixture was allowed to cool to 
CHAPTER FIVE: EXPERIMENTAL DETAILS 
- 169 - 
 
room temperature. The pH of the mixture was raised to 10.0 using aqueous ammonia 
solution and the solution was stirred for 1 h at room temperature to precipitate excess 
Gd
3+
 as Gd(OH)3. Syringe filtration was used to remove the resulting solid before 
restoring the pH of the mixture to 5.5 by the addition of glacial acetic acid. The sample 
was lyophilised to give a yellow oil, which was purified using preparative HPLC. The 
title complex was obtained as an off-white solid (3.4 mg, 0.004 mmol, 6%). m/z 
(HRMS
+
) 858.1806 [M]
+
 (C38H36N6O8
154
Gd requires 858.1803); (HPLC) tR = 5.9 min; 
λmax (H2O) 336 nm. 
 
(S)-2-Bromopentanedioic acid 5-benzyl ester 1-tert-butyl ester
139 
 
 
 
A solution of NaNO2 (5.50 g, 80.1 mmol) in H2O (50 mL) was added dropwise over 30 
min to a stirred solution of (S)-glutamic acid 5-benzyl ester (10.0 g, 42.1 mmol) and 
NaBr (16.0 g, 156 mmol) in 1 M HBr (250 mL), cooled at -5 
o
C. After 16 h, conc. 
H2SO4(aq) (5 mL) was slowly added to the reaction mixture, which was then extracted 
with diethyl ether (3 x 300 mL). The combined organic extracts were washed with brine 
(2 x 200 mL), dried over magnesium sulfate and filtered. Removal of the solvent under 
reduced pressure yielded a yellow oil, which was subsequently dissolved in a mixture of 
tert-butyl acetate (50 mL) and HClO4 in H2O (70%, 0.34 mmol). After the resulting 
solution had been stirred at room temperature for 16 h, H2O (60 mL) was added. The 
organic phase was separated and washed with H2O (60 mL), followed by 5% Na2CO3(aq) 
(60 mL) before being dried over magnesium sulfate and filtered. Removal of the solvent 
under reduced pressure yielded the crude product, which was purified by column 
chromatography on silica gel (gradient elution: hexane to 10% EtOAc-hexane) to give 
the title compound as a yellow oil (1.90 g, 5.32 mmol, 13%). Rf (SiO2, hexane-EtOAc, 
95 : 5) : 0.17; δH (400 MHz, CDCl3) 1.46 (9H, s, 
t
Boc CH3), 2.18 – 2.27 (1H, m, H
3
), 
2.30 – 2.39 (1H, m, H3), 2.47 – 2.59 (2H, m, H4), 4.24 (1H, dd, J = 8.0, 6.0 Hz, H2), 
5.09 (2H, s, CH2Ph), 7.23 – 7.39 (5H, m, Ar); δC (100 MHz, CDCl3) 27.7 (3C, 
t
Boc 
CH3), 29.8 (1C, C
3
), 31.6 (1C, C
4
), 46.6 (1C, C
2
), 66.4 (1C, CH2Ph), 82.4 (1C, 
t
Boc(q)), 
128.2, 128.3, 128.6 (5C, Ar), 135.9 (1C, Ar(q)), 168.1 (1C, 
t
Boc C=O), 171.7 (1C, Cbz 
C=O); m/z (HRMS
+
) 379.0516 [M + Na]
+
 (C16H21
79
BrO4Na requires 379.0521). 
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2-(1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester)-
pentanedioic acid 5-benzyl ester 1-tert-butyl ester 
 
 
 
1,4,7,10-Tetraaza-cyclododecane-1,7-dicarboxylic acid dibenzyl ester (1.17 g, 2.66 
mmol) was combined with (S)-2-bromopentanedioic acid 5-benzyl ester 1-tert-butyl 
ester (1.04 g, 2.92 mmol) and K2CO3 (368 mg, 2.66 mmol). The mixture was stirred in 
anhydrous acetonitrile (10 mL) at reflux for 36 h, under argon. After cooling to room 
temperature, the solvent was removed under reduced pressure. The resulting residue 
was dissolved in dichloromethane (20 mL) and the organic solution was then washed 
with water (3 x 10 mL), to facilitate the removal of KBr/K2CO3, before being dried over 
magnesium sulfate and filtered. Removal of the solvent under reduced pressure yielded 
the crude product, which was purified by column chromatography on silica gel (gradient 
elution: CH2Cl2 to 5% CH3OH-CH2Cl2) to give the title compound as a yellow oil (740 
mg, 1.02 mmol, 39%). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.19; δH (400 MHz, CDCl3) 
1.46 (9H, s, 
t
Boc CH3), 1.64 – 2.43 (5H, m, H
2,3,4
), 2.53 – 2.96 (6H, m, cyclen CH2), 
3.21 – 3.83 (10H, m, cyclen CH2), 5.09 (6H, s, CH2Ph), 7.16 – 7.61 (15H, m, Ar); δC 
(100 MHz, CDCl3) 24.7 (1C, C
3
), 28.4 (3C, 
t
Boc CH3), 30.5 (1C, C
4
), 47.7, 48.1, 49.3, 
49.8, 50.4, 50.8, 51.6 (8C, cyclen CH2), 60.1 (1C, C
2
), 66.3, 67.4, 67.6 (3C, CH2Ph), 
81.4 (1C, 
t
Boc(q)), 128.1, 128.3, 128.4, 128.5, 128.6 (15C, Ar), 136.2, 136.5, 136.7 (3C, 
Ar(q)), 156.8 (2C,Cbz C=O), 171.1 (1C, C
1
), 172.9 (1C, C
5
); m/z (HRMS
+
) 717.3862 [M 
+ H]
+
 (C40H53N4O8 requires 717.3863). 
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2- (7 - tert - Butoxycarbonylmethyl- 1,4,7,10 - tetraaza - cyclododecane -4,10- 
dicarboxylic acid dibenzyl ester)-pentanedioic acid 5-benzyl ester 1-tert-butyl ester
 
 
 
 
Caesium carbonate (526 mg, 1.61 mmol) and tert-butyl bromoacetate (252 mg, 1.29 
mmol) were added to a solution of 2-(1,4,7,10-tetraaza-cyclododecane-1,7-dicarboxylic 
acid dibenzyl ester)-pentanedioic acid 5-benzyl ester 1-tert-butyl ester (771 mg, 1.08 
mmol) in anhydrous acetonitrile (10 mL). The reaction mixture was stirred at reflux for 
18 h under argon. After this time the reaction mixture was allowed to cool to room 
temperature and the solvent was removed under reduced pressure. The resulting residue 
was dissolved in dichloromethane (20 mL) and the organic solution was washed with 
water (3 x 10 mL), to facilitate the removal of caesium salts, before being dried over 
magnesium sulfate and filtered. Removal of the solvent under reduced pressure yielded 
the crude product, which was purified by column chromatography on silica gel (gradient 
elution: CH2Cl2 to 1.5% CH3OH-CH2Cl2) to give the title compound as a yellow oil 
(590 mg, 0.71 mmol, 66%). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.59; δH (400 MHz, 
CDCl3) 1.45 (18H, s, 
t
Boc CH3), 1.64 – 2.41 (5H, m, H
2,3,4
), 2.63 – 2.98 (6H, m, cyclen 
CH2), 2.99 – 3.68 (12H, m, cyclen CH2; CH2CO), 5.01 – 5.21 (6H, m, CH2Ph), 7.20 – 
7.46 (15H, m, Ar); δC (100 MHz, CDCl3) 25.3 (1C, C
3
), 28.2 (6C, 
t
Boc CH3), 30.8 (1C, 
C
4
), 47.3, 48.2, 52.0 (8C, cyclen CH2), 54.5 (1C, CH2CO), 56.1 (1C, C
2
), 66.2, 67.1, 
68.6 (3C, CH2Ph), 81.0, 81.2 (2C, 
t
Boc(q)), 128.0, 128.1, 128.2, 128.3, 128.5, 128.6 
(15C, Ar), 136.2 (1C, Ar(q)), 136.9 (2C, Ar(q)), 156.6 (2C,Cbz C=O), 170.2 (1C, 
t
Boc 
C=O), 172.0 (1C, 
t
Boc C=O), 173.0 (1C, C
5
); m/z (HRMS
+
) 831.4559 [M + H]
+
 
(C46H63N4O10 requires 831.4544). 
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2-(7-tert-Butoxycarbonylmethyl-1,4,7,10-tetraaza-cyclododecane)-pentanedioic 
acid 1-tert-butyl ester
 
 
 
2- (4 - tert - Butoxycarbonylmethyl- 1,4,7,10 - tetraaza - cyclododecane -1,7- 
dicarboxylic acid dibenzyl ester)-pentanedioic acid 5-benzyl ester 1-tert-butyl ester (581 
mg, 0.70 mmol) in EtOH (15 mL) was shaken in a Parr hydrogenation flask at 40 psi 
over Pd(OH)2/C (150 mg) for 24 h. The resulting mixture was filtered through celite to 
give a colourless solution. The solvent was removed under reduced pressure, yielding 
the desired product as a yellow oil (333 mg, 0.70 mmol, 100%); δH (700 MHz, CDCl3) 
1.39 (18H, s, 
t
Boc CH3), 1.90 – 1.96 (2H, br m, H
3
), 2.29 (2H, d,  J = 5.5 Hz, H
4
), 2.69 
– 2.99 (16H, m, cyclen CH2), 3.18 (1H, d, J = 8.5 Hz, H
2
), 3.30 (1H, d, J = 17.5 Hz, 
CH2CO), 3.38 (1H, d, J = 17.5 Hz, CH2CO), 7.80 (3H, br s, OH; 2 x NH); δC (176 
MHz, CDCl3) 25.9 (1C, C
3
), 28.1 (6C, 
t
Boc CH3), 33.8 (1C, C
4
), 46.6, 46.8, 51.3 (8C, 
cyclen CH2), 56.8 (1C, CH2CO), 65.2 (1C, C
2
), 81.3, 81.8 (2C, 
t
Boc(q)), 170.9 (1C, 
CH2CO), 171.8 (1C, C
1
), 178.6 (1C, C
5
); m/z (HRMS
+
) 473.3316 [M + H]
+
 
(C23H45N4O6 requires 473.3339). 
 
2-(7-tert-Butoxycarbonylmethyl-1,4,7,10-tetraaza-cyclododecane)-pentanedioic 
acid 5-methyl ester 1-tert-butyl ester 
 
 
2-(4-tert-Butoxycarbonylmethyl-1,4,7,10-tetraaza-cyclododecane)-pentanedioic acid 1-
tert-butyl ester (282 mg, 0.60 mmol) was dissolved in methanol (5 mL) and the pH of 
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the solution was adjusted to 0 by the addition of conc. HCl(aq). The reaction mixture was 
left to stir at room temperature for 1 h and the solvent was removed under reduced 
pressure. The resulting residue was dissolved in dichloromethane (5 mL) and washed 
with saturated NaHCO3(aq) solution (10  mL) before being dried over magnesium sulfate 
and filtered. Removal of the solvent under reduced pressure yielded the title compound 
as a yellow oil (137 mg, 0.28 mmol, 47%); δH (700 MHz, CDCl3) 1.42 (18H, s, 
t
Boc 
CH3), 1.85 – 1.92 (1H, m, H
3
), 1.99 – 2.06 (1H, m, H3), 2.38 - 2.54 (6H, m, H4; cyclen 
CH2), 2.62 – 2.88 (12H, m, cyclen CH2), 3.22 - 3.34 (3H, m, H
2
; CH2CO), 3.63 (3H, s, 
CO2Me); δC (176 MHz, CDCl3) 24.8 (1C, C
3
), 28.0 (6C, 
t
Boc CH3), 30.7 (1C, C
4
), 46.1, 
46.2, 49.5, 52.1 (8C, cyclen CH2), 51.5 (1C, CO2Me), 57.0 (1C, CH2CO), 63.4 (1C, C
2
), 
80.8, 81.1 (2C, 
t
Boc(q)), 170.8 (1C, CH2CO), 171.6 (1C, C
1
), 173.5 (1C, C
5
); m/z 
(HRMS
+
) 487.3503 [M + H]
+
 (C24H47N4O6 requires 487.3496). 
 
2-(4,10-[2-Methyl-1-azaxanthone]-7-tert-butoxycarbonylmethyl-1,4,7,10-tetraaza-
cyclododecane)-pentanedioic acid 5- methyl ester 1-tert-butyl ester 
 
 
 
Caesium carbonate (184 mg, 0.56 mmol) and 2-methyl-1-azaxanthone (171 mg, 0.59 
mmol) were added to a solution of 2-(7-tert-butoxycarbonylmethyl-1,4,7,10-tetraaza-
cyclododecane)-pentanedioic acid 5-methyl ester 1-tert-butyl ester
 
(137 mg, 0.28 mmol) 
in anhydrous acetonitrile (5 mL). The reaction mixture was stirred at reflux for 18 h 
under argon. After this time the reaction mixture was allowed to cool to room 
temperature and filtered to facilitate the removal of caesium salts. Removal of the 
solvent under reduced pressure yielded the crude product. Column chromatography on 
silica gel (gradient elution: CH2Cl2 to 5% CH3OH-CH2Cl2) allowed isolation of a 
yellow oil containing the title compound (107.9 mg, 0.12 mmol, 20%). Rf (SiO2, 
CH2Cl2-CH3OH, 95 : 5) : 0.05; m/z (HRMS
+
) 905.4443 [M + H]
+
 (C50H61N6O10 requires 
905.4449). This compound was used directly in the following complexation reaction, 
without further purification. 
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(R)-[Eu.L
23
(OH2)]
+
 
 
 
 
 
 
 
 
 
 
 
Trifluoroacetic acid (1 mL) was added to a solution of crude 2-(4,10-[2-methyl-1-
azaxanthone] - 7 - tert - butoxycarbonylmethyl - 1,4,7,10 - tetraaza - cyclododecane) -
pentanedioic acid 5-methyl ester 1-tert-butyl ester (21.4 mg, 0.024 mmol) in 
dichloromethane (0.5 mL). The mixture was left for 48 h at room temperature. The 
solvent was removed under reduced pressure and the resulting residue re-dissolved in 
dichloromethane three times to aid the removal of excess acid and tert-butyl alcohol. 
The product was checked by LCMS after 18 h and 36 h to confirm complete ester 
hydrolysis, after 48 h the
 
signal relating to the unhydrolysed ligand (tR = 2.64 min) had 
disappeared completely from the LCMS trace and a new signal had appeared relating to 
the hydrolysed ligand (tR = 2.13 min). The product was used immediately for 
complexation with europium chloride.  
 
The ligand was dissolved in a mixture of methanol and water (1 : 2, 3 mL) and 
sonicated. The pH of the solution was raised to 5.5 by the addition of a 1 M solution of 
KOH(aq). EuCl3.6H2O (8.67 mg, 0.024 mmol) was added and the reaction mixture was 
heated at 90 
o
C overnight. Emission spectroscopy was used to ascertain whether 
complexation was complete before allowing the reaction mixture to cool to room 
temperature. The pH of the mixture was raised to 10.0 using dilute KOH(aq) and the 
solution was stirred for 1 h at room temperature to precipitate excess Eu
3+
 as Eu(OH)3. 
Centrifugation was used to remove the resulting solid before restoring the pH of the 
mixture to 5.5 by the addition of dilute HCl(aq). Removal of the solvent under reduced 
pressure gave a yellow solid which was lyophilised to give a crude mixture. The crude 
mixture was purified using preparative HPLC, yielding the title complex as an off-white 
solid (2.0 mg, 0.002 mmol, 9%). m/z (HRMS
+
) 941.2178 [M + H]
+
 (C42H42N6O10Eu 
requires 941.2161); (HPLC) tR = 10.9 min; λmax (H2O) 336 nm; τ(H2O) = 0.47 ms; 
τ(D2O) = 1.42 ms. 
 
 
CHAPTER FIVE: EXPERIMENTAL DETAILS 
- 175 - 
 
(R)-[Tb.L
23
(OH2)]
+
 
 
An analogous procedure to that described for the synthesis of (R)-[Eu.L
23
(OH2)]
+
 was 
followed, using TbCl3.6H2O (8.83 mg. 0.024 mmol) in place of EuCl3.6H2O. The title 
complex was isolated as an off-white solid, following preparative HPLC (2.0 mg, 0.002 
mmol, 9%). m/z (HRMS
+
) 949.2249 [M + H]
+
 (C42H42N6O10Tb requires 949.2216); 
(HPLC) tR = 11.1 min; λmax (H2O) 336 nm; τ(H2O) = 1.82 ms; τ(D2O) = 3.17 ms. 
 
5.2.2 Triazacyclononane-based complexes and precursors 
 
N’-(2-Aminoethyl)-L-phenylalaninamide200, 201 
 
L-Phenylalanine ethyl ester hydrochloride (3.30 g, 14.4 mmol) was added in small 
portions over 1 h to stirred ethylenediamine (30 mL) at 90 
o
C under an atmosphere of 
argon. The reaction mixture was heated at 120 
o
C for 3 h. Excess ethylenediamine was 
removed by distillation under reduced pressure, yielding an orange oil to which 
NaOH(aq) (4 M, 6 mL) was added. The solvent was removed under reduced pressure and 
the resulting residue dissolved in methanol (15 mL) before being filtered under vacuum. 
Dichloromethane (15 mL) was added to the resulting filtrate, which was subsequently 
filtered through celite. Removal of the solvent under reduced pressure yielded a gritty 
yellow oil, which was redissolved in dichloromethane (30 mL) and filtered through 
celite for a second time. This process was repeated once more, giving the title 
compound as a ‘grit-free’ yellow oil (2.42 g, 11.7 mmol, 81%). νmax / cm
-1
 3287 (amide 
N-H stretch), 2924 (C-H stretch), 1648 (C=O stretch); δH (600 MHz, CDCl3) 1.59 (4H, 
br s, 2 x NH2), 2.74 (1H, dd, J = 13.5, 9.0 Hz, H
5
), 2.79 (2H, t, J = 6.0 Hz, H
4
), 3.23 
(1H, dd, J = 13.5, 4.5 Hz, H
5
), 3.25 – 3.33 (2H, m, H3), 3.61 (1H, dd, J = 9.0, 4.5 Hz, 
H
1
), 7.17 – 7.34 (5H, m, Ar), 7.47 (1H, br s, NH); δC (151 MHz, CDCl3); 41.1 (1C, C
5
), 
41.4 (1C, C
4
), 41.8 (1C, C
3
), 56.5 (1C, C
1
), 126.7 (1C, C
8
), 128.6 (2C, C
7
), 129.2 (2C, 
C
6
), 137.8 (1C, C
5’
), 174.5 (1C, C=O); m/z (HRMS
+
) 208.1442 [M + H]
+
 (C11H18N3O 
requires 208.1450).  
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N’-(2-Aminoethyl)-D-phenylalaninamide200, 201 
 
The title compound was prepared using an analogous procedure to that described for N’-
(2-aminoethyl)-L-phenylalaninamide. The starting material, L-phenylalanine ethyl ester 
hydrochloride, was replaced by D-phenylalanine methyl ester hydrochloride (4.10 g, 
19.0 mmol). The title compound was isolated as a yellow oil (3.52 g, 16.9 mmol, 89%). 
Spectroscopic characteristics were identical to those observed for the L isomer.  
 
(S)-N’-(2-Aminoethyl)-1-benzylethane-1,2-diamine201 
 
A solution of BH3.THF in THF (1M, 100 mL) was added to N’-(2-aminoethyl)-L-
phenylalaninamide (2.40 g, 11.6 mmol) in a flask at 0 
o
C under a flowing stream of 
argon. The resulting reaction mixture was allowed to warm to room temperature then 
stirred under argon at 70 
o
C for 24 h. After this time, a small sample of the reaction 
mixture was taken and IR spectroscopy used to confirm that the reaction had reached 
completion. The remainder of the reaction mixture was quenched by addition of 
methanol (15 mL) at 0
 o
C. Removal of the solvent under reduced pressure yielded a 
white residue, which was stirred at reflux in HCl(aq) (2 M, 75 mL) for 18 h. The reaction 
mixture was allowed to cool to room temperature and the solvent was removed by co-
evaporation with methanol, giving the title compound as a highly hygroscopic, white 
solid (2.20 g, 7.3 mmol, 63%). νmax/cm
-1
 2927 (C-H stretch); δH (600 MHz, D2O) 2.92 
(1H, dd, J = 14.0, 8.5 Hz, H
5
), 3.09 (1H, dd, J = 14.0, 6.0 Hz, H
5
), 3.25 – 3.47 (6H, m, 
H
2,3,4
), 3.85 – 3.90 (1H, m, H1), 7.23 – 7.24 (2H, m, H6), 7.27 – 7.29 (1H, m, H8), 7.32 – 
7.34 (2H, m, H
7
); δC (151 MHz, D2O) 35.3 (1C, C
4
), 36.3 (1C, C
5
), 45.0 (1C, C
3
), 49.0 
(1C, C
2
), 49.8 (1C, C
1
), 128.2 (1C, C
8
), 129.4 (4C, C
6,7
), 133.6 (1C, C
5’
); m/z (HRMS
+
) 
194.1651 [M + H]
+ 
(C11H20N3 requires 194.1657).  
 
(R)-N’-(2-Aminoethyl)-1-benzylethane-1,2-diamine201 
 
The title compound was prepared using an analogous procedure to that described for 
(S)-N’-(2-Aminoethyl)-1-benzylethane-1,2-diamine. The starting material, N’-(2-
aminoethyl)-L-phenylalaninamide, was replaced by N’-(2-aminoethyl)-D-
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phenylalaninamide (2.26 g, 10.9 mmol). The title compound was isolated as a yellow oil 
(3.22 g, 10.7 mmol, 98%). Spectroscopic characteristics were identical to those 
observed for the L isomer.  
 
(S)-1-N'-1-Benzyl - 1, 5 - bistoluene - p - sulfonamido - 3 - toluene - p - sulphonyl - 3 
- azapentane
 
 
A solution of p-toluenesulfonyl chloride (2.52 g, 13.2 mmol) in dry dichloromethane 
(50 mL) was added dropwise to a solution of (S)-N’-(2-aminoethyl)-1-benzylethane-1,2-
diamine (1.14 g, 3.8 mmol) and triethylamine (3.43 g, 4.8 mL, 34.0 mmol) in dry 
dichloromethane (75 mL) over 1 h under an atmosphere of argon. The reaction mixture 
was stirred under argon for 16 h. The resulting organic phase was washed with H2O (3 x 
90 mL) and the solvent removed under reduced pressure, yielding the crude product as a 
brown oil. The crude product was subsequently purified by column chromatography on 
silica gel (gradient elution: CH2Cl2 to 5% EtOAc-CH2Cl2) to give the title compound as 
a white solid (0.78 g, 1.2 mmol, 31%).  m.p. 100.5-101 
o
C; Rf (SiO2, CH2Cl2-EtOAc, 95 
: 5) : 0.42; δH (700 MHz, CDCl3) 2.33 - 2.36 (9H, m, 3 x CH3
 
), 2.52 (1H, dd, J = 14.0, 
8.0 Hz, H
5
), 2.79 (1H, dd, J = 14.0, 6.0 Hz, H
5
), 2.97 – 3.08 (4H, m, H2,3,4), 3.12 (1H, 
dd, J = 13.5, 6.5 Hz, H
3
), 3.22 (1H, dd, J = 14.5, 6.5 Hz, H
2
), 3.59 – 3.64 (1H, m, H1), 
5.33 (1H, d, J = 6.5 Hz, NH), 5.58 (1H, t, J = 6.0 Hz, CH2NH), 6.88 (2H, d, J = 7.0 Hz, 
H
6
), 7.05 – 7.10 (5H, m, H7, 8, b), 7.21 – 7.25 (4H, m, Hb), 7.52 (4H, d, J = 8.0 Hz, Ha), 
7.71 (2H, d, J = 8.0 Hz, H
a); δC (176 MHz, CDCl3) 21.5 (3C, 3 x CH3), 38.7 (1C, C
5
), 
42.3 (1C, C
4
), 50.9 (1C, C
3
), 54.6 (2C, C
1, 2
), 126.5 (1C, C
8
), 127.0, 127.1, 127.4 (6C, 
C
a
), 128.5 (2C, C
7
), 129.1 (2C, C
6
), 129.7, 129.8, 129.9 (6C, C
b
), 134.4 (1C, C
a’
), 136.5 
(2C, C
a’,5’
), 136.8 (1C, C
a’
), 143.2, 143.4, 144.0 (3C, C
b’
); m/z (HRMS
+
) 678.1744 [M + 
Na]
+ 
(C32H37N3O6S3Na requires 678.1742). 
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(R)-1-N'-1-Benzyl - 1, 5 - bistoluene - p - sulfonamido - 3 - toluene - p - sulphonyl - 
3 - azapentane
 
 
The title compound was prepared using an analogous procedure to that described for 
(S)-1-N'-1-benzyl-1,5-bistoluene-p-sulfonamido-3-toluene-p-sulphonyl-3-azapentane. 
The starting material, (S)-N’-(2-aminoethyl)-1-benzylethane-1,2-diamine, was replaced 
by (R)-N’-(2-aminoethyl)-1-benzylethane-1,2-diamine (1.44 g, 4.8 mmol). The title 
compound was isolated as a white solid (1.24 g, 1.9 mmol, 40%). Spectroscopic 
characteristics were identical to those observed for the (S) isomer.  
 
(S)-2-Benzyl-1,4,7-tris(toluene-p-sulphonyl)-1,4,7-triazacyclononane 
 
A solution of ethylene glycol bis(toluene-p-sulphonate) (235 mg, 0.63 mmol) in 
anhydrous DMF (14 mL) was added dropwise over 1 h to a stirred solution of (S)-1-N'-
1-benzyl-1, 5-bistoluene-p-sulfonamido-3-toluene-p-sulphonyl-3-azapentane (396 mg, 
0.60 mmol) and caesium carbonate (591 mg, 1.81 mmol) in anhydrous DMF (27 mL), 
at room temperature. After 16 h, the temperature was increased to 65 
o
C and the 
reaction mixture was heated at this temperature for 5 h before being allowed to cool to 
room temperature. Removal of the solvent under reduced pressure yielded a yellow 
residue, which was redissolved in chloroform (40 mL) and washed with H2O (2 x 30 
mL), before being dried over magnesium sulfate and filtered. Removal of the solvent 
under reduced pressure yielded the crude product, which was purified by column 
chromatography on silica gel (gradient elution: CH2Cl2 to 2% EtOAc-CH2Cl2) to give 
the title compound as a white solid (0.34 g, 0.50 mmol, 82%). m.p. 116.5-119 
o
C; Rf 
(SiO2, CH2Cl2) : 0.13; δH (700 MHz, CDCl3) 2.35 (3H, s, CH3
 
), 2.38 (3H, s, CH3
 
), 2.41 
(3H, s, CH3
 
), 2.54 (1H, br s, H
10
), (second H
10
 proton is obscured under CH3 singlets), 
2.88 – 3.32 (6H, m, ring CH2’s), 3.56 – 3.84 (4H, m, ring CH2’s), 4.73 (1H, br s, H
2
), 
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7.04 – 7.13 (4H, m, Ha, b) 7.15 (2H, d, J = 7.5 Hz, H11), 7.29 – 7.33 (5H, m, Hb, 13), 7.34 
(2H, t, J = 7.5 Hz, H
12
), 7.62 (2H, d, J = 8.0 Hz, H
a
), 7.84 (2H, d, J = 8.0 Hz, H
a
); δC 
(176 MHz, CDCl3) 21.4, 21.5 (3C, 3 x CH3), 36.4 (1C, C
10
), 46.1, 50.9, 53.5, 53.6 (4C, 
C
5, 6, 8, 9
), 54.7 (1C, C
3
), 60.2 (1C, C
2
), 126.7 (1C, C
13
), 127.3, 127.5 (3C, C
a
), 128.7 
(2C, C
12
), 129.3 (2C, C
11
), 129.6, 129.9, 130.0 (3C, C
b
), 133.6, 134.2, 137.0, 137.1 (4C, 
C
a’, 10’
), 143.4, 143.8, 144.2 (3C, C
b’
); m/z (HRMS
+
) 682.2087 [M + H]
+ 
(C34H40N3O6S3 
requires 682.2079). 
 
(R)-2-Benzyl-1,4,7-tris(toluene-p-sulphonyl)-1,4,7-triazacyclononane 
 
The title compound was prepared using an analogous procedure to that described for 
(S)-2-benzyl-1,4,7-tris(toluene-p-sulphonyl)-1,4,7-triazacyclononane. The starting 
material, (S)-1-N'-1-benzyl-1, 5-bistoluene-p-sulfonamido-3-toluene-p-sulphonyl-3-
azapentane, was replaced by (R)-1-N'-1-benzyl-1, 5-bistoluene-p-sulfonamido-3-
toluene-p-sulphonyl-3-azapentane (0.93 g, 1.4 mmol). The title compound was isolated 
as a white solid (0.65 g, 1.0 mmol, 70%). Spectroscopic characteristics were identical to 
those observed for the (S) isomer.  
 
(S)-2-Benzyl-1,4,7-triazacyclononane
 
 
Ammonia (30 mL) was condensed into a solution of (S)-2-benzyl-1,4,7-tris(toluene-p-
sulphonyl)-1,4,7-triazacyclononane (350 mg, 0.51 mmol) in a mixture of anhydrous 
THF (15 mL) and anhydrous ethanol (1 mL) whilst stirring under argon at -78 
o
C. 
Sodium (580 mg, excess) was added in small portions to the solution and a strong blue 
colour developed. The solution was slowly warmed to RT overnight; during this period 
the solution evaporated to leave a white solid. The white solid was dissolved in ethanol 
(10 mL) and water (15 mL) and the solvent removed under reduced pressure. The 
resulting residue was dissolved in HCl(aq) (2 M, 15 mL) and washed with diethyl ether 
(2 x 15 mL). The aqueous layer was concentrated, and the resulting off-white solid was 
dissolved in KOH solution (6 M, 15 mL) and extracted with dichloromethane (3 x 15 
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mL). The organic layer was concentrated to give a colourless oil containing the title 
compound (102 mg, 0.46 mmol, 91%). δH (400 MHz, CDCl3) 1.75 (3H, br s, 3 x NH), 
2.37 – 2.47 (2H, m, H10), 2.50 – 2.81 (10 H, br m, ring CH2’s), 2.86 – 2.96 (1H, m, H
2
), 
7.09 – 7.25 (5H, m, Ar); δC (101 MHz, CDCl3) 40.7 (1C, C
10
), 43.7, 45.4, 46.6, 47.3, 
49.9 (5C, C
3, 5, 6, 8, 9
), 57.6 (1C, C
2
), 126.3 (1C, C
13
), 128.5 (2C, C
12
), 129.1 (2C, C
11
), 
139.0 (1C, C
10'
); m/z (HRMS
+
) 220.1815 [M + H]
+ 
(C13H22N3 requires 220.1814). This 
compound was used directly in the subsequent reaction, without further purification.  
 
(R)-2-Benzyl-1,4,7-triazacyclononane
 
 
The title compound was prepared using an analogous procedure to that described for 
(S)-2-Benzyl-1,4,7-triazacyclononane. The starting material, (S)-2-benzyl-1,4,7-
tris(toluene-p-sulphonyl)-1,4,7-triazacyclononane, was replaced by (R)-2-benzyl-1,4,7-
tris(toluene-p-sulphonyl)-1,4,7-triazacyclononane (0.66 g, 1.0 mmol). The title 
compound was isolated as a yellow oil (0.20 g,  0.93 mmol, 96%). Spectroscopic 
characteristics were identical to those observed for the (S) isomer.  
 
Ethyl methylphosphinate
181
 
 
 
Neat diethyl methylphosphonite (2 g, 14.7 mmol) was stirred under argon at RT and 
H2O (264 μL, 14.7 mmol) was added. The mixture was stirred at RT for 18 h. 
1
H- and 
31
P-NMR spectroscopy were used to confirm the formation of the title compound, 
which was subsequently used in situ without further purification. The reaction mixture 
also contained one equivalent of ethanol as a by-product (100% conversion by 
1
H-NMR 
spectroscopy). δH (400 MHz, CDCl3) 1.37 (3H, t, 
3
JH-H = 7.0 Hz, H
3
), 1.54 (3H, dd, 
2
JH-
P = 15.0 Hz 
3
JH-H = 2.0 Hz, H
4
), 4.01 – 4.24 (2H, m, H2), 7.22 (1H, dq, 1JH-P = 537 Hz, 
3
JH-H = 2.0 Hz);  δP (162 MHz, CDCl3) +32.5; m/z (HRMS
+
) 131.0246 [M + Na]
+ 
(C3H9O2PNa requires 131.0238). 
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Ethyl (6-methylpyridin-2-yl)(methyl)phosphinate
181
 
 
 
 
Toluene (20 mL), 2-bromo-6-methylpyridine (2.10 g, 12.3 mmol) and triethylamine 
(4.35 g, 43 mmol) were added to neat ethyl methylphosphinate (1.59 g, 14.7 mmol), 
containing one equivalent of ethanol. Argon was bubbled through the solution for 30 
min prior to the addition of PdCl2(dppf)·CH2Cl2 (0.22 g, 0.27 mmol). The reaction 
mixture was stirred at 125 
o
C for 16 h under argon. Once cooled to room temperature, 
the solvent was removed under reduced pressure. The crude product was purified by 
column chromatography on silica gel  (gradient elution: EtOAc-Hexane, 50 : 50, to 
EtOAc-Hexane, 80 : 20) to give the title compound as a brown oil (1.63 g, 8.21 mmol, 
67%). Rf (SiO2, EtOAc-Hexane, 75 : 25) : 0.10; δH (700 MHz, CDCl3) 1.06 (3H, t, 
3
JH-H 
= 7.0 Hz, OCH2CH3), 1.57 (3H, d, 
2
JH-P = 15.0 Hz, PCH3), 2.41 (3H, s, H
7
), 3.60 – 3.97 
(2H, m, OCH2CH3), 7.09 (1H, d, 
3
JH-H = 8.0 Hz, H
5
), 7.51 (1H, td, 
3
JH-H = 8.0 Hz 
4
JH-P = 
4.5 Hz, H
4
), 7.67 (1H, t, 
3
JH-H = 8.0 Hz, H
3
); δC (100 MHz, CDCl3) 13.0 (1C, d, 
1
JC-P = 
103.5 Hz, PCH3), 16.0 (1C, d, 
3
JC-P = 6.5 Hz, OCH2CH3), 24.1 (1C, s, C
7
), 60.4 (1C, d, 
2
JC-P = 6.0 Hz, OCH2CH3), 124.2 (1C, d, 
2
JC-P = 21.5 Hz, C
3
), 125.3 (1C, d, 
4
JC-P = 3.0 
Hz, C
5
), 135.7 (1C, d, 
3
JC-P = 10.0 Hz, C
4
), 153.3 (1C, d, 
1
JC-P = 158.5 Hz, C
2
), 159.0 
(1C, d, 
3
JC-P = 20.0 Hz, C
6
); δP (162 MHz, CDCl3) +39.0; m/z (HRMS
+
) 200.0824 [M + 
H]
+ 
(C9H15NO2P requires 200.0840). 
 
Ethyl (6-methyl-1-oxo-pyridin-2-yl)(methyl)phosphinate
181
 
 
 
 
3-Chloroperbenzoic acid (3.21 g, 18.6 mmol) was added to a solution of ethyl (6-
methylpyridin-2-yl)(methyl)phosphinate (1.85 g, 9.3 mmol) in anhydrous chloroform 
(40 mL). The reaction mixture was stirred at reflux for 18 h under argon. After this time 
the reaction mixture was allowed to cool to room temperature and the solvent was 
removed under reduced pressure. The resulting residue was dissolved in 
dichloromethane (50 mL) and the organic solution was washed with 0.5 M NaHCO3 (30 
mL) and then extracted with dichloromethane (50 mL). The organic extracts were 
subsequently combined with the original organic solution, dried over magnesium sulfate 
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and filtered. Removal of the solvent under reduced pressure yielded the crude product, 
which was purified by column chromatography on silica gel (gradient elution: CH2Cl2 
to 2% CH3OH-CH2Cl2) to give the title compound as a yellow oil (1.46 g, 6.8 mmol, 
73%). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.23; δH (400 MHz, CDCl3) 1.16 (3H, t, 
3
JH-H 
= 7.0 Hz, OCH2CH3), 1.84 (3H, d, 
2
JH-P = 16.5 Hz, PCH3), 2.37 (3H, s, H
7
), 3.73 – 4.09 
(2H, m, OCH2CH3), 7.15 (1H, td, 
3
JH-H = 8.0 Hz, 
4
JH-P = 2.0 Hz, H
4
), 7.29 – 7.35 (1H, 
m, H
5
), 7.77 (1H, td, 
3
JH-H = 8.0 Hz, 
3
JH-P = 2.0 Hz, H
3); δC (101 MHz, CDCl3) 14.1 (1C, 
d, 
1
JC-P = 111.0 Hz, PCH3), 16.0 (1C, d, 
3
JC-P = 6.0 Hz, OCH2CH3), 17.0 (1C, s, C
7
), 
61.2 (1C, d, 
2
JC-P = 7.0 Hz, OCH2CH3), 123.9 (1C, d, 
3
JC-P = 9.5 Hz, C
4
), 129.0 (1C, d, 
4
JC-P = 1.5 Hz, C
5
), 129.9 (1C, d, 
2
JC-P = 10.5 Hz, C
3
), 142.2 (1C, d, 
1
JC-P = 141.0 Hz, 
C
2
), 149.2 (1C, d, 
3
JC-P = 3.5 Hz, C
6
); δP (162 MHz, CDCl3) +33.0; m/z (HRMS
+
) 
238.0608 [M + Na]
+ 
(C9H14NO3PNa requires 238.0609). 
 
Ethyl [6-(hydroxymethyl)pyridin-2-yl](methyl)phosphinate
181
 
 
 
 
Trifluoroacetic anhydride (5 mL, 36.0 mmol) was added to a solution of ethyl (6-
methyl-1-oxo-pyridin-2-yl)(methyl)phosphinate (1.46 g, 6.8 mmol) in anhydrous 
chloroform (40 mL). The reaction mixture was stirred at 60 
o
C for 18 h under argon and 
was subsequently allowed to cool to room temperature. The solvent was removed under 
reduced pressure and 
1
H NMR spectroscopy used to confirm full conversion to the 
trifluoroacetate analogue of the title compound. The residue was dissolved in aqueous 
ethanol (50%, 35 mL) and stirred at 60 
o
C for 6 h. Removal of the solvent under 
reduced pressure yielded the crude product, which was purified by column 
chromatography on silica gel (gradient elution: CH2Cl2 to 4% CH3OH-CH2Cl2) to give 
the title compound as a yellow oil (1.35 g, 6.3 mmol, 92%). Rf (SiO2, CH2Cl2-CH3OH, 
95 : 5) : 0.31; δH (400 MHz, CDCl3) 1.17 (3H, t, 
3
JH-H = 7.0 Hz, OCH2CH3), 1.68 (3H, 
d, 
2
JH-P = 15.0 Hz, PCH3), 3.69 – 4.08 (2H, m, OCH2CH3), 4.76 (2H, s, CH2OH), 7.47 
(1H, d, 
3
JH-H = 8.0 Hz, H
5
), 7.75 (1H, td, 
3
JH-H = 8.0 Hz, 
4
JH-P = 4.5 Hz, H
4
), 7.83 (1H, t, 
3
JH-H = 8.0 Hz, H
3
); δC (176 MHz, CDCl3) 13.4 (1C, d, 
1
JC-P = 104.0 Hz, PCH3), 16.3 
(1C, d, 
3
JC-P
 
= 6.5 Hz, OCH2CH3), 61.1 (1C, d, 
2
JC-P = 6.5 Hz, OCH2CH3), 64.4 (1C, s, 
CH2OH), 123.0 (1C, d, 
4
JC-P = 3.0 Hz, C
5
), 126.0 (1C, d, 
2
JC-P = 21.5 Hz, C
3
), 136.7 
(1C, d, 
3
JC-P = 10.0 Hz, C
4
), 152.8 (1C, 
1
JC-P = 158.0 Hz, C
2
), 161.4 (1C, d, 
3
JC-P = 18.5 
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Hz, C
6
); δP (162 MHz, CDCl3) +39.3; m/z (HRMS
+
) 216.0778 [M + H]
+ 
(C9H15NO3P 
requires 216.0790). 
 
(6-[Ethoxy(methyl)phosphoryl]pyridine-2-yl)methyl methanesulphonate
181
 
 
 
 
Triethylamine (0.70 mL, 5.01 mmol) was added to a solution of ethyl [6-
(hydroxymethyl)pyridin-2-yl](methyl)phosphinate (359 mg, 1.67 mmol) in anhydrous 
THF (8 mL). The mixture was stirred at 5 
o
C and methanesulfonyl chloride (0.19 mL, 
2.51 mmol) was added. The reaction was monitored by TLC (SiO2, CH2Cl2-CH3OH, 95 
: 5, Rf(product) = 0.33, Rf(reactant) = 0.31) and stopped after 10 min. The solvent was 
removed under reduced pressure and the resulting residue dissolved in dichloromethane 
(20 mL) and washed with saturated sodium chloride solution (4 x 15 mL). Removal of 
the solvent from the organic layer, after it had been dried over magnesium sulfate and 
filtered, yielded the title compound as a yellow oil, which was used directly in the next 
step without further purification (421 mg, 1.44 mmol, 86%). Rf (SiO2, CH2Cl2-CH3OH, 
95 : 5) : 0.33; δH (400 MHz, CDCl3) 0.99 (3H, t, 
3
JH-H = 7.0 Hz, OCH2CH3), 1.49 (3H, 
d, 
2
JH-P = 15.0 Hz, PCH3), 2.90 (3H, s, SO2CH3), 3.52 – 3.95 (2H, m, OCH2CH3), 5.13 
(2H, s, H
7
), 7.39 (1H, d, 
3
JH-H = 8.0 Hz, H
5
), 7.60 – 7.83 (2H, m, H3, 4); δP (162 MHz, 
CDCl3) +38.2; m/z (HRMS
+
) 294.0560 [M + H]
+ 
(C10H17NO5PS requires 294.0565). 
 
It should be noted that in some instances this reaction was found to yield the formation 
of an additional product alongside the title compound. This was identified as ethyl [6-
(chloromethyl)pyridin-2-yl](methyl)phosphinate. In instances where the formation of 
this by-product occurred, its presence was signalled by the occurrence of an additional 
signal at 4.56 ppm in the 
1
H NMR spectrum, corresponding to H
7
. It was still possible to 
use the product directly in the subsequent alkylation step without further purification. 
However, it was necessary to add a catalytic amount of potassium iodide to the reaction 
mixture in order for the alkylation to proceed. Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.38; 
δP (162 MHz, CDCl3) +38.5; m/z (HRMS
+
) 234.0446 [M + H]
+ 
(C9H14NO2PCl requires 
234.0451). 
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Triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate)
 
and diethyl 6,6'-( 
(S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4 - diyl ) bis (methylene) bis 
(pyridine - 6, 2 - diyl) bis (methylphosphinate)
 
 
 
 
 
(S)-2-Benzyl-1,4,7-triazacyclononane (50 mg, 0.23 mmol), (6-
[ethoxy(methyl)phosphoryl] pyridine-2-yl)methyl methanesulphonate/ ethyl [6-
(chloromethyl)pyridin-2-yl](methyl)phosphinate (182 mg, 3:2, '0.68' mmol), potassium 
carbonate (94 mg, 0.68 mmol) and potassium iodide (90 mg, 0.54 mmol) were stirred in 
anhydrous acetonitrile (5 mL) at reflux under argon. The reaction was monitored by 
TLC to confirm that all the mesylated and chlorinated starting material had been 
consumed. After 2 h the reaction mixture was allowed to cool to room temperature and 
filtered to facilitate the removal of potassium salts. Removal of the solvent under 
reduced pressure yielded the crude products, which were separated and purified by 
column chromatography on silica gel (gradient elution: CH2Cl2 to 9% CH3OH-CH2Cl2), 
giving triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) 
tris (methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate) (66 mg, 0.08 mmol, 
35%) and diethyl 6, 6' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4 - diyl ) bis 
(methylene) bis (pyridine - 6, 2 - diyl) bis (methylphosphinate) (26 mg, 0.04 mmol, 
18%) as yellow oils. 
 
Triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate). Rf (SiO2, CH2Cl2-
CH3OH, 90 : 10) : 0.25; δH (400 MHz, CDCl3) 0.97 – 1.35 (9H, br m, 3 x OCH2CH3), 
1.50 – 1.94 (9H, br m, 3 x PCH3),  2.45 – 4.69 (25 H, br m, ring CH2’s, 3 x OCH2, 3 x 
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NCH2, H
2, 10
),  6.97 – 8.07 (14H, br m, Ar); δP (162 MHz, CDCl3) +39.0; m/z (HRMS
+
) 
811.3654 [M + H]
+ 
(C40H58N6O6P3 requires 811.3631). 
 
Diethyl 6, 6' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4 - diyl ) bis 
(methylene) bis (pyridine - 6, 2 - diyl) bis (methylphosphinate). Rf (SiO2, CH2Cl2-
CH3OH, 90 : 10) : 0.42; δH (400 MHz, CDCl3) 1.16 – 1.41 (6H, m, 2 x OCH2CH3), 1.63 
– 1.85 (6H, m, 2 x PCH3), 2.37 – 3.47 (12H, m, ring CH2’s, H
10
), 3.62 – 4.16 (8H, br m, 
2 x OCH2, 2 x NCH2), 4.14 – 4.24 (1H, m, H
2
), 7.20 – 7.90 (11H, br m, Ar); δP (162 
MHz, CDCl3) +39.0; m/z (HRMS
+
) 614.3018 [M + H]
+ 
(C31H46N5O4P2 requires 
614.3025) 
 
Triethyl 6, 6', 6'' - ( (R) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate) 
 
 
 
 
(R)-2-Benzyl-1,4,7-triazacyclononane (102 mg, 0.47 mmol), (6-
[ethoxy(methyl)phosphoryl] pyridine-2-yl)methyl methanesulphonate (420 mg, 1.43 
mmol) and potassium carbonate (193 mg, 1.39 mmol) were stirred in anhydrous 
acetonitrile (5 mL) at reflux under argon. The reaction was monitored by TLC to 
confirm that all the mesylated starting material had been consumed. After 3 h the 
reaction mixture was allowed to cool to room temperature and filtered to facilitate the 
removal of potassium salts. Removal of the solvent under reduced pressure yielded the 
crude product, which was purified by column chromatography on silica gel (gradient 
elution: CH2Cl2 to 25% CH3OH-CH2Cl2) to give the title compound as a yellow oil (91 
mg, 0.11 mmol, 24%). Rf (SiO2, CH2Cl2-CH3OH, 90 : 10) : 0.25; δH (700 MHz, CDCl3) 
1.14 – 1.21 (9H, br m, 3 x OCH2CH3), 1.63 – 1.74 (9H, br m, 3 x PCH3),  2.39 – 3.34 
(13H, br m, ring CH2's, H
2
, H
 10
), 3.51 –4.11 (12H, br m, 3 x OCH2 and 3 x NCH2),  
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7.00 – 7.06 (2H, m, H12), 7.07 - 7.12 (1H, m, H14), 7.12 - 7.16 (2H, m, H13), 7.33 – 7.49 
(3H, m, H
b
), 7.59 – 7.72 (3H, m, Hc), 7.81 – 7.87 (3H, m, Hd); δP (162 MHz, CDCl3) 
+39.3; δC (176 MHz, CDCl3) 13.0 - 13.6 (3C, m, PCH3), 16.3 - 16.4 (3C, m, 
OCH2CH3), 35.6 (br s, 1C, C
10
), 51.5 (br s, 1C, C
9
), 55.7, 56.2, 56.7 (3C, C
5, 6, 8
), 58.0 
(1C, C
3
), 60.8 (3C, m, OCH2CH3), 62.7 (1C, C
2
), 64.2, 64.6 (3C, NCH2), 125.0, 125.3, 
125.4 (3C, C
b
), 125.6, 125.7 (3C, C
d
), 125.8 (1C, C
14
), 128.2 (2C, C
12
), 129.0 (2C, C
13
), 
136.1 (3C, C
c
), 140.4 (1C, C
11
), 153.0 - 154.2 (3C, m, C
e
), 161.2, 162.1 (3C, C
a
); m/z 
(HRMS
+
) 811.3638 [M + H]
+ 
(C40H58N6O6P3 requires 811.3631). 
 
Diethyl 6, 6' - ( (R) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4 - diyl ) bis 
(methylene) bis (pyridine - 6, 2 - diyl) bis (methylphosphinate) 
 
 
 
(R)-2-Benzyl-1,4,7-triazacyclononane (128 mg, 0.58 mmol), (6-
[ethoxy(methyl)phosphoryl] pyridine-2-yl)methyl methanesulphonate (341 mg, 1.16 
mmol) and potassium carbonate (242 mg, 1.75 mmol) were stirred in anhydrous 
acetonitrile (5 mL) at reflux under argon. The reaction was monitored by TLC to 
confirm that all the mesylated starting material had been consumed. After 4 h the 
reaction mixture was allowed to cool to room temperature and filtered to facilitate the 
removal of potassium salts. Removal of the solvent under reduced pressure yielded the 
crude product, which was purified by column chromatography on silica gel (gradient 
elution: CH2Cl2 to 6% CH3OH-CH2Cl2) to give the title compound as a yellow oil (54 
mg, 0.09 mmol, 15%). Rf (SiO2, CH2Cl2-CH3OH, 90 : 10) : 0.39; δH (700 MHz, CDCl3) 
1.14 – 1.24 (6H, br m, 3 x OCH2CH3), 1.62 – 1.73 (6H, br m, 3 x PCH3),  2.60 – 3.28 
(15 H, br m, ring CH2's, H
10
), 3.75 – 4.06 (9H, br m, H2, OCH2 x 2, NCH2 x 2), 7.17 – 
7.22 (2H, m, H
14
 and 1 x H
b
), 7.24 – 7.29 (2H, m, H13), 7.29 – 7.33 (1H, m, 1 x Hb), 
7.37 - 7.43 (2H, m, H
c or d
), 7.51 (2H, br s, H
12
), 7.67 – 7.76 (2H, m, Hc or d); δP (162 
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MHz, CDCl3) +39.5; δC (176 MHz, CDCl3) 13.4 - 15.1 (2C, m, OCH2CH3), 16.4 - 16.5 
(2C, m, PCH3), 37.4, 45.8, 49.9, 50.6 (6C, ring CH2's, C
10
), 57.1 (1C, C
2
), 61.1 - 61.8 
(4C, m, 2 x NCH2, 2 x OCH2CH3), 124.7, 124.9 (2C, C
b
), 125.3 - 125.7 (4C, m, C
c, d
), 
127.3 (1C, C
14
), 129.0 (1C, C
13
), 129.5 (1C, C
12
), 135.7 (1C, C
11
), 152.8 - 154.4 (2C, m, 
C
e
), 159.3 - 159.8 (2C, m, C
a
); m/z (HRMS
+
) 614.3032 [M + H]
+ 
(C31H46N5O4P2 
requires 614.3025). 
 
(S)-[Eu.L
34
] 
 
 
Triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate) (32 mg, 0.04 mmol) 
was dissolved in CD3OD (3.5 mL) and a solution of 0.1 M NaOH in D2O (3.5 mL) was 
added. The reaction mixture was heated for 16 h at 90 
o
C with stirring. Subsequent 
removal of the solvent under reduced pressure yielded the deprotected ligand as a white 
solid. The product was checked by ESMS to confirm complete hydrolysis of the ester 
groups and was used immediately for complexation with europium chloride.  
 
The ligand was dissolved in H2O : CH3OH (4 : 1, 2.5 mL) and the pH of the solution 
adjusted to 5.5 using dilute HCl(aq). EuCl3.6H2O (15.9 mg, 0.04 mmol) was added and 
the reaction mixture was heated at 80 
o
C for 16 h. After allowing the reaction mixture to 
cool to room temperature, the pH was raised to 10.0 by the addition of dilute NaOH(aq). 
The resulting solution was stirred for 1 h causing excess Eu
3+
 to precipitate as Eu(OH)3, 
which was removed by filtration. The pH of the resulting solution was restored to 5.5 by 
the addition of dilute HCl(aq) and the solvent lypohilised to give the crude product. The 
crude product was taken in to CH2Cl2 : CH3OH (8 : 2, 2 mL) and the solution filtered to 
facilitate the removal of salts. Subsequent removal of solvent under reduced pressure 
yielded an off-white solid which was further purified by column chromatography on 
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silica gel (CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) to give the title compound as an off-
white solid (17 mg, 0.02 mmol, 50%). Rf (SiO2, CH2Cl2-CH3OH-NH3, 80 : 20 : 1) : 
0.16; δH (600 MHz, CD3OD) -6.06 (1H), -5.69 (1H), -4.08 (1H), -2.76 (1H), -2.26 (1H), 
-1.80 (1H), -1.62 (2H), -0.34 (1H), -0.05 (3H), 0.52 (1H), 0.86 (3H), 1.36 (1H), 2.18 
(3H), 2.93 (1H), 3.00 (1H), 3.35 (1H), 4.28 (1H), 4.57 (1H), 5.32 (1H), 6.27 (1H), 6.66 
(1H), 7.06 - 7.74 (12H), 8.46 (1H), 10.39 (1H); δP (243 MHz, CD3OD) 35.0, 40.3, 44.4; 
m/z (HRMS
+
) 875.1659 [M + H]
+ 
(
151
EuC34H43N6O6P3 requires 875.1656); (HPLC) tR = 
5.96 min; λmax (H2O) 268 nm; τ(H2O) = 1.34 ms; τ(D2O) = 1.60 ms. 
 
(S)-[Tb.L
34
] 
 
An analogous procedure to that described for the synthesis of (S)-Eu.L
34
] was followed, 
using TbCl3.6H2O (10.9 mg, 0.03 mmol) in the place of EuCl3.6H2O. Purification by 
silica gel chromatography (CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) yielded the title 
complex as an off-white solid (22.4 mg, 0.025 mmol, 88%).  Rf (SiO2, CH2Cl2-CH3OH-
NH3, 80 : 20 : 1) : 0.14; δH (600 MHz, CD3OD) -92.9 (1H), -78.4 (1H), -43.0 (1H), -
37.2 (H), -15.9 (1H), -13.7 (1H), -12.3 (1H), -10.8 -9.2 (5H), -4.4 (1H), -2.7 (1H), -2.4 
(3H), -0.2, 1.3 (9H), 7.3 (1H), 8.8 (1H), 12.6 (1H), 17.2 (2H), 21.5 (1H), 27.9 (3H), 
35.2 (1H), 40.2 (3H), 52.3 (1H), 54.2 (1H), 62.3 (1H); δP (243 MHz, CD3OD) -32.7, 
7.2, 51.1; m/z (HRMS
+
) 883.1718 [M + H]
+ 
(
159
TbC34H43N6O6P3 requires 883.1710); 
(HPLC) tR = 6.03 min; λmax (H2O) 268 nm; τ(H2O) = 2.62 ms; τ(D2O) = 2.71 ms. 
 
(R)-[Eu.L
34
] 
 
Triethyl 6, 6', 6'' - ( (R) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (pyridine - 6, 2 - diyl) tris (methylphosphinate) (34 mg, 0.04 mmol) 
was dissolved in CD3OD (3.0 mL) and a solution of 0.1 M NaOH in D2O (3.7 mL) was 
added. The reaction mixture was heated for 5 h at 90 
o
C with stirring. Subsequent 
removal of the solvent under reduced pressure yielded the deprotected ligand as a white 
solid. The product was checked by ESMS and 
31
P NMR spectroscopy (δP
 
(162 MHz, 
CDCl3) +26.4, 26.9, 27.4) to confirm complete hydrolysis of the ester groups and was 
used immediately for complexation with europium chloride.  
 
The ligand was reacted with europium chloride using an analogous procedure to that 
described for the synthesis of (S)-[Eu.L
34
]. Purification by silica gel chromatography 
(CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) yielded the title complex as an off-white solid (27 
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mg, 0.03 mmol, 73%). Spectroscopic characteristics were identical to those observed for 
the (S) enantiomer. 
 
(R)-[Tb.L
34
] 
 
An analogous procedure to that described for the synthesis of (R)-[Eu.L
34
] was 
followed, using TbCl3.6H2O (13.5 mg, 0.04 mmol) in the place of EuCl3.6H2O. 
Purification by silica gel chromatography (CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) yielded 
the title complex as an off-white solid (17.5 mg,  0.020 mmol, 55%).  Spectroscopic 
characteristics were identical to those observed for the (S) enantiomer. 
 
(S)-[Tb.L
35
(OH2)]
+
 
 
 
Diethyl 6, 6' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4 - diyl ) bis 
(methylene) bis (pyridine - 6, 2 - diyl) bis (methylphosphinate) (11 mg, 0.02 mmol) was 
dissolved in CD3OD (1.0 mL) and a solution of 0.1 M NaOH in D2O (1.0 mL) was 
added. The reaction mixture was heated for 3 h at 90 
o
C with stirring. Subsequent 
removal of the solvent under reduced pressure yielded the deprotected ligand as a white 
solid. The product was checked by 
31
P NMR spectroscopy (δP
 
(162 MHz, CDCl3) 
+27.3) to confirm complete hydrolysis of the ester groups and was used immediately for 
complexation with terbium chloride.  
 
The ligand was dissolved in H2O : CH3OH (4 : 1, 3.0 mL) and the pH of the solution 
adjusted to 5.5 using dilute HCl(aq). TbCl3.6H2O (7.5 mg, 0.02 mmol) was added and the 
reaction mixture was heated at 80 
o
C for 32 h. After allowing the reaction mixture to 
cool to room temperature, the pH was raised to 10.0 by the addition of dilute NaOH(aq). 
The resulting solution was stirred for 2 h causing excess Tb
3+
 to precipitate as Tb(OH)3, 
which was removed by filtration. The pH of the resulting solution was restored to 5.5 by 
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the addition of dilute HCl(aq) and the solvent lypohilised to give the crude product. The 
crude product was taken in to CH2Cl2 : CH3OH (8 : 2, 2 mL) and the solution filtered to 
facilitate the removal of salts. Subsequent removal of solvent under reduced pressure 
yielded an off-white solid which was further purified by preparative HPLC, giving the 
title compound as a white solid (1.8 mg,  0.003 mmol, 14%). m/z (HRMS
+
) 714.1414 
[M + H]
+ 
(
159
TbC27H35N5O4P2 requires 714.1418); (HPLC) tR = 4.54 and 4.73 min; λmax 
(H2O) 268 nm; τ(H2O) = 1.26 ms; τ(D2O) = 2.20 ms.  
 
(R)-[Tb.L
35
(OH2)]
+
 
 
An analogous procedure to that described for the synthesis of (S)-[Tb.L
35
(OH2)]
+
 was 
followed, using TbCl3.6H2O (23.0 mg, 0.06 mmol). Purification by preparative HPLC 
yielded the title complex as a white solid (14.6 mg,  0.02 mmol, 37%). Spectroscopic 
characteristics were identical to those observed for the (S) enantiomer. 
 
(4-Bromo-6-(ethoxy(methyl)phosphoryl)pyridine-2-yl)methyl methanesulfonate 
 
 
 
Triethylamine (0.26 mL, 1.85 mmol) was added to a solution of ethyl [4-bromo-6-
(hydroxymethyl)pyridin-2-yl](methyl)phosphinate (181 mg, 0.61 mmol) in anhydrous 
THF (4 mL). The mixture was stirred at 5 
o
C and methanesulfonyl chloride (0.07 mL, 
0.92 mmol) was added. The reaction was monitored by TLC (SiO2, CH2Cl2-CH3OH, 95 
: 5, Rf(product) = 0.38, Rf(reactant) = 0.28) and stopped after 10 min. The solvent was 
removed under reduced pressure and the resulting residue dissolved in dichloromethane 
(20 mL) and washed with saturated sodium chloride solution (2 x 15 mL). Removal of 
the solvent from the organic layer yielded the title compound as a yellow oil, which was 
found to be contaminated with small amounts of ethyl [4-bromo-6-
(chloromethyl)pyridin-2-yl](methyl)phosphinate (SiO2, CH2Cl2-CH3OH, 95 : 5, Rf = 
0.45). The product was used directly in the subsequent alkylation step without further 
purification (171 mg, '0.46 mmol', '75%'). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.38; δH 
(400 MHz, CDCl3) 1.19 (3H, t, 
3
JH-H = 7.0 Hz, OCH2CH3), 1.67 (3H, d, 
2
JH-P = 15.0 Hz, 
PCH3), 3.07 (3H, s, SO2CH3), 3.73 – 4.11 (2H, m, OCH2CH3), 5.26 (2H, s, H
7
), 7.70 
(1H, s, H
5
), 8.08 (1H, dd , 
3
JH-P = 6.0 Hz, 
4
JH-H = 2.0 Hz, H
3); δP (162 MHz, CDCl3) 
+37.2; m/z (HRMS
+
) 371.9666 [M + H]
+ 
(C10H16NO5PS
79
Br requires 371.9670). 
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Triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl) tris 
(methylene) tris (4 - bromopyridine - 6, 2 - diyl) tris (methylphosphinate) 
 
 
 
(S)-2-Benzyl-1,4,7-triazacyclononane (36 mg, 0.16 mmol), 4-bromo-6-
(ethoxy(methyl)phosphoryl)pyridine-2-yl)methyl methanesulfonate (171 mg, '0.46 
mmol'), potassium carbonate (68 mg, 0.49 mmol) and potassium iodide (33 mg, 0.20 
mmol) were stirred in anhydrous acetonitrile (7 mL) at reflux under argon. The reaction 
was monitored by TLC to confirm that all the mesylated starting material had been 
consumed. After 4 h the reaction mixture was allowed to cool to room temperature and 
filtered to facilitate the removal of potassium salts. Removal of the solvent under 
reduced pressure yielded the crude product, which was purified by column 
chromatography on silica gel (gradient elution: CH2Cl2 to 7% CH3OH-CH2Cl2) to give 
the title compound as a yellow oil (49 mg, 0.05 mmol, 29%). Rf (SiO2, CH2Cl2-CH3OH, 
95 : 5) : 0.27; δH (400 MHz, CDCl3) 1.12 – 1.43 (9H, br m, 3 x OCH2CH3), 1.54 – 1.93 
(9H, br m, 3 x PCH3),  2.36 – 4.89 (25 H, br m, ring CH2’s, 3 x OCH2, H
2, 10,
 
14
),  7.07 – 
8.22 (11H, br m, Ar); δP (162 MHz, CDCl3) + 36.1, +37.0, +37.2; m/z (HRMS
+
) 
1045.098 [M + H]
+ 
(C40H55N6O6P3
79
Br3 requires 1045.095). 
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(S)-[Eu.L
39
] 
 
 
Triethyl 6, 6', 6'' - ( (S) - 2 - benzyl - 1, 4, 7 - triazacyclononane - 1, 4, 7 - triyl ) tris 
(methylene) tris (4 - bromopyridine - 6, 2 - diyl) tris (methylphosphinate) (26 mg, 0.025 
mmol) was dissolved in CD3OD (2.4 mL) and a solution of 0.1 M NaOH in D2O (2.2 
mL) was added. The reaction mixture was heated for 5 h at 90 
o
C with stirring. 
Subsequent removal of the solvent under reduced pressure yielded the deprotected 
ligand as a white solid. The product was checked by ESMS and 
31
P NMR spectroscopy 
(δP
 
(162 MHz, CDCl3) +25.9) to confirm complete hydrolysis of the ester groups and 
was used immediately for complexation with europium nitrate.  
 
The ligand was dissolved in H2O : CH3OH (4 : 1, 1.5 mL) and the pH of the solution 
adjusted to 5.5 using dilute HBr(aq). Eu(NO3)3.5H2O (11.5 mg, 0.027 mmol) was added 
and the reaction mixture was heated at 80 
o
C for 16 h. After allowing the reaction 
mixture to cool to room temperature, the pH was raised to 10.0 by the addition of dilute 
NaOH(aq). The resulting solution was stirred for 1 h causing excess Eu
3+
 to precipitate as 
Eu(OH)3, which was removed by filtration. The pH of the resulting solution was 
restored to 5.5 by the addition of dilute HBr(aq) and the solvent lypohilised to give the 
crude product. The crude product was taken in to CH2Cl2 : CH3OH (8 : 2, 2 mL) and the 
solution filtered to facilitate the removal of salts. Subsequent removal of solvent under 
reduced pressure yielded an off-white solid which was further purified by column 
chromatography on silica gel (CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) to give the title 
compound as an off-white solid (21 mg, 0.02 mmol, 76%). Rf (SiO2, CH2Cl2-CH3OH-
NH3, 80 : 20 : 1) : 0.56; δH (400 MHz, CD3OD) -6.46 (1H), -6.03 (1H), -4.54 (1H), -
3.12 (1H), -2.76 (1H), -2.49 (1H), -2.38 (1H), -2.23 (1H), -0.70 (1H), -0.34 (5H), 0.52 
(3H), 1.30 - 1.48 (2H), 1.87 (3H), 2.52 (1H), 2.85 (1H), 4.24 (1H), 4.48 (1H), 6.16 
(1H), 7.16 - 7.52 (7H), 7.89 (2H), 8.51 (1H), 9.23 (1H), 10.87 (1H); δP (162 MHz, 
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CD3OD) 33.5, 40.2, 43.9; m/z (HRMS
+
) 1109.904 [M + H]
+ 
(
151
EuC34H40N6O6P3
79
Br3 
requires 1109.905); (HPLC) tR = 8.21 min; λmax (H2O) 268 nm; τ(H2O) = 1.25 ms; 
τ(D2O) = 1.59 ms.  
 
(S)-[Tb.L
39
] 
 
An analogous procedure to that described for the synthesis of (S)-[Eu.L
39
] was 
followed, using Tb(NO3)3.5H2O (7.4 mg, 0.02 mmol) in the place of Eu(NO3)3.5H2O. 
Purification by silica gel chromatography (CH2Cl2 : CH3OH : NH3, 80 : 20 : 1) yielded 
the title complex as an off-white solid (3.3 mg, 0.003 mmol, 18%). Rf (SiO2, CH2Cl2-
CH3OH-NH3, 80 : 20 : 1) : 0.53; δP (243 MHz, CD3OD) -30.4, 5.6, 50.2; m/z (HRMS
+
) 
1116.905 [M + H]
+ 
(
159
TbC34H40N6O6P3
79
Br3 requires 1116.903); (HPLC) tR = 11.24 
min; λmax (H2O) 268 nm; τ(H2O) = 2.32 ms; τ(D2O) = 2.40 ms.  
 
5.2.3 Chiral quenchers and precursors 
 
(S)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid methyl ester 
 
 
(S)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (200 mg, 0.80 mmol) 
was dissolved in methanol (5 mL) and the solution was acidified using conc. H2SO4(aq). 
The solution was heated at reflux for 4 h, allowed to cool to room temperature and then 
diluted with water (25 mL). The aqueous solution was extracted with ether (3 x 20 mL) 
and the organic extracts were combined and washed with saturated NaHCO3(aq) solution 
(2 x 30 mL) followed by water (2 x 30 mL) before being dried over magnesium sulfate 
and filtered. Removal of the solvent under reduced pressure yielded the title compound 
as a white crystalline solid (164 mg, 0.62 mmol, 78%). m.p. 137–140 oC (lit.202 134.5-
136
 o
C); δH (500 MHz, CDCl3) 1.62 (3H, s, H
2’
), 1.85 – 1.91 (1H, m, H3), 2.07 (3H, s, 
H
5’
), 2.17 (3H, s, H
7’
), 2.20 (3H, s, H
8’’
), 2.42 – 2.47 (1H, m, H3), 2.48 – 2.57 (1H, m, 
H
4
), 2.64 – 2.69 (1H, m, H4), 3.69 (3H, s, OCH3), 4.28 (1H, s, OH); δC (126 MHz, 
CDCl3) 11.5 (1C, C
5’
), 12.1 (1C, C
8’’
), 12.4 (1C, C
7’
), 21.2 (1C, C
4
), 25.7 (1C, C
2’
), 30.9 
(1C, C
3
), 52.6 (1C, OCH3), 79.8 (C
2
), 117.1 (1C, C
4’
), 118.6 (1C, C
5
), 121.5 (1C, C
7
), 
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122.8 (1C, C
8
), 145.5 (1C, C
6
), 145.7 (1C, C
8’
), 174.1 (1C, C=O); m/z (HRMS
+
) 
287.1256 [M + Na]
+
 (C15H20O4Na requires 287.1259). 
 
(R)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid methyl ester 
 
The title compound was prepared using an analogous procedure to that described for  
(S)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid methyl ester. The starting 
material (S)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid was replaced by 
(R)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (200 mg, 0.80 mmol). 
The title compound was isolated as a white crystalline solid (182 mg, 0.69 mmol, 86%). 
Spectroscopic characteristics were identical to those observed for the (S) isomer. 
 
(R)-Tert-butyl 2,2',2''-(2-benzyl-1,4,7-triazacyclononane-1,4,7-triyl)triacetate 
 
 
 
(R)-2-Benzyl-1,4,7-triazacyclononane (90 mg, 0.41 mmol), tert-butyl bromoacetate 
(200 mg, 1.02 mmol) and potassium carbonate (169 mg, 1.23 mmol) were stirred in 
anhydrous acetonitrile (5 mL) at 40 
o
C under argon. The reaction was monitored by 
LCMS to confirm that all the starting material had been consumed. After 30 min, the 
reaction mixture was allowed to cool to room temperature and filtered to facilitate the 
removal of potassium salts. Removal of the solvent under reduced pressure yielded the 
crude product, which was purified by column chromatography on silica gel (gradient 
elution: CH2Cl2 to 5% CH3OH-CH2Cl2) to give the title compound as a colourless oil 
(49 mg, 0.09 mmol, 21%). Rf (SiO2, CH2Cl2-CH3OH, 95 : 5) : 0.46; δH (700 MHz, 
CDCl3) 1.36 (9H, s, 
t
Boc CH3), 1.41 (9H, s, 
t
Boc CH3), 1.42 (9H, s, 
t
Boc CH3), 2.63 - 
2.71 (2H, m, ring CH2's), 2.77 (1H, dd, J = 14.0, 6.5 Hz, H
10
), 2.84 (1H, dd, J = 14.0, 
7.5 Hz, H
10
), 3.08 (2H, d, J = 3.0 Hz, NCH2), 3.17 - 3.54 (10H, br m, ring CH2's, H
2
, ½ 
x NCH2), 3.70 (1H, d, J = 17.5 Hz, ½ x NCH2), 3.81 (1H, d, J = 17.5 Hz, ½ x NCH2), 
4.22 (1H, d, J = 17.5 Hz, ½ x NCH2), 7.18 - 7.22 (3H, m, H
12, 14
), 7.24 - 7.30 (2H, m, 
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H
13
); δC (176 MHz, CDCl3) 27.9 (3C, 
t
Boc CH3), 28.0 (3C,
 t
Boc CH3),  28.1 (3C, 
t
Boc 
CH3), 34.8 (1C, C
10
), 43.7, 46.0, 50.5, 51.4, 51.5 (5C, ring CH2's, C
2
), 53.9 (1C, NCH2), 
54.4 (1C, ring CH2), 55.5 (1C, NCH2), 56.3 (1C, NCH2), 81.6, 82.0, 82.9 (3C, 
t
Boc(q)), 
126.7 (1C, C
14
), 128.8 (2C, C
13
), 129.1 (2C, C
12
), 137.8 (1C, C
11
), 166.4, 168.8, 170.7 
(3C, C=O); m/z (HRMS
+
) 562.3851 [M + H]
+ 
(C31H52N3O6 requires 562.3856). 
 
(R)-[Co.L
37
] 
 
Trifluoroacetic acid (1 mL) was added to a solution of (R)-tert-butyl 2,2',2''-(2-benzyl-
1,4,7-triazacyclononane-1,4,7-triyl)triacetate (142 mg, 0.24 mmol) in dichloromethane 
(0.5 mL). The mixture was left for 16 h at room temperature and was checked by LCMS 
to confirm complete ester hydrolysis. The solvent was removed under reduced pressure 
and the resulting residue re-dissolved in dichloromethane three times to aid the removal 
of excess acid and tert-butyl alcohol.  
 
The ligand was dissolved in water (2 mL) and the pH adjusted to 7.0 by the addition of 
conc. NaOH(aq). The solution was heated to 80 
o
C and CoCl2.6H2O (25 mg, 0.11 mmol) 
was added. Dropwise addition of 30% H2O2 solution (0.36 mL) led to the formation of a 
deep pink solution. The volume of the solution was reduced to approximately 1 mL by 
evaporation, it was then filtered and allowed to cool to room temperature. When the 
solution was left at 5 
o
C for 60 h, pink needle-like crystals precipitated, which were 
recrystallised from hot water (8.0 mg, 0.02 mmol, 16%). m/z (HRMS
+
) 450.1078 [M + 
H]
+ 
(
59
CoC19H25N3O6 requires 450.1075); λmax (H2O) 512 nm (ε = 330 M
-1
 cm
-1
); 
Crystals of the complex were examined by X-Ray crystallography: C19H24N3O6Co, Mr = 
449.34, monoclinic (P21); a = 8.9747(7) Å, b = 7.4776(6) Å, c = 15.0100(12) Å, V = 
962.28(13) Å
3
, Z = 2; µ = 0.864 mm
-1
, Dcalc = 1.551 mg.mm
-3
, T = 120 K; 3721 
independent reflections (Rint = 0.0541), R1 = 0.0693, ωR2 = 0.1772 (I ≥ 2σ(I)). 
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[Co.L
38
]
189 
 
 
1,4,7-Triazacyclononane-1,4,7-triacetic acid (264 mg, 0.87 mmol) was dissolved in 
water (2 mL) and the pH adjusted to 7.0 by the addition of conc. NaOH(aq). The solution 
was heated to 80 
o
C and CoCl2.6H2O (92 mg, 0.38 mmol) was added. Dropwise 
addition of 30% H2O2 solution (1.32 mL) led to the formation of a deep pink solution, 
which was allowed to cool to room temperature. Upon standing at room temperature for 
16 h, pink needle-like crystals precipitated (93 mg, 0.25 mmol, 68%). m/z (HRMS
+
) 
360.0600 [M + H]
+ 
(
59
CoC12H19N3O6 requires 360.0606); λmax (H2O) 512 nm (ε = 300 
M
-1
 cm
-1
). 
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APPENDIX ONE - CRYSTAL DATA 
 
Table A1: Crystal data and structure refinement for (R)-[Co.L
37
]. 
 
Empirical formula  C19H24N3O6Co 
Formula weight  449.34 
Temperature/K  120 
Crystal system  monoclinic 
Space group  P21 
a/Å  8.9747(7) 
b/Å  7.4776(6) 
c/Å  15.0100(12) 
α/°  90.00 
β/°  107.20(3) 
γ/°  90.00 
Volume/Å
3
  962.28(13) 
Z  2 
ρcalcmg/mm
3
  1.551 
m/mm
-1
  0.864 
F(000)  468.0 
Crystal size/mm
3
  0.05 × 0.04 × 0.001 
2Θ range for data collection  2.76 to 53° 
Index ranges  -11 ≤ h ≤ 11, -9 ≤ k ≤ 7, -11 ≤ l ≤ 19 
Reflections collected  6473 
Independent reflections  3721[R(int) = 0.0541] 
Data/restraints/parameters  3721/1/262 
Goodness-of-fit on F
2
  1.081 
Final R indexes [I>=2σ (I)]  R1 = 0.0693, wR2 = 0.1772 
Final R indexes [all data]  R1 = 0.0911, wR2 = 0.1916 
Largest diff. peak/hole / e Å
-3
  1.18/-1.02 
Flack parameter 0.06(4) 
 
